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Abstract
Yin Yang 1 (YY1) is a multifunctional transcription factor that is known mainly
for its ability to activate or initiate transcription of a wide assortment of genes involved in
cellular growth and differentiation.  In this study, Xenopus laevis oocytes and embryos
were used as a model to identify and characterize a potential developmental role for YY1.
Northern and Western blots of oocyte and embryonic extracts showed YY1 mRNA and
protein is expressed from the earliest stages of oocyte development through to tadpole
stages.  Examination of the transcriptional activity of YY1 in both oocytes and embryos
using reporter gene constructs containing YY1-binding elements demonstrated that YY1
does not act as a repressor or activator of transcription either in oocytes or in embryos.
Sub-cellular fractionation of oocytes and Western blot analysis showed YY1 is localized
almost exclusively to the cytoplasm of oocytes and in cells of early embryos.  Sequence
analysis of YY1 revealed that it contains an established RNA binding motif located
within the zinc fingers.  A series of biochemical assays were performed to address the
possibility that YY1 functions as a component of mRNPs in the oocyte cytoplasm.  RNA
gel mobility shift analyses using in vitro synthesized histone H2A transcripts and
supershifts using YY1-specific antibodies suggested that YY1 or YY1-containing
complexes in cytoplasmic extracts were able to bind RNA.  Chromatographic analysis of
oocyte lysates showed YY1 was specifically retained on oligo (dT) cellulose columns.
Treatment of the same lysates with RNase abolished binding to oligo (dT), indicating that
retention is dependent on the presence of intact polyadenylated RNAs.  This suggested
that YY1 may be a component of messenger ribonucleoprotein particles (mRNP).
Separation of oocyte lysates by size exclusion chromatography (SEC) revealed that YY1
was present in large complexes with an approximate molecular mass of 480 kDa.  RNase
or phosphatase treatment of oocyte extracts released YY1 from high mass complexes.
Analysis of phosphatase or RNase-treated extracts for DNA binding activity showed that
monomeric YY1 was able to bind DNA with high affinity. Immunoprecipitation of YY1
complexes followed by cDNA synthesis and sequencing revealed that YY1 is associated
with both ribosomal and messenger RNAs in the cytoplasm of the oocyte.  These results
indicate a novel function for YY1 as a component of messenger ribonucleoprotein
particles.  It is hypothesized that YY1 plays a role in regulating the storage and
metabolism of maternal RNAs in oocytes and embryos.
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11.0  Objectives
Over the last decade, YY1 has been implicated in both activation and
repression of a variety of genes and has been shown to play a role in
development and differentiation.  The vast majority of literature has focused on
its function as a transcriptional activator or repressor. Although several groups
have identified a role for YY1 in developing tissues, little research has been
aimed at defining its role during embryonic development.  The goal of this study
was to characterize and identify the transcriptional activity and developmental
significance of YY1 during oocyte and embryonic development in the Xenopus
laevis model system.  The initial hypothesis was that YY1 controls gene
expression differentially during development through its capacity as a
transcriptional repressor and/or activator.
The expression pattern of YY1 was analyzed by Northern and Western
blot analyses of RNAs and proteins isolated from oocytes and embryos. Gel
mobility shift assays were used to examine the ability of YY1 to bind DNA
during development and the transcriptional activity of YY1 was assessed by
reporter gene expression assays.  Subcellular localization of YY1 was determined
by manual dissections and biochemical fractionation of oocytes and embryos
followed by Western blotting.  The original hypothesis was disproven by data
obtained from the above described experiments.  YY1 was found to be expressed
through development in both oocytes and embryos however it remained in the
cytoplasm and appeared not to play a role in transcriptional regulation.
2Since YY1 contained an RNA binding motif the subsequent hypothesis
was that YY1 could function in the regulation of mRNAs in the cytoplasm.  To
test this, the in vitro and in vivo RNA binding ability of YY1 was determined by
RNA binding assays and Oligo (dT) chromatography.  Size exclusion
chromatography was used to determine the molecular mass of YY1-containing
complexes.  The identity of RNAs associated with YY1 complexes was
determined by immunoprecipitation of YY1 including associated RNAs.  These
RNAs provided templates from which cDNAs were synthesized and
subsequently sequenced.
32.0 YY1
2.1 YY1 Introduction
Yin Yang 1 (YY1), previously identified as FIII, NF-E1, d , F-ACT1,
CF1, and UCRBP, is a member of the GLI-Krupple family of transcription
factors that is capable of functioning as a repressor, activator or initiator element
binding protein depending on its cellular context (reviewed in Shi et al., 1997).
YY1 is a ubiquitously expressed protein that has been shown to regulate a variety
of genes in a number of cell and tissue types.  Structural analyses of mammalian
YY1 have revealed a number of prominent features such as four carboxy
terminal C2H2 zinc fingers and an amino terminal bi-partite transcriptional
activation domain (Shi et al., 1997).  Also distributed throughout the protein are a
number of protein-protein interaction domains which have been shown to
modulate transcription (Austen et al., 1997b; Bushmeyer et al., 1995).  It is a
highly conserved protein, consisting of 414 amino acids in humans and mice and
373 amino acids in Xenopus (Bushmeyer et al., 1995). While Xenopus YY1 is
somewhat smaller, it retains all functional motifs known for the mammalian
protein (Eliassen et al., 1998; Flanagan et al., 1992; Pisaneschi et al., 1994; Seto
et al., 1991).
A study conducted by Berns and  Bohenzky (1987) of the P5 promoter
from the adeno-associated virus (AAV), a defective human parvovirus, was
among the first to uncover the dual modes of YY1 transcriptional activity.  Under
normal circumstances, the P5 promoter is inactive, and binding of the E1A
4oncoprotein to the promoter is required for transcriptional activation (Chang et
al., 1989).  Analysis of the AAV P5 promoter indicated the presence of a cis
element that is responsible for mediating the E1A-induced transcriptional
activation.  In the absence of E1A, the cis element is capable of regulating
repression of basal as well as enhancer-mediated transcription.  YY1 was isolated
on the basis of its ability to bind to the P5 cis element, which was used as an
affinity reagent to isolate a protein with an approximate molecular mass of 68
kDa from HeLa cells (Seto et al., 1991).  Subsequent analysis indicated the
protein was capable of repressing transcription in the absence of E1A, yet was
able to activate transcription in its presence.  The name of the protein was
derived from its dual functionality depending on the cellular context.  Other early
studies identified YY1 as a transcriptional repressor.  For example,  YY1 was
found to bind the upstream conserved region (and thus was referred to as
UCRBP) of the Moloney Murine Leukemia Virus (MuLV) and down-regulated
promoter activity (Flanagan et al., 1992).  YY1 was also found to bind and down-
regulate the immunoglobulin k 3 enhancer (Park and Atchison, 1991).  Also in
early studies, YY1 was identified as a transcriptional activator known as d,
involved with the transcriptional activation of L30 and L32 ribosomal protein
genes in mouse (Hariharan et al., 1991).
YY1 has been shown to influence expression of a number of
developmentally regulated genes in primary tissue culture model systems.  In
differentiating cardiac myoblasts, the expression of dystrophin is controlled by
YY1-promoter interactions (Galvagni et al., 1998).  YY1 was implicated in type
switching of globin genes in mouse embryos from e  (embryonic) to g  (fetal)
5(Gumucio et al., 1993; Peters et al., 1993; Raich et al., 1995; Zhu et al., 1999).
In this case different sets of genes are expressed at different times during
development.  YY1 is a transcriptional repressor shown to bind a cis element
located in the first intron of the a -fetoprotein gene which is expressed in the yolk
sac, visceral endoderm and fetal hepatocytes (Scohy et al., 2000).  YY1 has been
found to influence immune cell differentiation through interactions with the
immunoglobulin k 3 enhancer (Park and Atchison, 1991) the pre-T-cell a
receptor (Reizis and Leder, 1999) and the g  interferon gene (Gilly et al., 1996).
Organ specific gene expression has also been attributed to the transcriptional
activity of YY1 in tissues such as bone (Guo et al., 1997), testes (Schulten et al.,
1999), and liver (Du et al., 1998).  In addition to these examples, YY1 has been
shown to be responsive to perturbations of the endoplasmic reticulum (Li et al.,
1997b; Roy and Lee, 1999), which induced binding of YY1 to promoter elements
of the glucose response proteins (GRPs) (Li et al., 1997b; Roy and Lee, 1999).
Thus, it has emerged that YY1 is a multifunctional transcription factor with a
variety of roles in cell growth and differentiation.
2.2 YY1 structural overview
Mammalian YY1 is a highly conserved 414 amino acid protein with a
predicted molecular mass of 44 kDa (Bushmeyer et al., 1995).  Analysis of YY1
by Western blots in several laboratories, however, indicates that it migrates at 65-
68 kDa, larger than its predicted molecular mass based on the size of the open
reading frame (reviewed in (Galvin and Shi, 1997).  This discrepancy in size has
been attributed to structural anomalies of the protein.  In Xenopus, the amino acid
6Figure 1
Schematic diagram of the Xenopus YY1 protein.  Amino acid positions and N and C-terminal
ends are indicated.  The four C H  type zinc fingers at the C-terminus are indicated.  The approxi-
mate positions of the activation and repression domains are shown below the figure.  The position of
the zinc finger/knuckle is shown above the diagram. Adapted from Shi et al., 1997.
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7sequence of YY1 is very similar to that of the mammalian form, however, it is
somewhat smaller at 373 amino acids (Pisaneschi et al., 1994).  Both mammalian
and Xenopus YY1 contain the major structural elements discussed below (shown
in Figure 1).  The most notable structural elements of YY1 are four C2H2-type
zinc fingers located in the C-terminus of the protein between amino acids 298-
397 of human YY1 (Hariharan et al., 1991).  Deletion analysis has indicated that
all four zinc fingers are required for DNA-binding activity (Austen et al., 1997b;
Bushmeyer et al., 1995).  Progressive carboxyl-terminal deletions have shown
that the activation domains are located toward the amino-terminus (Austen et al.,
1997b; Bushmeyer et al., 1995; Lee et al., 1995b; Lee et al., 1994).  This region
of the protein contains sequences that are able to form an acidic amphipathic
helix (residues 16-29) as well as 11 consecutive acidic residues (43-53), 11
consecutive histidines (70-80) as well as a region that is rich in glutamine and
proline (81-100) (Bushmeyer et al., 1995).  Austen and co-workers (Austen et al.,
1997b) constructed a series of mammalian YY1 deletion mutants and found that
two amino terminal acidic regions (residues 2-62 and 92-153) each contribute
approximately half of the activating potential of the protein.  They also found
that the spacer region located between the two acidic regions was essential for
full activator function however it was not able to function independently as an
activating region (Austen et al., 1997b).  They proposed that the spacer region
may be required for proper folding of the activation domains (Austen et al.,
1997b).
Several groups have found that the repression domain of YY1 is located
towards the carboxy terminus of the protein (Lee et al., 1995b; Lee et al., 1994;
8Seto et al., 1991).  Deletion of residues 397-414 was not sufficient to convert
YY1 from a repressor to an activator (Bushmeyer et al., 1995) when the protein
was expressed in 3T3 cells.  However, deletion of an additional 27 amino acids
to residue 370 was found to convert YY1 to a strong activator (Bushmeyer et al.,
1995).  These deletions demonstrated that residues located between amino acids
370-397 were sufficient to block YY1 activator function.  Further analysis of the
repressor function of YY1 by fusion of residues 201-414 or 333-414 to the GAL4
DNA binding domain resulted in repression of the GAL 4 reporter by the 333-
414 fusion (Bushmeyer et al., 1995).  These results indicate that the repression
domain is located between residues 333-397 (Bushmeyer et al., 1995).  The
identification of separate activation and repression domains clearly indicates that
the protein is multifunctional (Bushmeyer et al., 1995; Lee et al., 1995b; Lee et
al., 1994), however, the actual mechanisms by which its differing transcriptional
activities are modulated are not fully understood.
Austen and co-workers (Austen et al., 1997b) demonstrated that the
second and third zinc fingers are important for nuclear localization of YY1 in
RK13 cells.  Analysis of amino acids in the second and third zinc fingers
revealed the presence of a number of basic amino acids that may function in
nuclear localization (Austen et al., 1997b).  While a conventional NLS is not
present in YY1, protein-interactions may account for nuclear translocation of
YY1.  A yeast two-hybrid screen has demonstrated that YY1 is able to bind the
nucleolar phosphoprotein B23 which is involved in subcellular trafficking and
ribosome assembly (Borer et al., 1989; Busch et al., 1984; Inouye and Seto,
1994; Prestayko et al., 1974; Yung et al., 1985).  Since YY1 is able to bind B23
9(relieving YY1 mediated repression) (Inouye and Seto, 1994), and since B23 is
involved in shuttling between the cytoplasm and the nucleolus, Austen and co-
workers (Austen et al., 1997b) hypothesized that in the absence of a consensus
NLS, B23 may transport YY1 to the nucleolus.  A study conducted in HeLa and
Saos cells demonstrated that a subset of YY1 are co-localized in the nucleolus
with B23 (McNeil et al., 1998).
Mammalian and frog YY1 proteins are highly similar with only 1 amino
acid change found in the last 186 residues (Pisaneschi et al., 1994).  More
substantial differences have been noted in the N-terminus of frog YY1 in which
there is a higher ratio of acidic residues compared to mammalian YY1
(Pisaneschi et al., 1994).  The run of glycines that is present in mammalian YY1
(residues 176-194) is not well conserved and the series of histidines (residues 70-
80) is completely missing in the frog protein (Pisaneschi et al., 1994; Shi et al.,
1997).  Yet another prominent tract of amino acids located between residues 156-
201 of mammalian YY1 is absent from the frog protein (Pisaneschi et al., 1994).
 2.3 Gene structure of YY1
The promoter of YY1 does not contain a recognizable TATA box
(reviewed by Shi et al., 1997), but it contains multiple transcriptional start sites
as well as G+C rich regions and potential Sp1 binding sites (reviewed by Shi et
al., 1997), promoter features that are similar to many housekeeping and growth-
regulated genes.  The mammalian gene has been found to contain 5 exons that
encode the full length 414 amino acid protein (Safrany and Perry, 1993).  The
majority of the protein is encoded within the first exon including the region
10
containing the acidic and histidine rich regions.  The four zinc fingers are
encoded on three different exons (Safrany and Perry, 1993).  The intronic
separation of the zinc fingers is not unprecendented, and it is unclear whether this
is significant or imparts any regulatory advantage.
2.4 Transcriptional regulation by YY1
YY1 consensus sequences were identified using bacterially expressed
YY1 in conjunction with the PCR based binding site selection technique (Hyde-
DeRuyscher et al., 1995).  The currently accepted consensus sequence is 5’-
(G/c/a)(G/t)(C/t/a)-CAT(X)(T/a)(T/g/c)-3’ (the upper case indicates preferred
nucleotides), (Hyde-DeRuyscher et al., 1995).
2.4.1 YY1 mediated repression.
The transcriptional function of YY1 as a activator or repressor is thought
to be controlled either by a variety of factors in different cellular contexts
including relative YY1 concentration (Bushmeyer et al., 1995), the presence of
specific cellular proteins (Bauknecht et al., 1996; Inouye and Seto, 1994; Lee et
al., 1995a; Shrivastava et al., 1993; Yang et al., 1995) or the promoter sequences
surrounding YY1 binding sites (Shrivastava and Calame, 1994).
Several models have been proposed to explain YY1-mediated repression
including displacement, interference and interactions with co-regulators
(reviewed by Thomas and Seto 1999; Shi et al., 1997).  The displacement model
is based on displacement of transcriptional activators by YY1.  For example,
overlapping binding sites have been observed for YY1 and serum response factor
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(SRF, a 67 kDa phosphoprotein) on the c-fos serum response element (SRE)
(Gualberto et al., 1992; Natesan and Gilman, 1995), and the skeletal and smooth
muscle a -actin muscle regulatory elements (MRE) (Bushel et al., 1995;
Gualberto et al., 1992; Lee et al., 1992; MacLellan et al., 1994) as well as the
muscle creatine kinase CArG motif (Vincent et al., 1993).  An example of this is
the competition for binding on the a -actin promoter MRE which is important for
muscle differentiation (Lee et al., 1992).  During myoblast differentiation to
myotubules in culture, the levels of YY1 decrease while those of SRF are
observed to increase (Lee et al., 1992).  Myoblasts treated with BrdU (a
nucleotide analog that inhibits myoblast differentiation) expressed high levels of
YY1 and low levels of SRF suggesting a correlation between relative levels of
these factors and muscle differentiation (Lee et al., 1992).
The significance of YY1 binding to the SRE of c-fos however is unclear.
The c- fos SRE shares homology with the MRE of the a -actin promoter (Walsh,
1989).  While YY1 and SRF have similar affinities for the a -actin SRE (Lee et
al., 1992), Gualberto and co-workers (Gualberto et al., 1992) have shown in vitro
that SRF has a much higher affinity for the c-fos SRE than does YY1.
Furthermore, in vivo footprinting analysis has shown that both YY1 and SRF co-
occupy the SRE (Natesan and Gilman, 1995).  YY1 has been shown to repress
the serum amyloid A1 (SAA1) promoter which responds to acute inflammation
with a 200 fold increase in expression of SAA1 (Lu et al., 1994).  Located within
the promoter is a cytokine response unit (CRU) to which NF-k B and C/EBP bind
(Lu et al., 1994) both having a synergistic effect on SAA1 transcription.
Methylation interference studies indicate that YY1 binds within the CRU,
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overlapping the binding sites for both NF-k B and C/EBP  (Lu et al., 1994).  Gel
mobility shift assays showed that NF- k  B binding to the CRU was inhibited by
YY1 (Lu et al., 1994).  The inhibition of NF-k  B binding to the CRU resulted in
lowered SAA1 expression (Lu et al., 1994).   When the binding site for YY1 in
the CRU was disrupted, basal as well as serum induced expression of the SAA1
promoter was elevated (Lu et al., 1994).
Interference of activators may repress transcription by YY1.  The g
interferon promoter (IFN-g ) has been shown to be repressed by YY1 (Ye et al.,
1994).  A search of the IFN- g promoter for consensus YY1 binding sites revealed
that three YY1 binding sites (Y1, Y2, and Y3) are present in the promoter (Ye et
al., 1996; Ye et al., 1994).  Gel mobility shift assays demonstrated that YY1 was
able to bind two of these sites with high affinity (Ye et al., 1996).  One of the
YY1 binding sites (Y3) overlaps an AP-1 site.  Both YY1 and AP-1 were found
to compete for binding to their respective elements (Ye et al., 1996).  Repression
of the IFN- g promoter was observed when YY1 alone was bound (Ye et al.,
1996).  Binding of YY1 to the Y2 binding element was found to repress
expression only when an AP-2-like protein was present adjacent to YY1 (Ye et
al., 1996).  Both YY1 and the AP-2 like protein are able to bind the IFN-
g promoter separately, however, repression of the promoter was seen only when
both proteins were present (Ye et al., 1996).
The c-fos promoter contains two additional YY1 binding sites (in addition
to the one discussed above in the SRE) located between the cAMP responsive
element (CRE) and the TATA box (Zhou et al., 1995a).  E1A activation of c-fos
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is mediated by a 22bp E1A response element (ERE which is made of a CRE and
a neighboring YY1 binding site (Zhou et al., 1995b).  Both YY1, which represses
transcription, and members of the ATF/CREB family, which activate
transcription are capable of binding to the ERE (Berkowitz et al., 1989; Lee and
Lee, 1994; Natesan and Gilman, 1993; Zhou et al., 1995a).  Zhou and co-workers
(Zhou and Engel, 1995) have shown both in vivo and in vitro that YY1 can
physically interact with ATF/CREB members.  The interaction between YY1 and
the ATF/CREB members has been proposed to be responsible for the ability of
YY1 to repress transcription from the c-fos promoter (Natesan and Gilman, 1993;
Zhou et al., 1995).  The importance of the YY1/CREB interaction in c-fos
repression is further illustrated by the ability of adenovirus E1A to relieve YY1
mediated repression and to disrupt the YY1/CREB interaction in vitro (Zhou and
Engel, 1995).
The fact that proteins interacting with YY1 bind in one or both of the
repression domains suggests quenching as a possible explanation for alleviation
of YY1-mediated repression.  Galvin and co-workers have investigated this
possibility and found that YY1 mediated repression is activator specific (Galvin
and Shi, 1997).  Data from this study also showed that binding of Sp1 or CREB
is not required for repression.  They suggested that in this case, YY1 is
interacting with the targets of the activators instead of binding CREB or Sp1
(Galvin and Shi, 1997).
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2.4.2 Protein-protein interactions
Repression by YY1 may be accomplished through interactions with co-
regulators.  p300 which has been shown to bind both YY1 and CREB, may be
essential for YY1 repressor activity (Lee et al., 1995a; Lundblad et al., 1995).
p300, originally described as an adenovirus E1A-associated protein (Harlow et
al., 1986; Yee and Branton, 1985) has been identified as a transcriptional co-
activator that is related to, and functionally interchangeable with the CREB-
binding protein, CBP (Arany et al., 1995; Chrivia et al., 1993; Eckner et al.,
1994; Kwok et al., 1994; Lundblad et al., 1995).  E1A mediated repression by
YY1 has been shown to require p300 which appears to function as an adaptor
protein between E1A and YY1.
The activity of the YY1 binding site in the c-fos promoter is orientation
dependent, and it has been proposed that YY1 mediates c-fos transcription by
bending DNA and modulation of interactions with other proteins such as CREB
and the general transcriptional machinery (Natesan and Gilman, 1993).  This
model relied on orientation specific binding of YY1 to the promoter the result of
which is bending of the DNA in a particular direction.  The DNA bending model
of YY1-ediated repression is challenged by a study that identified YY1 binding
sites by PCR assisted site selection.  The YY1 sites were tested for their ability to
regulate transcription of a synthetic promoter (Hyde-DeRuyscher et al., 1995).
These experiments showed that all of the YY1 binding sequences were capable
of repressing the promoter regardless of orientation (Hyde-DeRuyscher et al.,
1995).  Also arguing against the DNA bending model is a study in which the co-
crystal structure of the zinc fingers of YY1 binding to the AAV P5 promoter was
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analyzed.  The results of these experiments did not indicate that YY1 was
capable of inducing DNA bending (Houbaviy et al., 1996).  However it is also
possible that YY1 is only capable of bending DNA when it is bound to certain
recognition sites.
2.4.3 Repression via recruitment of co-repressors
YY1 has been shown to bind p300, (an acetyltransferase) which also
binds another acetyltransferase, PCAF(p300 CBP associated factor) (Austen et
al., 1997b; Lee et al., 1995a; Yang et al., 1996).  Acetylation is known to regulate
a number of transcription factors such as p53 (Gu and Roeder, 1997), GATA-1
(Boyes et al., 1998; Hung et al., 1999), E2F (Martinez-Balbas et al., 2000;
Marzio et al., 2000), MyoD (Sartorelli et al., 1999), human immunodeficiency
virus Tat (Kiernan et al., 1999), E1A (Donohoe et al., 1999), TFIIE, TFIIF
(Imhof et al., 1997) and HNF-4 (Soutoglou et al., 2000).  A recent analysis of the
amino acid sequence of YY1 revealed several lysine residues that may act as
potential acetylation substrates (Yao et al., 2001).  To test for acetylation of YY1,
several deletions were constructed and in vitro acetylation reactions were
performed on the deletions using GST-tagged bacterially produced p300 and
PCAF (Yao et al., 2001).  Two regions of YY1 were shown to be acetylated.
The first region lies between amino acids 170-200 and was acetylated by p300 as
well as PCAF (Yao et al., 2001).  The second region, the C-terminal zinc fingers
were acetylated only be PCAF (Yao et al., 2001).
Acetylation of these regions produced significantly different functional
effects in vivo.  When residues 170-200 were acetylated, YY1 became a more
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effective transcriptional repressor in HeLa cells (Yao et al., 2001).  Additionally,
acetylation of these residues resulted in YY1 binding to histone deacetylases
(HDAC) which had the dual effect of histone H4 deacetylation and subsequent
deacetylation of YY1 (Yao et al., 2001).
The link between YY1 and histone acetylation is interesting for its global
control of transcription.  Histone acetylation is associated with activated genes
(Hebbes et al., 1988; Sealy and Chalkley, 1978; Vidali et al., 1978).  The
addition of acetyl groups to the lysine residues of the histones permits access of
transcription factors to the DNA by disrupting the packaging of the chromatin.
This outcome is caused by the neutralizing effect of acetyl groups on the positive
charge of the histones, which reduces their affinity for DNA (Hong et al., 1993).
Conversely, deacetylation increases histone affinity for DNA and reduces access
of transcription factors.  Thus it is possible that acetylation of YY1 and the
resulting association with histone deacetylases confers a histone H4 deacetylase
activity to YY1 and promotes repressor activity by YY1 by virtue of packaging
of the DNA such that transcription factors cannot access the (Yao et al., 2001).
Adding to the complexity of YY1 regulation, acetylation of the zinc
finger domain was demonstrated to decrease DNA binding activity (Yao et al.,
2001).  In situations were YY1 functions primarily as a repressor, acetylation of
residues 170-200 and the zinc finger domain creates a network of negative
feedback (Yao et al., 2001).  While acetylation of residues 170-200 increases
repressor potential through deacetylation of histone H4, it also results in the
deacetylation of YY1 itself and thus its histone H4 deacetylation activity.
Acetylation of the zinc fingers appears to have the dual effect of stabilizing the
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interaction between YY1 and the histone deacetylases (presumably maintaining
the packaged chromatin), and decreasing DNA binding activity of YY1.  This
results in YY1-mediated repression by two modes, YY1 in this state has a lower
DNA binding affinity, and stabilization of the HDAC activity ensures tighter
association of histones, thus impeding access of transcription factors (Yao et al.,
2001).
2.4.4  Transcriptional repression of YY1 via Poly(ADP-Ribosylation)
YY1 has been shown to physically interact with the poly(ADP-ribose)
polymerase (PARP-1) (Griesenbeck et al., 1999; Oei et al., 1997; Oei et al.,
1998) an enzyme involved in the regulation of several nuclear processes
including DNA repair, replication, recombination, transcription and apoptosis
(D'Amours et al., 2001; Dantzer et al., 2000; Oei et al., 1997).  PARP-1 has been
shown to induce poly(ADP) ribosylation of YY1 which interferes with its ability
to bind its recognition sequence (Oei et al., 1998).  Oei and Shi, ( 2001) showed
that DNA damage induced poly(ADP) ribosylation of YY1 and brought about
repression of its DNA binding activity.  This provides evidence for a mechanism
by which the cell is able to recognize DNA damage and cease transcription until
the lesion(s) are repaired.
2.5 YY1-mediated transcriptional activation
YY1 has been shown to activate a wide variety of genes including c-myc
(Shrivastava et al., 1996) HMG-CoA reductase (Gauthier et al., 1999), cardiac a -
actin (Chen and Schwartz, 1997), INFg  (Gilly et al., 1996) histones (Eliassen et
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al., 1998; Wu and Lee, 2001), p53 (Furlong et al., 1996), myelin PLP (Berndt et
al., 2001), AAV P5  promoter (Seto et al., 1991), ribosomal proteins rpL30 and
rpL32 (Hariharan et al., 1989), rpL14, rpL1 (Pisaneschi et al., 1994), ST5 (Lichy
et al., 1996), Surf-1 (Vernon et al., 2000; Cole et al., 1997; Gaston et al., 1995),
Surf-2 (Gaston and Fried, 1994; Gaston and Fried, 1995), gp91phox (Jacobsen and
Skalnik, 1999), Col1a1 (Riquet et al., 2001), proacrosin (Schulten et al., 1999),
g Globin (Yant et al., 1995), ribonucleotide reductase R1 (Johansson et al., 1998),
DR- a  (Hehlgans and Strominger, 1995), uterglobin (Klug and Beato, 1996),
osteocalcin, (Guo et al., 1997), grp78 (Li et al., 1997b) and a -1 acid glycoprotein
(Lee and Lee, 1994).
The mechanisms by which YY1 is able to activate transcription are not
fully understood. but several models of YY1 mediated activation have been
proposed (reviewed by Thomas and Seto, 1999).  YY1 may interact directly with
general transcription factors in the pre-initiation complex to initiate transcription.
YY1 contains two N-terminal acidic activation domains, and has been shown to
interact with general transcription factors TBP, TFIIB and TAFII55 (Austen et
al., 1997b; Chiang and Roeder, 1995; Usheva and Shenk, 1994).  Inhibition of
repressor domains and unmasking of the activator domains may be involved.
Two groups (Lee et al., 1995b; McNeil et al., 1998) suggested that the N-
terminal activation domains of YY1 are masked and may be exposed through
interactions with an unknown factor.  Structural and functional mapping has
suggested that the extreme C-terminal region of YY1 may regulate
transcriptional activation through interactions with the N-terminal activator
domain (Austen et al., 1997b; Bushmeyer and Atchison, 1998; Lee et al., 1995b).
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The only protein thus far demonstrated to interact with an activator
domain of YY1 is E1A, however it is also capable of interactions with the C-
terminal domain (Lee et al., 1995b; Lewis et al., 1995).  To accomplish this it is
possible that E1A binds the repression domain to block it while exposing the
activation domain (reviewed in Thomas and Seto, 1999).
YY1 may require co-activators to elicit a response on particular
promoters (Thomas and Seto, 1999).  This model has gained validity through the
findings that YY1 is able to interact with p300 and CBP (Austen et al., 1997b;
Lee et al., 1995a).  Both of these proteins are known to have histone
acetyltransferase activity and are known to function as co-activators in other
model systems (Boyes et al., 1998; Goldman et al., 1997; Kwok et al., 1994; Lee
et al., 1995a; Ogryzko et al., 1996; Yuan et al., 1996; Zhang and Bieker, 1998).
p300 and CBP are closely related in sequence and function (Goldman et al.,
1997) and have been shown to interact with a wide variety of DNA-binding
proteins such as, CREB, E1A, Jun, Fos, and TBP where they function as co-
activators (Bannister et al., 1995; Facchinetti et al., 1997; Goldman et al., 1997;
Kwok et al., 1994; Lee et al., 1995a; Lundblad et al., 1995; Sartorelli et al., 1999;
Swope et al., 1996; Yuan et al., 1996).  It is possible that recruitment of p300 by
YY1 causes relaxation of chromatin conformation (through histone acetylation)
and promotes transcription factor access to the promoter.  While it is clear that
YY1 is able to activate a number of promoters, the exact role of p300/CBP or
how YY1 is able to gain access to DNA in areas where the chromatin is
condensed in not understood (Thomas and Seto, 1999).
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2.6 YY1 activity as an initiator element binding protein
YY1 has been found to direct and initiate transcription in vitro through
binding to initiator elements (Inr) (Smale and Baltimore, 1989).  The first data
indicating that YY1 binds an initiator sequence was gathered from analyses of
the AAV P5 promoter (Seto et al., 1991).  The initiator function at this site was
shown in vitro, and further experiments demonstrated that YY1 binding to the
AAV P5 promoter was crucial for transcription, since HeLa cells depleted of
YY1 no longer were transcriptionally competent (Seto et al., 1991).  Mechanisms
controlling the Inr binding activity of YY1 have not been fully elucidated.  It is
possible that YY1 functions similar to TBP with regard to the recruitment of
RNA polymerases to the initiation site (reviewed by Shi et al., 1997).  Studies of
YY1 initiator function in a reconstituted in vitro system using purified proteins
demonstrated that YY1, TFIIB and RNA polymerase II were sufficient to direct
basal transcription from a supercoiled plasmid template (Usheva and Shenk,
1994).  YY1 has been shown to physically interact with TFIIB and the large
subunit of RNA polymerase II both in vivo and in vitro (Houbaviy et al., 1996).
Further, strand separation of the AAV promoter resulted in transcriptional
activation by YY1 from single stranded DNA, indicating that YY1 is able to
operate in a manner similar to TBP in vitro (Houbaviy et al., 1996).
2.7 Interactions between YY1 and cellular proteins
A large number of proteins have been documented to interact with YY1;
the majority of these are co-activators/co-repressors or transcription factors that
are essential in regulating a variety of promoters.  As well, YY1 has been found
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to interact with components of the nuclear matrix which may function to direct
YY1 to certain locations within the nucleus (Bushmeyer and Atchison, 1998).
In general there are two general domains at which protein-protein
interactions are known to occur: residues 150-200 including the repression
domain (Thomas and Seto, 1999), and the C-terminal region and including the
four zinc fingers as well as the second repression domain.   A number of proteins
such as the polycomb group protein EED, TBP, CBP/p300, TFIIB, E1A as well
as c-Myc have been found to interact with both domains (Austen et al., 1997a;
Galvin and Shi, 1997; Lee et al., 1995a; Lewis et al., 1995; Satijn et al., 2001;
Shrivastava et al., 1993).  Proteins such as histone deacetylase 2 (HDAC2), Sp1,
and ATF/CREB have been shown to bind only the C-terminal domain (Galvin
and Shi, 1997; Lee et al., 1995a; Seto et al., 1993; Yang et al., 1996).  Recently
pRb has been shown to interact with YY1 however the interaction domain(s)
have not yet been identified (Petkova et al., 2001).  Thus, a wide variety of
proteins can interact with YY1, expanding the regulatory potential of this protein.
2.8 Interactions between YY1 and viral promoters
YY1 is a transcriptional regulator of herpesvirus (Chen et al., 1992),
papillomaviruses (Bauknecht et al., 1992; Pajunk et al., 1997), polyomaviruses
(Martelli et al., 1996), adenoviruses (Zock et al., 1993), parvoviruses (Momoeda
et al., 1994; Seto et al., 1991) and retroviruses (Knossl et al., 1999; Mobley and
Sealy, 1998).  As discussed previously, one of the first promoters in which YY1
was observed to have translational activity was P5 from the adeno-associated
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virus (Seto et al., 1991).  Under normal circumstances, the promoter is
transcriptonally silent, but is activated in the presence of the E1A oncoprotein
(Chang et al., 1989).  In the absence of E1A, binding of YY1 to its cis element
was able to repress transcription. YY1 which is a repressor of the P5 promoter,
was revealed to bind E1A and in this context it was able to activate transcription
(Seto et al., 1991).    YY1 has also been found to bind to the upstream conserved
region of the Moloney Murine Leukemia Virus (MuLV) which down-regulates
the MuLV promoter activity (Flanagan et al., 1992).
The gene regulatory role of YY1 in different viruses has important
implications.  Park and colleagues (Park et al., 1999) have shown that a point
mutation in the YY1 binding site of the p97 gene promoter of HPV-16 virus is
present in 78% of the neoplasms they examined.  This mutation leads to a loss of
E2 gene expression which subsequently up-regulates the E6 and E7 genes (Park
et al., 1999).  The protein products of E6 and E7 are required for integration of
episomal HPV DNA into chromosomal DNA.  Thus YY1 plays an important role
in viral recombination.
Moriuchi and co-workers (Moriuchi et al., 1999) have shown that YY1
influences the invasiveness of HIV.  A number of cellular factors have been
demonstrated to directly reduce HIV expression at the promoter level, among
them is YY1.  For HIV-1 invasiveness, the CD4 molecule is required as well as a
fusion/entry co-factor (Margolis et al., 1994; Romerio et al., 1997).  Chemokine
receptors serve as the fusion/entry co-factors among which CXCR4, a receptor
for CXC chemokine stromal-derived factor-1 (SDF-1), is a major co-factor for T-
cell tropic HIV-1 (Bleul et al., 1996; Oberlin et al., 1996).  The association of
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YY1 and c-myc has been shown to mediate activity of the CXCR-4 promoter.
Up-regulation of the promoter is influenced by c-myc, while YY1 is able to
repress promoter activity.  Under normal circumstances, YY1 represses
expression of CXCR-4 thereby inhibiting invasiveness.  However mutation in the
YY1 binding site results in a loss of the repressor activity of YY1 which
facilitates HIV-1 invasiveness (Moriuchi et al., 1999).
YY1 is the first known cellular protein found to interact with the vaccinia
virus late promoter (Zhu et al., 1998; Zhu et al., 1999).  Vaccinia virus is the best
studied member of the poxvirus family whose members characteristically have
large genomes and replicate in the cytoplasmic compartment of infected cells.
Zhu and co-workers (1998) initially identified an unknown cellular protein that
was capable of vaccinia virus promoter binding activity.  Initial data indicated
that the protein was able to bind the promoter at the transcriptional start site and
was capable of stimulating transcription in vitro.  YY1 was identified as the
promoter binding protein through promoter binding analysis and SDS-PAGE
(Broyles et al., 1999).  Mutation of the promoter abolished YY1 binding
implicating it as a possible regulator of vaccinia virus late gene transcription
(Broyles et al., 1999).  An interesting aspect of vaccinia infection that is pertinent
to the data presented later in this thesis is that vaccinia replicates in the
cytoplasm.  Prior to infection, YY1 is located exclusively in the nucleus.
Immunofluoresence analysis of vaccinia infected BSC-40 cells indicate that
following infection, YY1 is localized to the cytoplasm within the virosomes
(Broyles et al., 1999).  The mechanism regulating the translocation of YY1 was
not identified, and analysis of other transcription factors did not reveal
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cytoplasmic translocation suggesting that YY1 was specifically redistributed to
the cytoplasm (Broyles et al., 1999).
2.9 Developmental function of YY1
The vast majority of research aimed at deducing the function of YY1 has
been carried out in tissue culture model systems.  Donohoe and co-workers
(Donohoe et al., 1999), were the first to examine the in vivo function of YY1
during early development by creating YY1 knockouts in mice and demonstrating
an essential role for YY1 in vertebrate development.  Embryos (at the blastocyst
stage) found to be YY1-/- implanted into uterine tissue but failed to develop to the
gastrulation stage thus knockout of YY1 resulted in embryonic death around the
time of implantation (Donohoe et al., 1999).  Blastocysts that were YY1-/+
survived but displayed a variety of defects such as lowered implantation
efficiency, neurulation defects, and exencephaly (Donohoe et al., 1999)
demonstrating a requirement for both alleles of YY1 for proper development.
Donohoe and co-workers analyzed the nuclear/cytoplasmic distribution of
YY1 in the mouse.  They showed that YY1 is localized to the cytoplasm of
mouse oocytes and remains in this cellular location until the 2-cell stage, at
which time zygotic transcription is initiated.  At stage E3.5, YY1 is present in the
nucleus and cytoplasm of blastocysts as well as the inner cell mass and the
trophectoderm of the developing embryos.
Examination of YY1 expression patterns in heterozygous embryos
demonstrated that it may be required for later differentiation of mouse tissues
(Donohoe et al., 1999).  YY1 was found to be highly expressed in somite, tail,
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limb bud and ectoplacental cone (Donohoe et al., 1999).  While Donohoe and co-
workers were able to demonstrate a requirement for YY1 during mouse
development, they did not determine its transcriptional activity during
development.
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3.0 Messenger Ribonucleoprotein Particles
 Overview
During oogenesis, which may take up to two years in the frog, a vast
supply of 2x1011 mRNAs and ~1012 ribosomes are synthesized (Davidson et al.,
1982).  This pool of mRNAs and ribosomes are necessary to supply the
developing embryo with new templates for protein synthesis during early
embryonic development until zygotic transcription is initiated at the midblastula
transition (MBT), approximately 12 hours post-fertilization (Davidson, 1986).
During early oogenesis, less than 2% of poly(A)+ RNA is assembled in
polysomes, this amount increases to 20% by stage VI (Smith, 1985).  The
remaining poly(A)+ RNA is maintained in a stable untranslated state during this
period of development by associating with a specific set of masking proteins in
early stage oocytes, which form messenger ribonucleoprotein particles (mRNP)
(Smith, 1985; Sommerville, 1990; Spirin, 1966).  Packaging of the mRNAs into
these particles serves an important function, which is to maintain the RNA in a
stable and untranslated state until they are required by the developing embryo for
new protein synthesis.
3.1 Messenger RNA binding motifs
Thus far a small number of motifs have been described for proteins that
bind RNA in the cytoplasm (reviewed by Burd and Dreyfuss, 1994; Cusack,
1999).  Although the current knowledge of RNA binding motifs is limited,
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structural similarities among different motifs exist.  RNA-binding proteins are
characteristically modular in structure consisting of defined RNA binding
motif(s) as well as auxiliary domains that are able to perform additional functions
(Cusack, 1995; Nagai et al., 1996).
3.1.1  RNA Recognition Motif (RRM)
The most common and best characterized RNA binding domain is the
RNP domain which is also referred to as the RNA recognition motif (RRM)
(Kenan et al., 1991; Query et al., 1989).  This motif, first described in the yeast
polyadenylate-binding protein, consists of approximately 90-100 amino acids
which form the core of the RNA binding domain (Burd and Dreyfuss, 1994a;
Mattaj, 1993; Nagai et al., 1995).  This motif has been discovered in over 200
proteins such as hnRNP A1 and hnRNP C1/C2 (Dreyfuss et al., 1993), CStF
(Takagaki and Manley, 1997), Drb1 (Tamada et al., 2002), U2AF (Kellenberger
et al., 2002), TIAR and TIA-1 (Li et al., 2002) that are involved with pre-
mRNAs, mRNA, small nuclear RNA (snRNA), pre-ribosomal RNAs ribosomal
RNAs (rRNA) and viral RNAs (Bandziulis et al., 1989; Birney et al., 1993;
Nagai et al., 1990).  This motif is highly conserved amongst animal, plant,
fungal, and bacterial proteins suggesting an evolutionary importance in the
regulation of RNA (Kenan et al., 1991; Mattaj, 1993).
Characteristic among RRM containing proteins is the RNP consensus
sequence (RNP-CS) which is composed of two short regions, RNP1 and RNP2 as
well as a number of other predominantly hydrophobic amino acids spread
throughout the motif (Bandziulis et al., 1989; Dreyfuss et al., 1988a; Kenan et al.,
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1991; Swanson et al., 1987).  Some RRM containing RNA-binding proteins lack
conserved RNP1 and RNP2 domains, however they contain other well conserved
essential residues producing an overall domain framework that is sufficiently
similar to the RNP1 and 2 that they retain their function (Birney et al., 1993;
Dreyfuss et al., 1988b; Kenan et al., 1991).   Structurally the RNP domain
consists of a four-stranded antiparallel b  sheet flanked on one of its sides by two
a  helices (Garrett et al., 1994; Gorlach et al., 1992; Hoffman et al., 1991; Lu and
Hall, 1995; MacLellan et al., 1994; Nagai et al., 1990)  The RNP1 and RNP2
motifs, located in the two middle b  sheets are responsible for direct contact with
RNA (Burd and Dreyfuss, 1994).
A subset of RRM-containing proteins are able to bind different RNA
sequences simultaneously (Dreyfuss et al., 1988a; Swanson et al., 1987).  When
RNA is bound to the RRP motif, there is little change in the shape of the protein
and the RNA is left relatively exposed making it accessible for interaction with
other RNAs or RNA binding proteins (Gorlach et al., 1992).  This permits the
possibility of complimentary nucleic acid annealing, an activity that can change
RNA structure in a manner similar to protein folding by chaperones (Krainer et
al., 1990; Kumar and Wilson, 1990; Munroe and Dong, 1992; Pontius and Berg,
1990; Portman and Dreyfuss, 1994).
3.1.2 RGG Motif
The RGG RNA binding domain is a 20-25 amino acid long motif that
appears to bind RNA non-specifically and is typically found in proteins that
contain other RNA binding domains (Kiledjian and Dreyfuss, 1992).
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Structurally, the motif contains closely spaced Arg-Gly-Gly (RGG) repeats that
are interspersed with other predominantly aromatic amino acids (Burd and
Dreyfuss, 1994a).  This domain was first identified in hnRNP U which is
involved in mRNA biogenesis and is able to bind both RNA and ssDNA
(Kiledjian and Dreyfuss, 1992), and has since been identified in Nucleolin
(Dreyfuss et al., 1993).  The number of RGG repeats required for RNA binding
varies, from six repeats in hnRNP A1 to eighteen repeats in the yeast protein
GAR1 (Girard et al., 1994).
3.1.3 K-homology (KH) RNA binding domain
The K homology (KH) domain is a motif common among a number of
diverse RNA binding proteins (reviewed by Nagai, 1996).  First identified in
hnRNP K (Siomi et al., 1993), this domain is present in proteins such as
ribosomal S3 (Gibson et al., 1993; Siomi et al., 1993), Mer1p, (Engebrecht and
Roeder, 1990), FMRP (Ceman et al., 1999; Reyniers et al., 1996), NusA (Gibson
et al., 1993),  QK1 (Chen and Richard, 1998), Xqua (Zorn et al., 1997) and
NOVA (Buckanovich et al., 1993; Ramos et al., 2002) is able to directly bind
RNA.  Mutation of conserved residues within the domain has been shown to
abolish binding to single stranded RNAs (Siomi et al., 1993).  Reminiscent of
other RNA binding motifs, the KH domain is found alone or in multiple copies or
in conjunction with other RNA binding motifs (Ceman et al., 1999 ; Dreyfuss et
al., 1993; Gibson et al., 1993; Siomi et al., 1993).  The presence of KH domains
in a number of diverse organisms suggests that it is an evolutionarily conserved
motif with essential cellular functions.  For example, a link between human
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cognitive function and RNA binding proteins was established by the finding that
mutation of the FMR-1 gene whose protein product is FMRP (which contains an
RGG domain as well as the KH motif) is responsible for fragile X mental
retardation, the most common form of hereditary retardation in males (Eberhart
et al., 1996).  FMRP has been found to bind its own RNA as well as a subset of
brain mRNAs (Ashley et al., 1993; Brown et al., 1988; Siomi et al., 1993; Ceman
et al., 1999).  As well, FMRP in mRNP complexes has been observed to
associate with ribosomes in an RNA-dependent manner (Eberhart et al., 1996,
Tamanini et al., 1996, Ceman et al., 1999).  The exact mechanism by which
FRMP mutation results in mental retardation is not fully understood.
3.1.4 Double stranded RNA binding domain
The double stranded RNA binding domain (dsRBD) is a short sequence
motif of approximately 65 amino acid residues (Gibson et al., 1994; St. Johnston
et al., 1992) that is found in proteins involved in RNA processing, localization,
maturation and most recently post-transcriptional gene silencing (Green and
Mathews, 1992; Grishok et al., 2001; Knight and Bass, 2001; Nicholson and
Nicholson, 2002; St Johnston et al., 1992).   This motif, first discovered in the
Drosophila protein Staufen is found either in single or multiple copies, and has
since been described in a number of eukaryotic and prokaryotic proteins such as;
Xlrbpa (Hitti et al., 1998; Eckmann, et al., 1997), hsTRBP (Cosentino et al.,
1995), ADAR1 (Brooks et al., 1998), and Xenopus RNA binding protein A
(Krovat and Jantsch, 1996).
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Staufen plays a critical role in the anterior-posterior axis determination in
Drosophila and was the first protein deemed to be essential for mRNA
localization within the developing embryo (St. Johnston, 1995).  Staufen
associates with two sets of mRNAs that are the axial regulators of the embryo.
During oogenesis, Staufen binds oskar mRNA and transports it to the posterior
pole of the oocyte an event that demarcates the location of the abdomen and
future germline (Ephrussi et al., 1991; Kim-Ha et al., 1995; St Johnston et al.,
1991).  Once the egg has been laid, Staufen accumulates at the anterior pole
where it anchors bicoid mRNA, which is the anterior determinant of the embryo
(Ferrandon et al., 1994; St Johnston et al., 1989).  As well, Staufen plays a role in
mRNA relocation in somatic cells.  During the asymmetric cell divisions of the
embryonic neuroblasts, Staufen associates with prospero mRNA and mediates its
segregation into the apical crescent of neuroblasts (Broadus et al., 1998; Li et al.,
1997a; Schuldt et al., 1998).
The mammalian form of Staufen contains 4 dsRBDs, only one of which
(dsRBD3) is able to bind RNA with high affininity, although dsRBD4 was
shown to have weak RNA binding activity (Wickham et al., 1999).
Additionally, Staufen was shown to bind tubulin in vitro (Wickham et al., 1999).
Examination of Staufen distribution in neurons and fibroblasts showed that it co-
localized with markers for the rough endoplasmic reticulum (RER) (Kohrmann et
al., 1999; Marion et al., 1999; Wickham et al., 1999).  Cell fractionation of Hela
cells showed that Staufen was associated with ribosomes and polysomes (Marion
et al., 1999).  Kohrmann and co-workers (Kohrmann et al., 1999) demonstrated
that in humans, Staufen (hStau) is a component of RNA containing granules in
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hippocampal neurons.  Luo and co-workers (Luo et al., 2002) examining the role
of Staufen in COS7 cells have shown that it is predominantly associated with
ribosomes.  To demonstrate this, point mutations were introduced into either
dsRBD3 or both dsRBD3 and dsRBD4.  The RNA binding capability of the
mutant proteins was analyzed by Northwestern blot analysis which showed that
while mutations of both domains were sufficient to eliminate dsRNA binding
activity, mutation of the dsRBD3 is essential for RNA binding (Luo et al., 2002).
This mutation reduced but did not eliminate the association of Staufen with
ribosomes indicating that protein-protein interactions may also play a role as its
ability to associate with the ribosomes (Luo et al., 2002).  RNase treatment of
cell lysates was not sufficient to dissociate Staufen from the ribosomes,
suggesting that Staufen-ribosome interactions are not dependent on intact
mRNAs (Luo et al., 2002).
The role of Staufen illustrates the essential function that dsRBD proteins
play during development.  Similar to studies of mRNA localization in other
systems, the cis-acting sequences that are necessary for oskar, bicoid, and
prospero reside within the 3’untranslated regions (Kim-Ha et al., 1993;
Macdonald and Kerr, 1997).  Mutation of several amino acid residues located in
the region of protein-RNA interaction result in a blockage of Staufen-dependent
localization of RNA within the embryo (Ramos et al., 2000).  These results do
not indicate whether there is a direct interaction between Staufen and the target
RNA, however it does suggest that essential amino acid residues lie within the
dsRBD (Schuldt et al., 1998).
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Recently a second Staufen homologue (Stau2) has been isolated (Buchner
et al., 1999).  Stau2 has been found to associate with RNA in cultured neurons
suggesting that it may be involved in delivery of RNA to dendrites (Tang et al.,
2001).  Duchaine and co-workers (Duchaine et al., 2002), showed there are three
differentially spliced isoforms (Stau262, Stau252/59).  Similar to Stau1, Stau2 was
found to be located in the somatodendritic compartment of neurons co-localizing
with the microtubules (Duchaine et al., 2002).  However double
immunofluoresence microscopy showed that Stau1 and Stau2 are not located in
the same particles (Duchaine et al., 2002).  Stau2 isoforms were shown by cell
fractionation to be components of large mass complexes that were not affected
by EDTA treatment or high concentrations of KCl.  Additionally, RNase
treatment was found to release only very small amounts of Stau2 isoforms
(Duchaine et al., 2002).  The different isoforms of Stau2 were found to be
distributed in several complexes.  Stau262 was found to fractionate (by sucrose
gradient fractionation) to low density fractions which also contain RER and
ribosomal protein L7, however these complexes do not contain ribosomes.
Stau252/59 were found to fractionate with both the 40S and 60S ribosomal
subunits (Duchaine et al., 2002).  Ohashi and co-workers (Ohashi et al., 2002)
have recently shown that Staufen is released from polyribosomes in conjunction
with FMRP, Pur a , and Myosin Va.  Treatment of lysates with RNase A was
sufficient to abolish immunoprecipitation of this complex indicating that it is
RNA-depdendent.
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3.1.5 Zinc finger knuckle binding domain
The zinc finger knuckle RNA binding domain is composed of critically
spaced cysteine and histidine residues which can be generalized as CX2-5CX4-
12C/HX2-4C/H (where X can be any amino acid) located within a typical zinc
finger DNA binding domain (Burd and Dreyfuss, 1994).  Proteins that contain
this motif include; TFIIIA (involved in ribosome biosynthesis) (Miller et al.,
1985; Searles et al., 2000), NAB2 (involved in mRNA biogenesis) (Anderson et
al., 1993), and the RSZ family of splicing factors from Arabidopsis (Lopato et
al., 1999).  At present, this motif has not been characterized further.
3.1.6 Cold shock domain
The cold shock domain (CSD) family of RNA binding proteins is a
diverse group of evolutionarily conserved proteins.  They are able to bind single
stranded RNA and single stranded DNA and have been found in Xenopus (Tafuri
and Wolffe, 1990), chicken (Grant and Deeley, 1993), rat (Ozer et al., 1990),
mouse, and human (Tafuri et al., 1993).  These proteins contain a common
structure, the OB fold which consists of five antiparallel b -strands that form a
barrel structure.  Proteins containing this motif have been identified through
searches for transcription factors that are able to bind the Y box, a promoter
element with the sequence, CTGATTGGCCAA, that is present on the non-
coding strand of a variety of genes  (Didier et al., 1988; Tafuri and Wolffe, 1993;
Wolffe et al., 1992).  The CSD itself is one of the most highly conserved motifs
having more than 60% sequence similarity between bacteria and vertebrates
(Graumann and Marahiel, 1998; Tafuri and Wolffe, 1992; Wolffe, 1994).
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Proteins containing CSDs bind to non-translating RNAs during development
(Sommerville, 1999).  The CSD-containing proteins have been found to associate
with DEAD-box RNA helicases and the two protein types appear to coordinately
function to maintain the structure of single stranded RNA (ssRNA) (reviewed by
Sommerville, 1999).
3.2 Major Xenopus mRNPs
The Xenopus model is one of the best biological systems in which to
study the masking and unmasking of stored mRNPs.  In Xenopus, the zygotic
genome is not activated until the MBT which occurs after the 12th round of cell
division approximately 7 hours after fertilization at 23 C˚ (Gerhart, 1980).  Due to
this, all mRNAs and proteins that are required for assembly of the first 4096 cells
must be present in the unfertilized egg.  Measurements of RNA synthesis during
oogenesis has revealed that the majority of polymerase II transcription occurs
during the first two stages of oogenesis (Bacharova, 1966; Dumont, 1972;
Gerhart, 1980).  Thus there is a requirement for storage and protection of these
mRNAs until they are utilized in later stages of development.
3.2.1 FRGY2
Isolation of Poly(A)+ mRNPs from Xenopus oocytes has demonstrated
that two major mRNPs are present, p50 and FRGY2 (Minich et al., 1993; Richter
and Smith, 1984).  p50 originally described as the major core protein of inactive
globin mRNPs, posesses strong RNA-binding activity and can be phosphorylated
in vivo and in vitro in somatic cells (Blobel, 1972; Evdokimova et al., 1995;
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Minich et al., 1993; van Venrooij et al., 1977).  The amount of p50 in non-
translating mRNPs is twofold higher than in actively translating mRNPs
(Evdokimova and Ovchinnikov, 1999; Minich and Ovchinnikov, 1992).  At low
concentrations (approximately 10 molecules per globin mRNA), p50 can
stimulate translation in vitro, conversely at high concentrations (approximately
20 molecules per globin mRNA), p50 fully inhibits translation (Davydova et al.,
1997; Evdokimova et al., 1998; Minich et al., 1993).  Evdokimova and co-
workers cloned rabbit p50 and revealed that it is a member of the Y-box family
of transcription factors binds the Y-box in a sequence specific manner but binds
binds RNAs without sequence specificity (Evdokimova et al., 1995).  The
molecular mass of free p50 in solution is 800 kDa (the monomeric form is 35
kDa) however it is not known whether this large complex persists when binding
RNA, or if it dissociates into subunits which then bind the RNA.  P50 has been
shown to promote annealing of complimentary RNA and DNA strands and its
DNA binding is mediated throough phosphorylation carried out by casein kinase
II (Skabkin et al., 2001).
FRGY2 is the second major component of ribonucleoprotein storage
particles in Xenopus oocytes.  It binds ssRNAs and has been shown to play an
essential role in managing masking and transcriptional silencing of maternal
mRNAs (Bouvet and Wolffe, 1994; Deschamps et al., 1991; Deschamps et al.,
1992; Marello et al., 1992; Murray, 1994; Murray et al., 1992; Ranjan et al.,
1993; Tafuri and Wolffe, 1990; Tafuri and Wolffe, 1993; Yurkova and Murray,
1997).
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FRGY2 was first identified due to its abundance as indicated by
coomassie blue staining of isolated mRNP proteins (Darnbrough and Ford,
1981), and was originally referred to as mRNP3+4 (partnered with several
polypeptides).  These polypeptides have subsequently been named p54 and p56
(Murray et al., 1991; Richter and Smith, 1983) and pp56 and pp60 (Cummings
and Sommerville, 1988), and most recently FRGY2a+b (Tafuri and Wolffe,
1990).  mRNP3 and mRNP4 (FRGY2) are closely related polypeptides (85%
amino acid homology) and are thought to represent pseudoalleles in Xenopus
(Murray et al., 1992).  Currently mRNP3+4 complexes are known to contain
additional polypeptides such as nucleolin, a protein kinase activity and mRNA
binding polypeptides of approximately 34 and 36 kDa (Yurkova and Murray,
1997).  FRGY2 (and its somatic homolog FRGY1) is particularly interesting as it
has dual functions, in RNA binding and transcription through interactions with
the Y-box (CTGATTGGCCAA) promoter element in MHC class II genes
(Didier et al., 1988; Wolffe et al., 1992) as well as a number of genes selectively
active in oocytes (Marello et al., 1992; Tafuri and Wolffe, 1990; Tafuri and
Wolffe, 1992; Wolffe et al., 1992).
FRGY2 is highly expressed in the cytoplasm of oocytes, but is absent in
somatic cells (Wolffe et al., 1992).  Tafuri and Wolffe (1993) demonstrated that
FRGY2 binds RNAs non-specifically however, it does not associate with 5 S, 18
S and 28 S rRNAs or tRNAs in vivo.  FRGY2 accumulates to maximum levels in
oocytes by stage II, however storage particles containing FRGY2 assemble later
in oogenesis reaching maximum levels by stage IV and persisting until stage VI
(Tafuri and Wolffe, 1993).  Following fertilization, FRGY2 levels decline
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through early development correlating with the utilization of stored maternal
mRNAs (Tafuri and Wolffe, 1993).
FRGY2 is phosphorylated early in oogenesis, and its ability to mask
mRNAs depends on its phosphorylation state (Dearsly et al., 1985; Kick et al.,
1987; Yurkova and Murray, 1997).  Several groups have observed casein kinase
II-like proteins to be associated with mRNPs (Marello et al., 1992; Murray et al.,
1991), which have been proposed to phosphorylate FRGY2.  Deschamps and co-
workers (Deschamps et al., 1997) indeed showed that FRGY2 is phosphorylated
by casein kinase II, however phosphorylation (or dephosphorylation by calf
intestinal alkaline phosphatase) did not have any effect on the binding affinity of
FRGY2 for RNA (Deschamps et al., 1997).
Reconstitution experiments demonstrated that FRGY2 repressed
translation of mRNA templates in vitro (Kick et al., 1987; Matsumoto et al.,
1996; Ranjan et al., 1993; Richter and Smith, 1984; Yurkova and Murray, 1997).
Expression of FRGY2 in somatic cells had two effects, an increase in mRNA
accumulation in transcripts expressed from Y-box containing promoters and
translational silencing of these mRNAs (Ranjan et al., 1993).  Overexpression of
FRGY2 in oocytes translationally silenced mRNAs that were synthesized in vivo
(Bouvet and Wolffe, 1994).  Microinjection of antibodies against FRGY2 was
sufficient to relieve transcriptional silencing mediated by FRGY2 (Braddock et
al., 1994; Gunkel et al., 1995).  This data demonstrated that FRGY2 functions in
two separate cellular compartments and interacts with both DNA and RNA either
as a transcription factor or a translational regulator.
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Similar to other RNA binding proteins, FRGY2 is modular in structure.
The most prominent nucleic acid binding structure is a cold shock domain near
the N-terminus (Bouvet and Wolffe, 1994).  Contained within this domain is an
RNP-1 RNA binding domain which is able to confer sequence specific RNA
binding to FRGY2 (Bouvet et al., 1995; Burd and Dreyfuss, 1994; Schindelin et
al., 1993).  A second RNA binding domain is near the C-terminal end of FRGY2
(Murray, 1994) which consists of islands of basic/aromatic amino acids that are
able to bind RNA non-specifically (Bouvet et al., 1995; Marello et al., 1992;
Tafuri and Wolffe, 1990).  Matsumoto and co-workers (Matsumoto et al., 1996)
showed that both the cold shock domain and the basic/aromatic islands are
necessary for stable association of FRGY2 with RNA.  FRGY2 has been detected
in ribosome containing fractions from sucrose gradients which suggests that its
presence did not prevent association of mRNAs with ribosomes (Matsumoto et
al., 2000).
There are several aspects of FRGY2 that make it a good model for
comparison in this study of YY1.  It contains RNA binding domains, and is able
to bind both RNA and DNA.  FRGY2 protein is present in early oocytes and is
assembled into mRNPs during mid to late oogenesis.  Following fertilization,
FRGY2 levels decline as development proceeds and stored mRNAs are utilized.
3.2.2 CCAAT box transcription factor (CBTF)
CBTF contains two dsRBDs and is a transcriptional activator of the
hematopoietic regulatory factor GATA-2.  GATA-2 expression has been shown
to be necessary for hematopoietic and urogenetical development in mouse (Tsai
40
et al., 1994; Tsai and Orkin, 1997; Zhou et al., 1998), and has been implicated in
the formation of ventral mesoderm in Xenopus (Sykes et al., 1998).  The binding
site for CBTF in the promoter of GATA-2 is evolutionarily conserved, and is
required for the proper expression of GATA-2 transcription in amphibian
embryos and in avian and murin hematopoietic cells (Brewer et al., 1995;
Fleenor et al., 1996; Minegishi et al., 1998; Nony et al., 1998).  In Xenopus, the
122 kDa subunit of CBTF (CBTF122) changes its subcellular localization through
development (Orford et al., 1998).  In oocytes, CBTF122 is nuclear, relocates to
the cytoplasm after germinal vesicle breakdown, and remains in this location
until the midblastula transition at which time it relocates to the nucleus (Orford et
al., 1998).  Orford and co-workers (Orford et al., 1998) have proposed that the
subcellular sequestration of CBTF122 is essential for proper GATA-2 expression.
Analysis of the amino acid sequence of CBTF122 has revealed that it
contains two regions that have a high degree of homology to the dsRBD
(Brzostowski et al., 2000) and an RGG RNA binding domain in the C-terminal
region (Brzostowski et al., 2000).  A nuclear localization signal has also been
located preceding the first dsRBD (Brzostowski et al., 2000).  Northern analysis
of RNAs isolated from oocytes and embryos showed that CBTF122 mRNAs are
present during development, and Western blot analysis demonstrated that
CBTF122 levels accumulate through oogenesis (Brzostowski et al., 2000).  Co-
immunporecipitation experiments using CBTF122 antibodies followed by Western
blotting indicated that CBTF122 is part of mRNP3+4 complexes (Brzostowski et
al., 2000; Yurkova and Murray, 1997).
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Brzostowski et al, examined three potential mechanisms for cytoplasmic
retention of CBTF122; phosphorylation state of the protein, binding to the
cytoskeleton, and RNA anchoring (Brzostowski et al., 2000).  Neither disruption
of the cytoskeleton nor phosphorylation were able to bring about translocation of
CBTF122 to the nucleus of embryos (Brzostowski et al., 2000).  However,
degradation of endogenous RNAs in pre-MBT embryos was sufficient to cause
nuclear accumulation of CBTF122 (Brzostowski et al., 2000).  Thus it was
postulated that degradation of maternal mRNAs at the MBT (Duval et al., 1990)
is likely to cause release of CBTF122 from the cytoplasm and nuclear relocation
(Brzostowski et al., 2000).  This mechanism appears to couple activation of the
zygotic genome with the depletion of maternal mRNAs.
3.2.3 Cold inducible RNA binding protein
The cold inducible RNA binding protein (CIRP) which contains both
RRM and RGG domains has recently been identified as a major cytoplasmic
RNA-binding protein in Xenopus oocytes (Matsumoto et al., 2000).  CIRP2 was
first identified in mouse by cDNA cloning of an RRM containing RNA binding
protein (Nishiyama et al., 1997).  In mouse CIRP is found to be highly expressed
in testis where the temperature is maintained below that of the body.  Levels of
CIRP mRNA were found to increase upon temperature downshift from 37˚C to
32˚C (Nishiyama et al., 1997).  Matsumoto and co-workers (Matsumoto et al.,
2000) found that the Xenopus form of CIRP (xCIRP) is abundantly expressed in
testis, ovary, brain, liver, kidney, and heart.  The subcellular localization of
xCIRP was determined by Western blotting of oocyte cytoplasmic fractions.
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These experiments showed that xCIRP is predominantly localized to the
cytoplasm (Matsumoto et al., 2000).  This is in contrast to mammalian cells
where CIRP2 is localized to nuclei (Nishiyama et al., 1997).  This discrepancy
may be due to cell type; CIRP may be nuclear in somatic cells and cytoplasmic in
germ line cells (Matsumoto et al., 2000).  Nishiyama and colleagues (Nishiyama
et al., 1998) have provided evidence for this hypothesis by showing that in mouse
testis, CIRP was cytoplasmically localized, while it was found to be nuclear in
round spermatids.  In Xenopus, it is also possible that xCIRP2 does not possess a
nuclear localization signal that is present in the mammalian form of the protein
despite the high degree of amino acid conservation (82-83%) between the
mammalian and amphibian forms of the protein (Matsumoto et al., 2000).
Gel retardation assays demonstrated that both xCIRP2 and FRGY2 were
able to bind the same histone H1 mRNA simultaneously (Matsumoto et al.,
2000).  Interestingly, density gradient and Nycodenz gradient fractionation of
oocyte lysates revealed that xCIRP2 associates with ribosomes in the cytoplasm
(Matsumoto et al., 2000).  The association between cytoplasmic RNA binding
proteins and ribosomes has been observed previously with FRGY2
(Sommerville, 1990; Tafuri and Wolffe, 1993).  Separation of oocyte lysates by
sucrose gradient centrifugation revealed that xCIRP2 was associated with
monosomes (Matsumoto et al., 2000).
The finding that both xCIRP2 and FRGY2 are associated with ribosomes
in oocytes is intriguing.  FRGY2 displays a 43% amino acid homology with the
bacterial cold shock inducible protein CspA, as well as a C-terminal translation
repression domain (Graumann and Marahiel, 1998; Matsumoto and Wolffe,
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1998; Sommerville and Ladomery, 1996).  Matsumoto and co-workers have
proposed a function for the association observed between xCIRP2, FRGY2 and
ribosomes.  They propose that similar to the function of the bacterial cold shock
protein CspA which acts as a ribosome bound modulator of translation, xCIRP2
may function in the regulation of translational efficiency of specific mRNAs by
associating with ribosomes while FRGY2 acts to repress overall transcription in
the oocyte (Matsumoto et al., 2000).
3.2.4 TFIIIA
The best studied protein containing a zinc finger-knuckle motif is TFIIIA
which contains 9 zinc fingers, the middle three of which contain the zinc finger
RNA binding motif (Miller et al., 1985; Searles et al., 2000).  This transcription
factor has two essential functions in Xenopus which exhibit its versatility to
interact with both DNA and RNA.  TFIIIA is a transcription factor that is
required for the expression of 5S ribosomal RNA (5S rRNA) genes.  Binding of
TFIIIA to the internal coding region of the 5s rRNA gene is mediated through
binding of the first three zinc fingers (Clemens et al., 1993; Hamilton et al.,
2001). The second role that TFIIIA plays is as an RNA binding protein in the
cytoplasm of developing oocytes.  The association of TFIIIA with 5S rRNA
(within the central half of the molecule) forms the 42S ribonucleoprotein particle
which functions to stabilize the 5S rRNA until it is required for ribosome
assembly (Baudin et al., 1989; Baudin et al., 1991; Bogenhagen et al., 1992;
McBryant et al., 1995; Rawlings et al., 1996; Setzer et al., 1996; Theunissen et
al., 1998; Searles et al., 2000).
44
3.2.5 RNA-Associated protein 55
RNA-associated protein (with a molecular mass of 55 kDa, RAP55) is a
recently discovered protein found to associate with RNAs in Xenopus oocytes
(Lieb et al., 1998).  Sequence analysis of RAP55 has indicated that it contains
two RGG domains located at the C-terminus (Lieb et al., 1998).  An examination
of the subcellular localization of RAP55 has show that it is located in the
cytoplasm in oocytes, however following fertilization, the levels of RAP55
decrease until stage 6 after which it is no longer detectable (Lieb et al., 1998).
Interestingly, following the loss of detection of RAP55, a 70 kDa protein was
detected in its place.  Lieb and co-workers consider it possible that the 70 kDa
protein represents a post-translationally modified form of RAP55, however they
did not fully investigate this possibility (Lieb et al., 1998).  Initial
characterization of RAP55 interactions with RNA has suggested that it does not
directly bind cytoplasmic RNAs (Lieb et al., 1998).  The exact function that
RAP55 plays in the developing frog is not currently known however Lieb and co-
workers (Lieb et al., 1998) postulate that it may function as an inhibitor of
cytoplasmic polyadenylation element binding protein (CPEB) thus blocking
polyadenylation and the resulting translational activation.
3.2.6 RNA helicases
RNA helicases catalyze the unwinding of RNA duplexes in an ATP-
dependent manner and are implicated in many cellular processes that require
reorganization of RNA structure, such as transcription, mRNA splicing and
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editing, translation initiation, export and degradation (reviewed by Lorsch, 2002).
Single stranded RNAs are able to form double helical regions, the minimum
requirement being the presence of complimentary sequences within the same
molecule which can form double helices (reviewed by Lorsch, 2002).  The longer
the RNA molecule, the higher the chance that two regions within the same
molecule are able to hybridize.  Karpel and co-workers (Karpel et al., 1982) were
the first to identify a class of RNA binding protein that are able to identify errant
double helical RNA regions, and return them to their native single stranded state.
These proteins termed nucleic acid destabilizing proteins, function by
destabilization of RNA structures, and inducing a single stranded molecule in
their place.  The DEAD box class of RNA-dependent ATPases contain conserved
motifs, including a conserved NTPase ‘A’ (AXXGXXGKT) and ‘B’ (DEAD)
motifs that are required for RNA binding and hydrolysis.  (Schmid et al., 1992;
Staley and Guthrie, 1998; Tanner and Linder, 2001).
In Xenopus an abundant helicase activity has been observed to associate
with the major RNA binding complex, mRNP3+4 (Ladomery et al., 1997).
Photocrosslinking of [a -32P] ATP to mRNPs in solution showed that only two
proteins having molecular masses of 54 and 68 kDa were covalently labeled
(Ladomery et al., 1997).  Isolation of the 54 kDa ATP-binding protein followed
by cyanogen bromide digestion resulted in a series of polypeptides that were
partially sequenced.  These sequences were aligned with the human p54 helicase,
and were found to be a perfect match (Ladomery et al., 1997).  The full length
Xenopus homolog was subsequently cloned by PCR using degenerate primers
(Ladomery et al., 1997).  Xp54 possess an ATP-dependent RNA helicase activity
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and belongs to a family of DEAD box helicases which includes human p54 (Lu
et al., 1992), mouse p54 (Akao et al., 1995), Drosophila ME31B (de Valoir et al.,
1991), S. pombe Ste13 (Maekawa et al., 1994), and S.cerevisae DHH1 (Strahl-
Bolsinger and Tanner, 1993).
Western blotting for protein levels in developing oocytes showed that
Xp54 levels are highest in stage I oocytes and remain constant throughout the
remainder of oogenesis, fertilization and to blastula stages after which they
decline (Ladomery et al., 1997).  Immunostaining of oocytes showed that Xp54
is predominantly localized to the cytoplasm.  When Xenopus tissue culture cells
were examined a small portion of Xp54 was found to be localized to the nucleus
(Ladomery et al., 1997).  In order to determine whether Xp54 was associated
with mRNPs in oocytes, lysates were separated through glycerol gradients.
Analysis of gradient fractions by Western blotting indicated that Xp54 sediments
with FRGY2 suggesting that both proteins are able to bind the same population
of mRNAs (Ladomery et al., 1997).
Two possible scenarios may explain the function of Xp54 in the oocyte.
With regard to its presence in mRNPs, Xp54 may be required for efficient
translational recruitment of stored mRNAs (Ladomery et al., 1997).  In this case,
Xp54 is thought to facilitate efficient translation by unwinding RNAs mobilized
from mRNPs.  Akao and co-workers (Akao et al., 1995) have observed mouse
p54 to be present on the rough endoplasmic reticulum, consistent with such a role
in translation.  Alternatively, Xp54 may be involved in the formation of mRNPs
which occurs in the nucleus (Sommerville and Ladomery, 1996).  In this
scenario, Xp54 would participate in RNA unwinding resulting in single stranded
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RNAs, to which FRGY2 (which has a binding preference for single stranded
RNAs) would then bind (Marello et al., 1992).  Immunostaining of Xenopus
tissue culture cells revealed some reactivity to Xp54 in nuclei (Ladomery et al.,
1997).  Analysis of Xp54 expression and distribution in oocytes and early
embryonic stages showed that Xp54 levels are highest in stage I/II oocytes, and
decline through oogenesis such that by stage VI, no nuclear signal is present
(Smillie and Sommerville, 2002).  Since RNA transcription from lampbrush
chromosomes is highest in stage I/II oocytes, and the majority of stored mRNPs
are established by the end of stage II, it is possible that Xp54 is incorporated into
mRNP particles as they are formed in the nucleus (Smillie and Sommerville,
2002).
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4.0 Xenopus laevis Development
4.1 Fertilization and developmental outline
Xenopus laevis embryos and oocytes are a widely used and well
characterized model system amenable to a variety of experimental studies.  From
a single female frog, large numbers of oocytes or embryos can be obtained and
easily cultured in simple salt solutions.  Eggs can be fertilized in vitro, and
embryos develop outside the mother therefore making then easily accessible for
experimentation.  The oocytes, eggs and embryos are large (0.5mm-2mm), which
provide ample amounts of cellular material for biochemical analyses, and
allowing for experimental manipulations such as microinjection and
microsurgery.  In addition to these morphological aspects, Xenopus development
has been fully characterized from fertilization to maturity (Nieuwkoop and Faber,
1967).
4.2 Oogenesis
The ovaries of mature Xenopus females consist of 24 lobes which
vary in size throughout the year (Dumont, 1972).  During oogenesis, which may
last 6-8 months or longer, a large reservoir of cellular materials essential for early
embryonic growth accumulates.  The majority of this accumulation occurs during
the extended meiotic prophase I.  Cellular components synthesized during this
time include general and specific transcription factors, RNA and DNA
polymerases, tRNA, deoxyribonucleic triphosphates, yolk proteins, and
ribosomes, as well as a large and diverse store of mRNAs which are sufficient to
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direct protein synthesis to the blastula stage (Davidson and Hough, 1971; Bravo
and Knowland, 1979; Woodland, 1980; Laskey 1974).  Reorganization of
cytoskeletal elements also occur during oogenesis (Gard et al., 1995;
Klymkowsky and Karnovsky, 1994). These rearrangements influence the
distribution of many organelles and molecules that are transported, anchored,
sequestered or otherwise organized along the cytoskeleton.
When the oocytes have matured to stage VI they arrest in metaphase I.
Before the oocytes mature further (into a fully developed egg) completion of the
cell cycle is required.  Progesterone secreted by the ovarian follicle in response to
gonaotropic hormones released by the pituitary induce completion of the cell
cycle (Dumont, 1972).  Responding to the progesterone, the oocytes undergo
several biochemical changes, including a decrease in cAMP levels, increases in
both protein synthesis, and total protein phosphorylation levels along with
activation of maturation promoting factor (MPF) (Maller et al., 1979; Wasserman
et al., 1982; Maller et al., 1977; Wu and Gerhart, 1980).  Approximately 6 hours
following progesterone release, the germinal vesicle begins to degrade, followed
by passage of the oocyte through the oviduct (ovulation).  At this point, the
oocyte has progressed to metaphase II of meiosis and is termed an egg.
Fertilization stimulates the egg to complete the second meiotic division at which
time embryonic development begins.
4.2.1 Stages of oocyte development
Oocytes have been divided into 6 distinct developmental stages based on
both morphological and physiological changes.  Stage I oocytes which are
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arrested in prophase I, are transparent and are 50-300um in diameter.  At this
stage both the germinal vesicle (nucleus) and mitochondrial mass are visible and
the chromosomes are very active in tRNA transcription (Dumont, 1972).
Vitellogenin (the yolk precursor protein which is synthesized in the liver) begins
to accumulate and the oocyte is tightly associated with the follicle cells (Dumont,
1972).  This is the period during which mRNA transcription and mRNP
accumulation is at its highest levels (Wahli et al., 1981).  Stage II oocytes assume
an opaqueness and increase in size to 300-450um.  During this stage the oocyte
begins to accumulate large amounts of vitellogenin, and its chromosomes begin
to exhibit a lampbrush morphology permitting a high rate of transcription
(Dumont, 1972).  The follicle cells begin to separate and numerous microvilli
form on the surface of the oocyte.  Stage III oocytes show extensive lampbrush
chromosomes, absorption of vitellogenin continues, and the size of the oocyte
increases to 450-600um.  Pigment begins to appear and is dispersed uniformly on
the entire oocyte surface.  By stage IV, oocytes (600-1000um in diameter) begin
to show separation of animal and vegetal poles; the darkly pigmented animal
pole is separated from the lightly pigmented vegetal hemisphere.  At this point,
vitellogenin uptake is maximized with the majority deposited in the vegetal
hemisphere.  Stage V oocytes are 1000-1200um in diameter with clearly
separated animal and vegetal hemispheres.  The chromosomes are fully
condensed, and vitellogenin uptake ceases (Dumont, 1972).  Once the oocytes
have progressed to stage VI they are 1200-1300um in diameter. The animal and
vegetal hemispheres are separated by an unpigmented equatorial band
approximately 0.2mm wide.  The cytoplasm is highly stratified with
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mitochondria and cortical granules (organelles containing proteolytic enzymes)
located at the oocyte surface, while the yolk platelets aggregate toward the
vegetal pole.  Glycogen granules and endoplasmic reticulum amass in the animal
hemisphere where the large nucleus (germinal vesicle) is located near the
surface.  Total protein synthesis during oogenesis increases 127 fold from
0.18ng/hr-1 in stage I oocytes to 22.8ng/hr-1 in stage VI oocytes (Taylor and
Smith, 1985).
4.3 RNA synthesis during oogenesis
Early research focussed on the rate and nature of RNAs synthesized in the
oocyte. RNA synthesis in oocytes is initiated during stage I at which time
lampbrush chromosomes facilitate high rates of transcription (Pardue and Gall,
1969; Thomas, 1970;Hill and Macgregor, 1980;Ficq, 1970; Gerhart, 1980).  It
was previously believed that mature lampbrush chromosomes reach a maximum
level at stage III oocytes then decline, however Martin and co-workers (Martin et
al., 1980) have demonstrated that they persist in fully mature stage VI oocytes.
Thus, lampbrush chromosomes are present throughout oogenesis, however they
are only readily observed in stages III-IV.
Anderson and Smith (1977; 1978) measured synthesis rates of RNA in
both stage III and stage VI oocytes.  They found that the transcription rate in
oocytes is approximately 10-20 nt sec-1 (Anderson and Smith, 1978).  Oocytes of
both stages are capable of synthesizing unstable high molecular weight (<7kb)
RNAs as well as a greater amount of unstable, smaller RNA.  The half lives of
the RNAs in stage III is shorter than in stage VI, the result of which is an
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accumulation of RNAs in the latter stage oocytes (Anderson, 1977).    They
showed that accumulation of RNA in the cytoplasm proceeds at 1.7-2.2 pg min-1
(Anderson, 1982).    The total amount of RNA in an oocyte is seen to increase
from 0.04ug in stage I to at least 4.3ug in mature stage VI oocytes (Rosbash et
al., 1974).  Of the total amount of RNA in a mature oocyte, 0.7-1.0% (~40ng) is
poly(A)+ RNA representing approximately 20,000 different species of mRNA
(Perlman and Rosbash, 1978).  Ribosomal RNA comprises the major portion (80-
90%) of the remainder of total RNA (Rosbash et al., 1974).
4.3.1  Splicing
The capacity of Xenopus oocytes to carry out splicing reactions was
discovered by injecting cloned genes that included introns followed by analysis
of proper translation of the protein.  Wickens and co-workers (Wickens et al.,
1980) injected clones that coded for ovalbumin which was correctly expressed.
Proper expression of ovalbumin required that seven introns be removed in order
to produce the functional protein.  Rungger and Turler (1978) were able to inject
oocytes with clones that coded for the SV40 T antigen.  In this case the mRNA
was spliced correctly with the removal of one intron producing the correct
protein.  Additionally, several groups were able to show accurate splicing of
yeast tRNAtyr (Melton et al., 1980; Nishikura and De Robertis, 1981).  This
splicing reaction involves the removal of a 5’ leader sequence as well as
nucleotides at the 3’ in addition to several base modifications.  The enzymes
required for these reactions are located in the nucleus (De Robertis et al., 1981).
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4.3.2 Ribosomal RNA accumulation
In the developing oocyte, approximately 1012 ribosomes are assembled
for use during early development of the frog.  Synthesis of the ribosomes is
initiated in stage I oocytes whose primary transcription products are tRNAs and
5S RNAs (Thomas, 1974).  Thomas (Thomas, 1974) conducted experiments
which showed that following 24 hours of labeling, 24% of the labeled RNA were
tRNAs while 39% is 5S rRNAs.  Confirming this data, Rosbash and Ford
(Rosbash et al., 1974) showed that 5S RNAs and tRNAs account for
approximately 80% of the total RNA present in previtellogenic oocytes.
Synthesis of 18 and 28S RNA are initated at stage I, and their levels increase
through to stage VI, while the synthesis of 5S RNA and tRNA declines through
the remainder of oogenesis (Davidson, 1986).  Approximately 50% of the 5S
RNA synthesized in previtellogenic oocytes is stored in a 7S particle where it is
complexed with TFIIIA (Hamilton et al., 2001).  The remaining 50% is present
in 42S particles which also contain TFIIIA, and tRNA (Barrett et al., 1983; Denis
et al., 1972; Guddat et al., 1990; Hamilton et al., 2001; Picard et al., 1980; Picard
and Wegnez, 1979).  42S particles have a half life of 4-36 hours depending on
the species of associated tRNA (Denis and le Maire, 1985).  Following synthesis
of 18/28S rRNAs, they are packaged with a number of ribosomal proteins and
then translocated to the cytoplasm as 40S and 60S ribosomal subunits.  However
storage of ribosomal precursors in the cytoplasm has not been fully
characterized.
The requirement of the developing oocyte for 18 and 28S rRNA is the
same as that for 5S rRNA however it is accumulated in a different mechanism.
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While there are approximately 20,000 5S rRNA genes, there is a significantly
smaller number of genes that code for 18 and 28S rRNAs (approximately 600 per
haploid genome) (Brown and Weber, 1968; Davidson, 1986).  In order to obtain
the correct amount of 18 and 28S rRNAs, their genes are amplified during early
oogenesis and packaged into extrachromsosmal circular DNA molecules (rDNA)
that are then packaged into nucleolar structures (Hourcade et al., 1973; Peacock,
1965).  Transcription of the ribosomal DNA during oogenesis thus occurs from
the amplified ribosomal DNA.  The amplification process results in
approximately 2.5 x 106 rRNA genes (Thiebaud, 1979), resulting in an
approximate 1400-fold increase in gene number.
Table 1.  RNA amounts in stage VI oocytes.                                                 
Type Amount Reference
mRNA 70ng (Dolecki and Smith, 1979)
rRNA 3.8ug (Scheer, 1973)
tRNA 60ng (Gordon and Wickens, 1993)
Ribosomes 1012 (Davidson, 1986)
4.3.3 Polyadenylation
The majority of masked RNAs in the oocyte have short poly(A) tails.  As
oocyte maturation proceeds, these tails lengthen concomitant with unmasking
and translational activation (McGrew et al., 1989; Stebbins-Boaz et al., 1999;
Wickens et al., 1997).  It is generally believed that polyadenylation of mRNAs
confers translational activation while deadenylation results in translational
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silencing.  A number of laboratories have established that the translation of many
Xenopus maternal mRNAs such as cyclins A1 and B1 (Sheets et al., 1994;
Stebbins-Boaz et al., 1996), B4 (Paris and Richter, 1990; Stebbins-Boaz et al.,
1996), c-mos (Sheets et al., 1994; Stebbins-Boaz et al., 1996), and cdk2
(Stebbins-Boaz et al., 1996; Stebbins-Boaz and Richter, 1994) is dependent on
polyadenylation.  The 3’ untranslated regions contain critical information
directing adenylation and deadenylation of mRNAs in oocytes (Barkoff et al.,
1998; Richter, 1991; Wormington, 1993).
4.3.3.1 Cis Elements required for polyadenylation
Two sequences in the 3’ UTR are responsible for polyadenylation.  The
first sequence which is nearly ubiquitous, AAUAAA is also required for nuclear
pre-cleavage and polyadenylation, and a U-rich region (cytoplasmic
polyadenylation element, CPE) that is usually located approximately 20
nucleotides 5’ of the AAUAAA (reviewed in (Richter, 1999).  During
maturation, the polyadenylation of differing mRNAs may vary. This is controlled
by additional regulatory information contained in the CPE, additionally the
location of the CPE in relation to the hexanucleotide influences the timing of 3’
end modification (Ballantyne et al., 1997; de Moor and Richter, 1997).  For
example, maturation of the oocyte is dependent on Mos which is an activator of
mitogen-activated protein kinase kinase (MAPK) (Posada et al., 1993; Shibuya et
al., 1996).  The translational control of Mos is controlled by polyadenylation of
Mos (Sheets et al., 1994; Sheets et al., 1995).  In the immature oocyte Mos
mRNAs have short poly-A tails which lengthen as Mos protein is needed by the
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oocyte (Sheets et al., 1994; Fox et al., 1989; McGrew et al., 1989; Paris et al.,
1991).
4.3.3.2 Cytoplasmic factors required for polyadenylation
Three factors are necessary for polyadenylation to be carried out on
transcripts during maturation.  The cytoplasmic polyadenylation element (CPE)
is bound by cytoplasmic polyadenylation element binding protein (CPEB), which
is an RNA recognition mofit (RRM) containing protein (Bally-Cuif et al., 1998;
Gebauer and Richter, 1996; Hake and Richter, 1994; Minshall et al., 1999).  It is
believed that CPEB functions to recruit and/or stabilize the cytoplasmic form of
CPSF which binds the hexanucleotide sequence (Dickson et al., 1999).   CPSF
functions to bind Poly(A) polymerase (PAP) which is necessary to synthesize the
addition of the adenine residues to the transcript (reviewed in (Stebbins-Boaz et
al., 1999).  Dickson and co-workers (Dickson et al., 2001), have recently shown
that CPSF and PAP are able to initiate in vivo polyadenylation of a subset of
mRNAs in the absence of CBEP.
4.3.2.3 Elements required for deadenylation
Cytoplasmic deadenylation is associated with translational silencing of
mRNAs in the oocyte.  The mRNAs encoding ribosomal proteins act as a good
example of this.  During oocyte maturation, these transcripts are translationally
silenced (Varnum et al., 1992; Varnum and Wormington, 1990).  Deadenylation
of these mRNAs is not controlled by a specific signal, rather it is controlled by
the lack of a CPE therefore the deadenylated state is reached by default (Fox and
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Wickens, 1990; Varnum and Wormington, 1990).  A contrasting scenario exists
in the embryo which requires a specific mRNA deadenylation signal.  During
oocyte development, cdk2 mRNAs are adenylated (Stebbins-Boaz et al., 1996;
Stebbins-Boaz and Richter, 1994) through the standard CPE-mediated pathway,
however soon after fertilization these transcripts are deadenylated.  The
deadenylation step requires two sequences, a 58 nucleotide element immediately
upstream of the CPE and a 14 nucleotide element situated downstream (Stebbins-
Boaz and Richter, 1994).  Each of these is capable of promoting a partial
deadenylation of transcripts, but together they facilitate a complete deadenylation
of transcripts and the consequent translational inactivation (Stebbins-Boaz and
Richter, 1994).  While the deadenylation signals in cdk2 have been identified,
they are not inherently obvious in other embryonic transcripts.
4.4 Localization of RNAs within Xenopus oocytes.
A key feature of Xenopus development is that molecular components
such as proteins and mRNAs are asymmetrically distributed in oocytes
(Carpenter et al., 1982; King, 1985; Moen and Namenwirth, 1977; Phillips, 1982;
Sagata et al., 1980).  Moen and Namenwirth (1977) were able to show that
differences existed in molecular components between animal and vegetal
hemispheres by freezing and sectioning the oocytes perpendicular to the A-V
axis followed by 2 dimensional gel electrophoresis.  King (1985) isolated
poly(A)+ RNA from animal and vegetal hemispheres which was used as
templates for translation and found that a number of RNAs were enriched in the
vegetal hemisphere (King, 1985).  Rebagliati and co-workers (Rebagliati et al.,
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1985) were the first to identify messages that are preferentially localized to the
animal or vegetal poles.  This was shown by isolating poly(A)-RNAs from whole
oocytes which were used to generate cDNA libraries.  Analysis of animal and
vegetal cDNA libraries showed that there is a qualitative difference in messages
localized within each hemisphere.  Four messages, localized to the animal
hemisphere were An1, An2, and An3, while Vg1 was sequestered in the vegetal
hemisphere (Rebagliati et al., 1985).  Northern blot analysis of RNAs isolated
from eggs showed that An messages are highly concentrated to the the animal
pole of the oocyte while Vg messages are restricted to the vegetal pole and they
remain in these locations after fertilization (Rebagliati et al., 1985).  Since the
discovery of these messages, several others have been identified.  The
information shown in Table 2 was obtained from Mowry and Cote, 1999 (Mowry
and Cote, 1999) and lists RNAs localized to either the animal or vegetal
hemispheres.
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Table 2.  RNAs localized within Xenopus oocytes.
RNA                Encoded Protein                                  Reference:                   
Localized to the vegetal hemisphere:
Xcat-2 potential RNA helicase (Mosquera et al., 1993)
VegT T-box transcription factor (Horb and Thomsen, 1997;
Lustig et al., 1996;
Stennard et al., 1996; Zhang et
al., 1998)
Xcat-3 nanos like zinc finger protein (Elinson et al., 1993)
Xdazl related to DAZ (Houston et al., 1998)
Xlsirts nontranslated RNA (Kloc et al., 1993)
Xpat novel protein (Hudson and Woodland, 1998)
Xwnt11 wnt protein (Ku and Melton, 1993)
                                                                                                                                    
Localized to the animal hemisphere:
Oct-60 POU domain transcription factor (Hinkley et al., 1992)
Xlan4 novel protein (Reddy et al., 1992)
X121 novel protein (Kloc et al., 1991)
PABP Poly(A) binding protein (Schroeder and Yost, 1996)
Retention of RNAs within the vegetal hemisphere appears to be mediated
through binding or attachment of the mRNAs to cortical cytoskeletal elements
(Forristall et al., 1995; Kloc and Etkin, 1995; Yisraeli et al., 1990).  Localization
of mRNAs to the animal hemisphere has not been as well documented however it
is believed that mRNAs destined for this region of the oocyte are retained by an
entrapment mechanism (reviewed in (Mowry and Cote, 1999).  Interestingly,
RNAs retained in the vegetal hemisphere appear to be tightly regionalized to the
cortex while those located in the animal hemisphere appear to be present in a
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graded distribution along the A-V axis (reviewed in (Mowry and Cote, 1999;
Perry-O'Keefe, 1990)
Polarity of the developing oocyte and embryo is determined by
differential localization of RNAs.  Certain subsets of RNAs within somatic cells
may encode proteins that play essential roles in the establishment and
maintenance of cell motility and may provide the cell with regional functional
specification (reviewed by St. Johnston, 1995).  For example, Vg1 mRNA is
localized to the vegetal pole of the oocyte.  Vg1 has been shown to be an inducer
of endodermal tissues (Henry et al., 1996).  Overexpression of mutant Vg1
results in a disruption of endoderm formation (Joseph and Melton, 1997),
suggesting Vg1 acts as a positive regulator of endodermal formation.  The
specific localization of this message is governed by by a 340 nucleotide sequence
(vegetal localization element, VLE) located in the 3’ UTR (Mowry and Melton,
1992).  This sequence is recognized by Vg1RBP (VERA), which is an RNA
binding protein containing two RRMs and four KH domains (Git and Standart,
2002).  Retention of Vg1 appears to be governed by Xlsirts which is also
localized to the vegetal hemisphere (Reddy et al., 1992).  Xlsirts contains a 81
nucleotide sequence that is randomly repeated between 1 and 13 times (Kloc and
Etkin, 1994).   Destruction of Xlsirts by microinjection of antisense
oligonucleotides results in release of Vg1 from the vegetal hemisphere which
suggests that Xlsirts is essential for Vg1 localization (Kloc and Etkin, 1994).  In
the absence of this sequence Vg1 does not localize to the vegetal hemisphere.
Conversely if this sequence is placed into other mRNAs, they are localized to the
vegetal hemisphere.
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Xenopus oocytes are first polarized along the animal-vegetal hemisphere
axis (Cheng and Bjerknes, 1989).  Axis specification in oocytes begins by mitotic
divisions of oogonia which produce 16 cells that are connected by a cytoplasmic
bridge (Coggins, 1973).  After these cells have been generated the first signs of
cellular polarity are present and are dictated by the position of the cytoplasmic
bridge, the centriole pair and the chromosomes (al-Mukhtar and Webb, 1971;
Kalt, 1973).  Gerhart and co-workers (Gerhart, 1986) have proposed that the
alignment of these structures within the developing oocyte specifies the animal-
vegetal axis that becomes visually evident by mid-oogenesis.
The developmental potential along the A-V axis is coincident with the
fate map of the three primary germ layers, ectoderm, endoderm and mesoderm
(reviewed by Heasman, 1997).  Cells derived from the animal hemisphere give
rise to ectodermal structures such as skin and nervous system.  Cell arising from
the vegetal pole develop into endodermal structures, primarily the gut.
Mesodermal structures are derived from cell arising from the marginal zone
(Dale and Slack, 1987).
4.5 Embryogenesis 
Xenopus development has been very well characterized at the
morphological level (Nieuwkoop and Faber, 1967).  Newly laid Xenopus eggs lie
within a clear vitelline membrane encased by a jelly coating.  Fertilization occurs
when a single sperm enters the animal hemisphere, blocking further fertilization,
as well as marking the future ventral side of the embryo.  This also releases the
embryos from metaphase II thus allowing completion of the second mitotic
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division (Gerhart et al., 1980).  Following fertilization, the vitelline membrane
detaches from the embryonic surface.  The A-V axis established during
oogenesis is disrupted during the first cell cycle due to cortical rotation of the
embryo where the cortex rotates 30  ˚relative to the interior (Vincent and Gerhart,
1987).  The first cell division occurs approximately 90 minutes after fertilization
followed by 12 subsequent synchronous divisions occurring at 30-35 minute
intervals producing an embryo with 4096 cells (Graham and Morgan, 1966).
These cell cycles are biphasic, oscillating rapidly between S and M phases
(Newport and Kirschner, 1982 a,b; Graham and Morgan, 1966).  G1 and G2
phases as well as zygotic transcription are absent at this time (Graham and
Morgan, 1966; Newport and Kirschner, 1982 a,b).  As the embryo develops, the
yolk proteins are degraded and the derived amino acids are used for de novo
protein synthesis (Tata, 1976; Wahli et al., 1981).  The MBT occurs 13 cell
divisions after fertilization, at which time the zygotic genome is activated
(Newport and Kirschner, 1982 a,b; Brown and Littna, 1964; Bacharova and
Davidson, 1966; Gerhart, 1980).
Following fertilization, the first cleavage occurs in the axial plane,
separating the embryo into right and left halves.  The embryo then divides at
right angles to the first, separating future dorsal and ventral aspects of the
embryo.  The third cleavage is equatorial, separating the animal and vegetal
hemispheres.  As in other systems, the large cells of the early embryo are referred
to as blastomeres.  As development proceeds, a cavity is formed within the
animal hemisphere called the blastocoel at which point the embryo is referred to
as a blastula (Kalt, 1971).
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During cleavage stages, the number of cells increases exponentially while
the gross size of the zygote remains unchanged (Newport and Kirschner,
1982a,b).  Prior to the midblastula transition, there is no measurable zygotic
transcription (although there is a low rate of mitochondrial RNA synthesis)
(Chase and Dawid, 1972).  Therefore the developing zygote must rely on
maternally transcribed and stored mRNAs as well as proteins that were translated
during oogenesis (Newport and Kirschner, 1982a,b).  The midblastula transition
marks a dramatic shift in the cell cycle.  At this time both G1 and G2 phases are
re-acquired, cell divisions become asynchronous, zygotic transcription is
initiated, and cells within the embryo become motile (Newport and Kirschner,
1982a,b).
The mechanism(s) controlling the onset of the midblastula transition has
been described by several hypothesis.  Newport and Kirschner (1982a)
demonstrated that the timing of the MBT is independent of time after
fertilization, cleavage number, number of nuclear divisions, and RNA synthesis,
however it may be dependent on a critical nucleocytoplasmic ratio.  They
suggested that the nucleocytoplasmic ratio is detected by cytoplasmic factors
present in the unfertilized egg which may be titrated by a critical mass of DNA
that is reached only at the midblastula transition (Newport and Kirschner, 1982a).
Prioleau and colleagues (1994) demonstrated that pre-MBT gene repression was
not due to an unavailability of TBP or a transcriptional apparatus.  Rather, they
showed that the mechanism controlling the onset of the midblastula transition
appears to be depletion of the large store of histones accumulated during
oogenesis.  Previous studies have shown that pre-midblastula transition embryos
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contain a very large reservoir of histones (an amount sufficient to package ~ 20,
000 nuclei) (Adamson and Woodland, 1974; Woodland and Adamson, 1977).
Prioleau et al (1994) provided evidence that the excess pool of histone could
repress gene expression by means of a dynamic competition of between
chromatin assembly and the formation of transcription complexes (Prioleau et al.,
1994).  The depletion of maternally produced histone through packaging of
newly synthesized DNA was hypothesized to permit the assembly of
transcription complexes at a given point, defining the MBT (Prioleau et al.,
1994).
Following the MBT, the process of gastrulation begins.  The three germ
layers, ectoderm, mesoderm and ectoderm as well as the anterior-posterior axis
are formed (reviewed by Slack, 1992).  Gastrulation proceed until embryos reach
stage 12.  The first observable sign of gastrulation is the appearance on the dorsal
side of the embryo of an area of condensed pigmentation.  The primary motive of
gastrulation is the relocation of the mesoderm and endoderm to the inside of the
embryo which displaces the blastocoel and forms a new body cavity, the
archenteron.  At the beginning of gastrulation, boundaries between the germ
layers are not visible, however by the time it is complete margins are visible.
During neurulation, (stages 13-20) the central nervous system of the frog
is formed.  At the end of gastrulation, the neural plate becomes prominent on the
dorsal aspect of the embryo.  The neural plate is composed of a thickened
ectodermal region that forms all of the components of the central nervous system.
The edges of the neural plate (the neural folds) give rise to the neural crest cells
(Baker and Bronner-Fraser, 1997).  The movements of these cells as well as the
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underlying mesoderm give rise to the neural tube (reviewed in Smith and
Schoenwolf, 1997).  The closure of the neural tube marks the commencement of
organogenesis, when all of the major body organs are formed.
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5.0 Materials and Methods
5.1 Oocyte manipulations
Oocytes were obtained by surgical removal of ovary lobules from mature
female Xenopus laveis.  Frogs were anesthetized in 0.2% 3-aminobenzoic acid
ethyl ester methansulfonate salt (Sigma) for 20 minutes at room temperature.
Anesthetized frogs were then placed on ice for surgery.  An incision was made in
the right or left ventral abdomen through the muscle wall and 2-6 lobes were
pulled though the incision.  Surgical thread (Ethicon silk, 4-0) was then looped
around the blood vessels supplying the dissected lobes and tied tightly.  The
dissected lobes were then cut from the ovary, and the ligated ovary was placed
back into the abdomen.  The body muscle wall and skin were individually closed
with 4-6 sutures each.  In order to remove the follicles, dissected ovarian lobes
were placed in 0.2% type II collagenase (Sigma),  in Ca2+ free OR2 (82.5mM
NaCl, 2.5mM KCL, 1mM MgCl2, 1mM NaH2PO4, 5mM potassium N-2-
hydroxyehtylpiperazine-N’-2-ethanesulfonic acid (HEPES; (pH 7.6)), 10mg/L
streptomycin sulfate, 10mg/L benzyl penicillin) and placed on a gyrotory shaker
at 100 rpm at 23 C˚ for 2-3 hours (hr).  The oocytes were then washed several
times in OR2 (same as above + 1 mM CaCl2; (Wallace et al., 1973)), and stored
at 18°C.  Oocytes were staged according to Dumont (1972).
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5.1.1 Oocyte enucleation
Nuclei of st VI oocytes were obtained by manual dissection.  Oocytes
were scored at the centre of the animal pole with Dumont No. 5 forceps.  Nuclei
were discharged by gently applying pressure to oocytes at the equator while
simultaneously applying equal pressure on the animal hemisphere next to the
perforation with a second pair of Dumont No.5 forceps.  Cytoplasmic debris was
removed from the nuclei by careful pipetting in and out of a Pasteur pipette 3-4
times.  Nuclei and enucleated cells were then transferred to separate 1.5 ml
microfuge tubes and residual OR2 was aspirated.
5.2 Embryo manipulation
Eggs for fertilization were collected in petri dishes from mature Xenopus
laevis (from Xenopus I, Ann Arbor, Michigan) by manually squeezing females
12 hours after they had been injected in the dorsal lymph sac with 1000U Human
Chorionic Gonadotropin (HCG) (Sigma).  Testes were obtained by surgical
removal from adult males and stored in 200% Steinberg's solution (0.12 M NaCl,
1.3 mM MgSO4, 0.46 mM Ca(NO3)2, 9 mM Tris (pH7.4)) for up to 1 week at
4°C.  Sperm suspensions for fertilization were prepared by crushing 1/2 of one
testicle in 80% Steinberg's solution.  Eggs were fertilized by pouring an aliquot
of the sperm suspension over the eggs.  After incubation for 10 minutes (min) at
RT, the dishes were flooded with 20% Steinberg's solution.  Fertilized eggs
(visualized after cortical rotation) were de-jellied by agitation in a solution of 2%
(w/v) L-cysteine in 20% Steinberg's for 5 min.  Embryos were then washed
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extensively in 20% Steinberg's and incubated at 18°C throughout development.
Embryo stages were determined according to Nieuwkoop and Faber (1967).
Only normally developing embryos, as judged by established morphological
criteria (Nieuwkoop and Faber 1967), were used in all experiments.
5.2.1 Whole cell oocyte/embryonic protein extracts
Embryos or oocytes (at the desired developmental stage) were placed in
1.5 ml microfuge tubes to which buffer C (50mM Tris-HCl (pH 7.8), 20%
glycerol, 50 mM  KCl, 0.1 mM EDTA, 2 mM DTT, 10 ug/ml aprotinin, 10 ul/ml
leupeptin) was added (10 ul per embryo/oocyte) and were homogenized at 4° C
by pipetting several times with a Gilson Pipettman (P200) or in some
experiments in a Dounce homogenizer with a tight fitting pestle on ice.
Homogenates were centrifuged (Eppendorf model 5415C) for 5 min at 14,000 x
g at 4°C, supernatants were removed, placed in fresh microfuge tubes and stored
at -80°C.
5.2.2 Cytoplasmic/Nuclear embryonic protein extracts
For embryonic cytoplasmic/nuclear extracts, primary crude extracts were
prepared using the method of LeMaitre et al (1995), and were subsequently used
for separation of nuclear and cytoplasmic fractions.  Embryos at the desired
developmental stage were isolated and homogenized by centrifugal crushing for
10 min at 14,000 x g at 4 C˚ producing the primary extract.  Nuclear extracts were
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prepared by a 10 fold dilution of the primary extract with N buffer (20 mM
HEPES (pH 7.6), 2% w/v sucrose, 10 mM KCl, 1.5 mM MgCl2, 0.2 mM EDTA,
0.5 mM DTT, 5ug/ml leupeptin, 5ug/ml pepstatin).  Nuclei were collected by
centrifugation for 8 min at 5,000 x g at 4˚C, then pelleted by centrifugation
through a 0.8 M Sucrose cushion in N buffer.  Pelleted nuclei were extracted for
45 min at 4˚C in E buffer (20 mM HEPES (pH 7.6), 2% sucrose, 150 mM KCl,
1.5 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 0.5% Nonidet P-40, 5ug/ml
leupeptin, 5ug/ml pepstatin).  Insoluble material was separated from the nuclei by
centrifugation for 5 min at 14,000 x g at 4˚C, and the supernatants were
discarded.  Nuclear extracts were stored at -80 C˚.
For isolation of cytoplasmic fractions, the primary extract was diluted 5
fold in E buffer that did not contain Nonidet P-40, and was centrifuged 10 min at
14,000 x g at 4˚C to pellet the nuclei.  The supernatant was transferred to 1.5 ml
microfuge tubes and diluted 1:1 in E buffer containing 1% Nonidet P-40, and
gently mixed for 45 min at 4˚C.  Samples were centrifuged for 10 min at 14,000
x g at 4˚C and supernatants were transferred to 1.5 ml microfuge tubes and stored
at -80 C˚.
5.2.3 Oocyte nuclear protein extracts
Nuclear extracts were made by homogenizing nuclei in 2 ul Buffer C,
followed by snap freezing in liquid N2, and samples were stored at -80° C.
Cytoplasmic extracts were made by adding 10 ul Buffer C per enucleated cell,
followed by homogenization at 4° C. Homogenates were centrifuged (Eppendorf
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model 5415C) for 5 min at 15,000 rpm at 4°C, and supernatants were transferred
to microfuge tubes and frozen at -80°C.
5.3 32P-labeling of YY1 and AP-1 binding elements__
Oligonucleotides containing the YY1 and AP-1 binding elements were
purchased from Life Technologies (Gibco BRL).  The positive strand
oligonucleotides for YY1, [5'-ggatcCTCGGCCTCATGCGGCTGCAGAGGC-3']
were mixed with the negative strand [3’-
GAGCCGGAGTACGCCGACGTCTCCGggatc-5’] (BamHI overhang is
represented by the lower case letters) oligonucleotides in a solution containing
100 mM NaCl, and annealed by heating to 100 C˚ then allowing the solution to
cool to 22 C˚ overnight.  Annealing of the AP-1 positive [5’-
ggatcCCGGAAAGCATGAGTCAGACAC-3’] and negative [3’-
GGCCTTTCGTACTCAGTCTGTG-‘5] strands was carried out as described
above.  The oligonucleotide duplexes containing the YY1 binding element were
labeled with [a -32P] dCTP (Mandel) for use in gel shift assays.  End labeling
reactions contained 5 U Reverse Transcriptase (Promega), 100 ng YY1
oligonucleotides, 2 ul 5x Reverse Transcriptase reaction buffer (Promega), 1 ul
of 1 mg/ml bovine serum albumin (BSA), 2 ul of a mixture containing 10 mM
dATP, dGTP, and dTTP, and 2 ul [a -32P] dCTP (Mandel).  Following
incubation for 45 min at 37 C˚ 90 ul of dH2O was added and labeled probes were
extracted with 90 ul phenol/chloroform then precipitated at -20°C with 2 ug of
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carrier tRNA, 10 ul of 5M ammonium acetate, and 300 ul ethanol.  Precipitated
oligonucleotides were collected by centrifugation for 10 min at 14,000 x g at 4 C˚,
the ethanol was removed and pellets were dried at 23 C˚ then, re-suspended in 30
ul dH2O and stored at -20°C.
5.4 DNA-Binding reactions and gel mobility shift assays
DNA binding reactions contained 1 oocyte or embryo equivalent (20 ug
of protein in 10 ul) mixed with a solution containing 0.5 ug poly dI-dC (Sigma),
100 cps labeled probe (section 5.3) and binding buffer (10 mM Tris-HCl (pH
7.8), 50 mM NaCl, 1 mM EDTA, 5% v/v glycerol) then incubated at 4 C˚ for 20
minutes.  Samples were mixed with 5 ul non-denaturing loading dye (50% (v/v)
glycerol, 0.005% (w/v) bromophenol blue, and 0.005% (w/v) xylene cyanol),
loaded onto 5% non-denaturing polyacrylamide gels (5% 29:1 acrylamide (v/v),
4 ml 10X TNANA) and electrophoresed in Tnana buffer (6.7 mM Tris-HCl (pH
7.5), 1 mM EDTA, 3.3 mM sodium acetate) for 2 hours at 150 volts (V).  Gels
were dried at 80°C on a Savant Slab Gel Dryer (model SDG2000) for 70 min and
exposed to Kodak X-OMAT AR x-ray film overnight at -80°C with an
intensifying screen (Fisher).
Oligonucleotides for competition experiments were as follows; AP-1 [5’
ggatcCCGGAAAGCATGAGTCAGACAC-3’] (positive strand).  Competitor
concentrations were determined spectrophotometrically using a Pharmacia
GeneQuant spectrophotometer and confirmed visually after gel electrophoresis
on 16% non-denaturing polyacrylamide gels in TBE (890 mM Tris, 890 mM
Boric acid, 20 mM EDTA) followed by staining with ethidium bromide (10
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pg/ml).  Competitor oligonucleotides were added to binding reactions
immediately prior to the addition of radiolabeled oligonucleotide probes, and
binding reactions were carried out as described above.
5.5 Phosphatase treatments
In some experiments, embryonic or oocyte extracts were treated with
phosphatase.  1U Calf Intestinal Alkaline Phosphatase (CIAP) (Boehringer
Mannheim) was added directly to extracts (1 oocyte or embryo equivalent) with
10x reaction buffer (100 mM TRIS-acetate, 100 mM magnesium Acetate, 500
mM potassium acetate) and the mixtures were incubated either at at 4°C for the
specified pre-incubation times.  Treated extracts were then used for DNA-
binding reactions, immunoblots or fractionated by size exclusion
chromatography (SEC).
5.6 In vitro transcription
5.6.1 Radiolabeling of histone H2A
Plasmids for the synthesis of histone H2A probes for RNA binding
reactions were a gift of Dr. A. Johnson, Florida State University, Tallahassee
Florida.  Plasmids were prepared by insertion of a 393 nucleotide (nt) histone
H2A PCR product into the SmaI site of Bluescript KS+ (Promega).  Plasmids
were linearized at the 3’ end by digestion with BamHI for 2 hours at 37˚C.
73
Probes for RNA binding assays were synthesized from the T7 promoter
of bluescript KS+ and in vitro transcription reactions were assembled with the
following components in 25 ul reactions; 100mM DTT, 1mg/ml BSA, 5mM
ATP, GTP, UTP, 50 uM CTP, 1U RNAGuard (Pharmacia), 50 ng H2A plasmid,
5ul [ a -32P]-rCTP (Mandel), 4ul T7 reaction buffer (40 mM Tris-HCl (pH 8.0), 6
mM MgCl2, 2 mM spermidine, 10 mM NaCl) 250 ug/ml BSA, and 10U T7 RNA
polymerase (Pharmacia).  Reactions were incubated for 2 hr at 37˚C, followed by
addition of 10U DNase (Pharmacia) and further incubation for 20 min at 37˚C.
Labeled probes were extracted once with phenol, twice with phenol/chloroform
(1:1), and once with chloroform followed with recovery by precipitation at -20˚C
in 1/10 volume 3M sodium acetate, and 2 volumes ethanol.  Probes were
centrifuged for 30 min at 12,500 x g at 4 C˚, resuspended in 50ul TE (10 mM
Tris-HCl, 1 mM EDTA), 1U RNAGuard was added and samples were stored at -
20˚C.  Labeling of probes was confirmed by electrophoresis of a 5ul aliquot on
5% (w/v) acrylamide/8.3 M urea gels in TBE, and transcript length was
measured against co-electrophoresed 32P-labeled MspI (New England Biolabs)
digested PUC19 marker.
5.6.2 Synthesis of capped YY1 mRNAs
Plasmids used for the synthesis of YY1 mRNAs were a gift of a gift of
Dr. Elena Beccari, Universita di Roma La Sapienza, Rome Italy, Accession
#X77698.  YY1 cDNAs were inserted into the EcoRI site of pBluescript KS+
(Promega).  YY1 RNAs were synthesized from the T7 promoter of bluescript
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KS+ and in vitro transcription reactions were assembled with the following
components in 25 ul reactions; 100mM DTT, 1mg/ml BSA, 1U RNAGuard
(Pharmacia), 50 ng YY1 plasmid, 10 ul of 5X NTP capping solution (5 mM each
ATP, CTP, UTP, 0.25 mM GTP, 5 mM m7GpppG) 4ul T7 reaction buffer (40
mM Tris-HCl (pH 8.0), 6 mM MgCl2, 2 mM spermidine, 10 mM NaCl) 250
ug/ml BSA, and 10U T7 RNA polymerase (Pharmacia).  Reactions were
incubated for 2 hr at 37 C˚ and reactions were stopped by the addition of 10U
FLPC-pure DNase I (Pharmacia) and subsequent incubation at 37 C˚ for 20 min.
Capped mRNAs were extracted once with phenol, twice with phenol/chloroform
(1:1), and once with chloroform followed with recovery by precipitation at -20˚C
in 1/10 volume 3M sodium acetate, and 2 volumes ethanol.  Following
precipitation, mRNAs were pelleted by centrifugation for 30 min at 12,500 x g at
4 C˚, resuspended in 50ul TE (10 mM Tris-EDTA) and concentrations were
determined by spectrophotometric analysis and diluted to 2 mg/ml.
5.7 RNA binding reactions
RNA binding reactions were performed as previously described by
Bouvet et al (1995) with minor modifications.  Binding reactions were carried
out for 20 min at 4˚C in RNA binding buffer (20 mM Tris-HCl (pH 7.4), 4 mM
MgCl2, 100 mM KCl, 30% v/v glycerol, 1mM DTT, 20 ug/ml BSA) with 0.5 ng
of labeled RNA probe and 20 ug soluble oocyte protein in a total reaction volume
of 20 ul.  In some reactions antibodies against YY1 (Santa Cruz Biotechnology,
Santa Cruz California, polyclonal, CAT# sc-281) and Proliferating Cell Nuclear
Antigen (PCNA) (Santa Cruz Biotechnology, monoclonal, CAT# sc-56) were
75
added to cell lysates at 4 C˚ for 20 minutes prior to the binding reactions in a
range of concentrations (25-400 ng).  Following binding reactions, samples were
loaded onto non-denaturing 5% polyacrylamide gels containing 6.7 mM Tris-
HCl (pH 7.5), 1 mM EDTA, 3.3 M sodium acetate, 5% v/v Glycerol.  Gels were
electrophoresed for 2.5 hr at 160 volts in a chromatography refrigerator
maintained at 4 C˚, and were dried at 80°C on a Savant Slab Gel Dryer (model
SDG2000) for 70 min and exposed to x-ray film overnight at -80°C with an
intensifying screen.
5.8 RNA isolation
TRIzol (Life Technologies) RNA isolation reagent was used to isolate
total RNA from Xenopus oocytes and embryos.  Batches of 30 oocytes/embryos
at the desired developmental stages were transferred to 1.5 ml microfuge tubes
and were homogenized on ice in 1 ml TRIzol reagent using an Eppendorf p1000
pipette.  Homogenates were incubated for 5 min at 23 C˚ followed by the addition
of 200 ul chloroform, vortexed for 15 sec and incubated for 3 min at 23 C˚.  The
mixtures were centrifuged for 15 min at 14,000 x g at 4 C˚ and the upper aqueous
phases were transferred to 1.5 ml microfuge tubes, 450 ul isopropyl alcohol was
added, and samples were incubated for 10 min at 23 C˚.  Samples were
centrifuged for 10 min at 14,000 x g at 4 C˚, supernatants were discarded, and
pellets were washed with 1 ml 70% ethanol.  Residual ethanol was evaporated
and RNA pellets were resuspended in 50 ul dH2O, and stored at -80 C˚ as ethanol
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precipitates after the addition of 150 ul ethanol (95%), 5 ul ammonium acetate,
and 1 ug tRNA.
5.8.1 PolyA+RNA isolation
PolyA+RNA was isolated from selected total RNA samples by Oligo(dT)
cellulose chromatography (Aviv and Leder, 1972).  For batches of total RNA
containing no more than 150 ug, 100 ug (dry weight) of Oligo(dT)25 cellulose
(New England Biolabs CAT# 1401) was resuspended in 200 ul loading buffer
(20 mM Tris-HCl (pH 7.5), 500 mM NaCl, 1 mM EDTA). The bead slurry was
equilibrated by centrifugation in a 1.5 ml microfuge tube for 20 sec at 5,000 x g
at 23 C˚.  The loading buffer was aspirated and the beads were resuspended in
500 ul loading buffer.  Pellets containing 150 ug of total oocyte/embryo RNA
were dissolved in 200 ul loading buffer, heated for 5 min at 65 C˚ then
immediately chilled for 5 min at 4 C˚.  RNA mixtures were added to equilibriated
Oligo(dT)25 cellulose beads and slurries were gently agitated for 5 min at 23 C˚
followed by centrifugation for 20 sec at 5,000 x g at 23 C˚.  Unbound RNA was
decanted, re-heated, for 5 min at 65 C˚, then chilled for 5 min at 4 C˚ and re-
applied to the Oligo(dT)25 cellulose beads and gently mixed for 5 min at 23 C˚.
Beads were washed 5 times with 500 ul loading buffer followed by a wash in 500
ul low salt buffer (0.1 M NaCl, 20 mM TRIS-HCl (pH 7.5), 1 mM EDTA).
PolyA+ RNA was eluted from the cellulose beads with 2 x 250 ul washes of
elution buffer (10 mM TRIS-HCl (pH 7.5), 1 mM EDTA) at 70 C˚, and
precipitated overnight at -20 C˚ by the addition of 1/10 volumes of 3 M sodium
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acetate and 2.5 volumes ethanol.  PolyA+ RNA samples were collected by
centrifugation for 30 min at 14,000 x g at 4 C˚ and the resulting pellets were
resuspended in 10 ul formamide and stored at -80 C˚.
5.9 Random prime labelling
Probes for Northern blots were synthesized from Xenopus YY1 cDNAs (a
gift of Dr. Elena Beccari, Universita di Roma La Sapienza, Rome Italy,
Accession #X77698) or immunoprecipitated cDNAs; 051 (527 bp), 060 (203 bp),
164 (522 bp), 121 (679 bp), 039 (581 bp), 005 (493 bp) and 121 (600 bp).
Random primed reactions were assembled in  25 ul volumes containing 50 ng
DNAs (boiled 10 minutes, then immediately chilled on ice),  5 ul dH2O,  3 ul  of
a mixture containing 10mM ATP, GTP, UTP, 2 ug random hexamer mix
(GibcoBRL), 50 uCi [ a -32P] dCTP (Mandel), 3 ul Klenow reaction buffer (670
mM HEPES, 170 mM TRIS-HCl, 17 mM MgCl2, 33 mM 2-mercaptoethanol,
1.33 mg/ml BSA), 3 U DNA Polymerase I (Klenow) (Pharmacia).   Reactions
were incubated for 1 hr at 37° C and terminated by the addition of 175 ul STE
(100 mM NaCl, 10 mM Tris, 1 mM EDTA (pH 8.0)).  Reactions were passed
through G-50 Sephadex columns (equilibriated with 200 ul STE) then boiled 5
minutes, chilled at 4 C˚ and added to hybridization solutions or stored at -20 C˚.
5.10 Northern blot analysis
Northerns were performed as previously described (Sambrook, 1989)
with modifications.  10 ug of RNA was suspended in 20 ul formamide and
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diluted with an equal volume of sample diluent (7.35% formaldehyde (v/v), 10
mM  3-(N-Morpholino) propanesulfonic acid (MOPS), 0.1 M sodium acetate, 10
mM EDTA) and heated for 15  min at 55 C˚ then allowed to cool for 5 min at 4 C˚
prior to gel loading.  Samples were mixed with 8 ul loading dye (1x MOPS,
18.5% formaldehyde, 10% formamide, 0.05% bromophenol blue) loaded onto
1% agarose/formaldehyde gels (1% agarose, 1x MOPS, 0.6 M formaldehyde)
and electrophoresed for 2h at 100 V in 1x MOPS buffer (1x MOPS, 40 mM
sodium acetate, 5 mM EDTA (pH 8.0).  Following electrophoresis, the RNA
ladder (New England Biolabs, Cat# N0362S, 9000bp, 7000bp, 5000bp, 3000bp,
2000bp, 1000bp, 500bp) was excised with a scalpel blade (Beaver #32), stained
with ethidium bromide (10 pg/ml) (Sigma) 1 hour, then destained with dH2O for
3 hours at 23 C˚.  The remainder of the gel was soaked for 20 min in 0.5x TBE
and RNA molecules were electrophoretically transferred at 3mA/cm2 to Hybond
N membranes (Amersham) using a Trans-Blot SD (Bio-Rad) semi dry transfer
apparatus then UV-crosslinked at 1200J/cm2 using a Stratagene Stratalinker
1800.  Membranes were prehybridized 4 hr at 42° C in prehybridization solution
(500 mM NaPO4, 7% SDS (v/v), 1 mM EDTA) then hybridized overnight at
65 C˚ in hybridization solution (500 mM NaPO4, 7% SDS (v/v), 1 mM EDTA)
containing 1 x 106 cpm/ml labeled probes.  Membranes were washed 5 times for
5 min at 23 C˚ in wash solution (40 mM NaPO4, 0.1% SDS (v/v), 1 mM EDTA)
then 2 times for 15 min at 55 C˚.  Membranes were exposed to Kodak X-OMAT
film overnight at -80° C.
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5.11 Immunoblotting
Protein samples were prepared by mixing equal volumes of protein
extract with 2x Laemli buffer (100 mM Tris-HCl (pH 6.1), 200 mM DTT, 4%
SDS (v/v), 0.2% bromophenol blue (w/v), 20% glycerol (v/v)) followed by
heating for 5 min at 100° C.  Samples were separated on 10% SDS-
polyacrylamide gels (30% acrylamide (33.5g acrylamide: 0.8g bis-acrylamide),
0.38 M Tris (pH 9.1), 5 ul TEEMED, 0.2% APS (v/v), 0.1% SDS (v/v)) for 45
minutes at 150 V in 1x SDS tank buffer (0.2M Tris, 0.76 M glycine, 14 mM
SDS, pH 8.5).  Separated proteins were electrophoretically transferred using a
semi-dry transfer apparatus (Trans-Blot SD, Bio-Rad) for 20 min at 15 V to
polyvinylidene difluoride (PVDF) membranes (Bio-Rad) which were prepared
immediately prior to transfers by soaking in methanol for 5 min at 23° C, then in
transfer buffer (25 mM Tris, 47 mM glycine, 0.8 mM SDS, 20% methanol (v/v))
15 min at 23° C.  Membranes were blocked 2hr at 23° C in TBST (20mM Tris-
HCl (pH 7.6), 137 mM NaCl, 0.1% Tween 20 (v/v)) containing 5% milk powder
(w/v) (Bio-Rad).  Primary antibodies: rabbit anti-human YY1 polyclonal, (Santa
Cruz Biotechnology Cat # sc-281), mouse anti-human PCNA monoclonal, (Santa
Cruz Biotechnology Cat # sc-56), rabbit anti-Xenopus FRGY2 polyclonal (Gift
of Dr. K. Matsumoto, RIKEN, Saito, Japan), rabbit anti-Xenopus polyclonal
nucleolin (Gift of Dr. Patrick DeMario, Louisana State University) were diluted
1:3500 in TBST containing 2.5% (w/v) milk powder and incubated with
membranes for 2h at 23° C.  Membranes were washed 3 x 5 min at 23 C˚ with
TBST followed by incubations with secondary antibodies (HRP-conjugated goat
anti-rabbit IgG, HRP-conjugated goat anti-mouse IgG, Bio-Rad) diluted 1:10,000
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in TBST with 2.5% milk (w/v) for 2h at 23 ° C.  Membranes were washed 3 x 5
minutes at 23 ° C in TBST with 2.5% milk (w/v), followed by 3 x 5 min in TBST.
Proteins were visualized by chemiluminescence (Renaissance system; Dupont
NEN Life Science Products) and autoradiography using Kodak X-OMAT film.
5.11.1 Coomassie Blue Staining
For detection of total proteins, SDS gels were soaked in 0.005%
bromophenol blue (w/v) (Bio-Rad), 10% methanol (v/v), 10% acetic acid (v/v)
for 2 hr at 23 C˚.   Gels were de-stained for 18 hr in a solution containing 10%
methanol (v/v), 10% acetic acid (v/v).
5.12 Microinjections
Oocytes and embryos were visualized using a Leica Wild 3X microscope.
All microinjections were performed using a Narishge IM 300 microinjector and a
Narishge micromanipulator (model MN-151).  
5.12.1 Plasmid microinjections
Equal amounts of CAT plasmids (20 pg for oocytes, and 100 pg for
embryos in a volume of 20 nl) were microinjected into the nuclei of stage VI
oocytes or the animal hemisphere of stage 2 embryos at 18 C˚.  Reporter plasmids
(courtesy of Dr. M. Hurt, Florida State University, Tallahassee, Florida)
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contained YY1 binding elements as follows;  pCAT, no promoter elements ahead
of the CAT gene, TKCAT, contains a thymidine kinase promoter ahead of the
CAT gene, YY1 TKCAT, contains 6 copies of the YY1 binding element
upstream of the TK promoter and CAT gene, YY1R-TKCAT , identical to YY1
TKCAT except that the YY1 consensus element is in the reverse orientation,
CRAS TKCAT, contains the coding region activating sequence from histone
H2A upstream of the TK promoter and CAT gene, YY1M-TKCAT, contains a 6
copy repeat of a mutated YY1 binding element.
Following injections, oocytes were placed at 18 ° C for 18 hours in OR2 to
allow for CAT expression. Oocytes were then homogenized in 250 mM Tris
(10ul/oocyte) on ice and centrifuged for 6 minutes 12,000 x g at 4° C.
Supernatants were placed in 1.5ml microfuge tubes and stored at -80° C.
Embryos for microinjections were placed in 20% steinberg’s solution
containing 4% Ficoll (w/v), and injected with test plasmids.  Following
microinjections embryos were allowed to recover at 18° C in 4% Ficoll for 3
hours, after which the Ficoll concentraion was reduced 1% per hour.  Embryos
were allowed to develop until stage 10 at which time extracts were prepared as
described above.
5.12.2 RNase microinjections
200 ng RNase A (Sigma) in a volume of 20 nl was injected into the
animal hemisphere of stage VI oocytes and incubated at 18 C˚ for 8 h.
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Enucleations were performed as described in section 5.1.1.  Nuclear and
cytoplasmic extracts were prepared as described in section 5.2.1.
5.12.3 YY1 mRNA microinjections
For expression of YY1 in oocytes, 200 pg of in vitro synthesized mRNA
(described in section 5.6.2) was injected into the animal hemishpere of stage VI
oocytes which were incubated for 18 hours at 18 C˚ followed by preparation of
protein extracts as described in section 5.2.1.
5.13 CAT assays
CAT assays were performed as described previously by Gorman et al.
(1982).  Reaction mixtures were assembled with 10 ul of protein extract, 20 ul
dH2O, 1 mM acetyl CoA, 0.5 ul 
14C-labelled Chloramphenicol (Mandel) (final
14C-Chloramphenicol concentration of 0.2 mCi per reaction).  Positive control
reactions contained 0.5 ul Chloramphenicol Acetyl Transferase in place of
sample protein.  Reactions were incubated for 60 min at 37 ° C then extracted with
250 ul cold ethyl acetate by centrifugation at 14,000 X g for 5 min.  Supernatants
were placed in 1.5 ml microfuge tubes and lyophilized.  Dried pellets were
resuspended in 10 ul ethyl acetate and spotted on silica Thin Layer
Chromatography (TLC, Whatman) plates.  Plates were placed in a closed TLC
chamber containing 95% chloroform/5% methanol (v/v).  Separation of reaction
products was allowed to continue until the solvent front reached the top of the
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plate at which time plates were removed from the chamber and dried at 23° C
then exposed to Kodak X-OMAT 5 film overnight at 23 ° C.
5.14 Cell culture, stable transfections and CAT assays
Chinese hamster ovary (CHO) cells were grown in McCoy’s 5A medium
supplemented with 10% calf serum, and stable transfections were performed as
described by Bushmeyer and colleagues (Bushmeyer et al., 1995).  CAT assays
with CHO cells were performed with the CAT enzyme assay system (Promega)
using liquid scintillation counting as described in the Promega technical bulletin
(part number. TB084).
5.15 Oligo(dT)-cellulose chromatography
5.15.1 Batch oligo(dT)-cellulose chromatography
Lysates were prepared by homogenization of oocytes at 4 C˚ in 4 volumes
of buffer (8% glycerol (v/v), 50 mM NaCl, 2 mM MgCl2, 10 mM TRIS-HCl (pH
7.5), 100 U/ml RNAGuard (Promega)).  Homogenates were centrifuged for 12
min at 14,000 x g at 4 C˚ supernatants were transferred to fresh tubes and were
centrifuged a second time under the same conditions to remove residual cell
debris.  Yolk proteins were removed by extraction with an equal volume of 1,1,2-
trichlorofluororethane (Freon), and supernatants were adjusted to 100 mM NaCl.
Lysates (300 ul) were applied to 100 ul aliquots of Oligo(dT)-Cellulose (New
England Biolabs) that was pre-equlibriated with 10 volumes of binding buffer
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(100 mM NaCl, 2 mM MgCl2, 10 mM TRIS-HCl (pH 7.5)) and incubated for 2.5
hr at 4 C˚ with gentle rotation.  The Oligo(dT)-Cellulose was washed with 6
volumes binding buffer and bound proteins were eluted with 400 ul binding
buffer containing 25% formamide (Fluka).
5.15.2 High pressure oligo(dT)-cellulose chromatography
Columns maintained at 4 C˚ were run at a flow rate of 0.1ml/min using a
BioLogic HR (Bio-Rad) high pressure chromatography control unit.  Oligo-(dT)-
cellulose pre-equlibriated in buffer (100 mM NaCl, 2 mM MgCl2, 10 mM TRIS-
HCl (pH 7.5)) was packed into 5 ml Econo-Column Chromatography columns
(Bio-Rad) with a resulting bed volume of 1ml.  Lysates (300 ul) were applied to
columns and PolyA+ bound proteins were eluted in 200 ul fractions with binding
buffer containing a range of NaCl from 100 mM to 2M.  Proteins were
precipitated in 5 volumes of acetone at -80 C˚, and pelleted by centrifugation for
30 min at 14,000 x g at 4 C˚ and analyzed by Western blotting as described in
section 5.11.
5.16 Size exclusion chromatography
5.16.1 Lysates
Lysates for size exclusion chromatography (SEC) were prepared by
homogenization of oocytes at the desired developmental stages in buffer C
containing 100 U/ml RNAGuard (Promega).  Homogenates were centrifuged 7
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min at 14,000 x g at 4 C˚ and supernatants were filtered through 0.2 um nylon
membranes (Gelman Laboratories) and stored at -80 C˚.  HepG2 cells were
obtained from American Type Culture Collection (ATCC) and grown in
Dulbecco’s modified Eagle’s medium (Invitrogen) supplemented with 10% fetal
bovine serum.  Cells were washed, and lysates were prepared by three freeze-
thaw cycles in 5 volumes of lysis buffer (50 mM TRIS-HCl, 50 mM KCl, 20%
glycerol(v/v), 100 um EDTA, 10 ug/ml aprotinin, 10 ug/ml leupeptin).
Homogenates were centrifuged for 5 min at 4000 x g at 4 C˚ and supernatants
were filtered through 0.2 um nylon membranes (Gelman Laboratories) and stored
at -80 C˚.
For RNase treatments, 300 ug/ml RNase A was added to lysates (that
were prepared as above but did not include RNAGuard) and incubated for 30 min
at 23 C˚.  For phosphatase treatments, lysates were incubated with 33U/ml Calf
Intestinal Alkaline Phosphatase (Boehringer Mannheim), 10x reaction buffer
(100 mM TRIS-acetate, 100 mM Mg Acetate, 500 mM potassium acetate), and
were incubated for 30 min at 23 C˚.  
5.16.2 Column running conditions
Columns maintained at 4 C˚ and run with column buffer (50mM TRIS-
HCl (pH 7.5), 50 mM NaCl, 0.1 mM EDTA) at 0.4ml/min using a BioLogic HR
(Bio-Rad) high pressure chromatography control unit.  Lysates (300 ul) were
separated on either Bio-Sil 250-5 (Bio-Rad, separation separation range 10-300
kDa) or Superdex 200 HR 10/30 (Amersham Biosciences, separation range 10-
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11,000 kDa).  Fractions (200 ul) were precipitated in 5 volumes acetone for 2 hr
at -80 C˚, and proteins were pelleted by centrigfugation for 30 min at 14,000 x g
at 4 C˚ and resuspended with 60 ul 2x Laemli buffer.  Columns were calibrated
using gel filtration standards (Bio-Rad, Cat# 151-1091) containing the following
markers: thyroglobulin (670 kDa), g  globulin (158 kDa), ovalbumin (44 kDa),
myoglobin (17 kDa), vitamin B-12 (1.35 kDa).
5.17 Immunoprecipitation of endogenous YY1 containing mRNP complexes
Overview of the procedure;
RNAs for cDNA synthesis were obtained by immunoprecipitation of
YY1-mRNPs using polyclonal YY1 antibodies (a flow chart of this procedure is
shown in Appendix 1).  Immunoprecipitated RNA was dissociated from YY1-
mRNP complexes by Protinase K digestions and precipitated in ethanol and used
as templates from which cDNAs were synthesized.  The cDNAs were digested
with HaeII (a four cutter) which produced a varied number of fragments with
blunt ends.  Adaptors that contained the restriction site for MluI were ligated to
the cDNA fragments, digested with MluI, and inserted into the BssHI (an
isoschizomer of MluI) site of modified Bluescript plasmids.  DH5a  cells were
transformed with the plasmids, positive colonies were identified then plasmids
isolated from the cells.  Plasmids containing inserts were verified by XhoI
digestions and PCR from the M13 foreward and reverse sites diluted to 100ng/ul
and sent for external sequencing at the Plant Biotechnology Centre DNA
Sequencing Facility.  Returned sequences were converted to Microsoft Word
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documents the 5’ and 3’ plasmid sequences were removed and the sequences
were used to search databases at the National Centre for Biotechnology
Information (NCBI) using the Basic Local Alignment Search Tool (BLAST).
5.17.1  Immunoprecipitations
Immunoprecipitations were performed as described by Tenenbaum et al
(2000) with modifications using Protein-A Sepharose beads (Sigma).  Stage VI
oocytes were homogenized in lysis buffer (100 mM KCl, 5 mM MgCl2, 10 mM
HEPES (pH 7.0), 0.5% Nonidet P-40 (v/v), 1 mM DTT, 100 U/ml RNAguard
(Pharmacia), 10 ug/ml Aprotinin, 10 ul/ml Leupeptin, 1 mg/ml pepstatin A) and
centrifuged for 7 min at 15,000 x g at 4 C˚.  Protein-A beads were swollen
overnight 1:5 (w/v) in NT2 buffer (50 mM Tris (pH 7.4), 150 mM NaCl, 1 mM
MgCl2, 0.05% Nonidet P-40 (v/v)) supplemented with 5% BSA (w/v).  300 ul
aliquots of the pre-swollen slurry were used for each immunoprecipitation.
Antibodies (rabbit anti-human YY1 polyclonal, Santa Cruz Biotechnology Cat #
sc-281, anti-human PCNA monoclonal, Santa Cruz Biotechnology Cat # sc-56)
were added in excess (2000 ng) to the Protein-A Sepharose beads and were
incubated overnight at 4˚C with slow rotation.  Antibody coated Protein-A beads
were washed 5 times with 1 ml of ice-cold NT2 buffer, and centrifuged following
each wash for 30s at 500 x g at 23˚C, then resuspended with 850 ul NT2.
Immunoprecipitation reactions were assembled by adding 20 mM EDTA, 100
U/ml RNAGuard, 1 mM DTT, 200 ul cell lysate to the washed Protein-A beads
and incubating the mixtures for 3 hr at 23˚C with slow rotation (45 rpm).
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Reactions were washed 5 times with 1 ml NT2 buffer and centrifuged 30s at 500
x g at 23˚C discarding the supernatant after each wash.  The beads were
resuspended with 100 ul NT2 buffer supplemented with 0.1% SDS (v/v), 30 ug
Protinase K (Sigma) and incubated for 30 min at 55˚C.  Reactions were
centrifuged 1 min at 14,000 x g at 23˚C and supernatants were transferred to 1.5
ml microfuge tubes.  The beads were washed 3 times with 200 ul NT2 buffer
followed by centrifugation for 1 min at 14,000 x g at 23 C˚ to collect residual
RNAs.  Immunoprecipitated RNAs were extracted once with phenol/chloroform
(1:1) and precipitated overnight with 1/10 volume 3M sodium acetate and 2
volumes ethanol.  RNAs were recovered by centrifugation for 30 min at 14,000 x
g at 4˚C, ethanol was aspirated and pellets were washed with 1 ml of 70%
ethanol then centrifuged 2 min at 14,000 x g at 4˚C.  RNAs were re-suspended
with 5 ul DEPC treated dH2O supplemented with 100 U/ml RNAGuard and used
immediately in cDNA synthesis reactions.
5.18 cDNA synthesis.
RNAs were heated for 5 min at 65 C˚ then immediately placed on ice.
First strand reactions were assembled in a total volume of 200 ul as follows: 500
uM dNTPs (dATP, dCTP, dGTP, dTTP), 40 ul RT buffer (250 mM TRIS-HCl
(pH 8.2), 250 mM KCl, 30 mM MgCl2), 10 mM DTT, 10ug random hexameric
primers (GibcoBRL), and 10 U RNAGuard (Pharmacia).  Chilled RNAs were
added to reaction mixtures on ice and 200 U AMV Reverse Transcriptase
(Promega) was added then gently mixed.  The reactions were incubated 10 min at
89
23 C˚, then 1.5 hr at 37 C˚, and were terminated by the addition of 10 mM EDTA.
First strand cDNAs were extracted with 200 ul Phenol (1:1) and were centrifuged
5 min at 14,000 x g at 4 C˚.  The phenol was re-extracted with 100 ul TE (pH 7.6)
centrifuged 5 min at 14,000 x g at 4 C˚ and both the phenol and TE extractions
were pooled then precipitated 24 hr at -80 C˚ in 2 M ammonium acetate and 950
ul of 95% ethanol.  Precipitates were centrifuged 15 min at 14,000 x g at 4 C˚,
supernatants were discarded and pellets were washed with 1 ml of 70% ethanol
and centrifuged for 2 min at 14,000 x g at 4 C˚.  Pellets were dried 10 min at 37 C˚
and resuspended with 284ul dH2O.
Second strand reactions (400 ul total reaction volume) contained 284 ul
first strand DNA, 50 uM dNTPs (dATP, dCTP, dGTP, dTTP), 80 ul second
strand reaction buffer (100 mM Tris-HCl (pH 8.2), 500 mM KCl, 25 mM MgCl2,
50 mM (NH4)2SO4, 50 mM DTT, 250 ug/ml BSA), 150 um NAD
+, 1 mM ATP,
10 U/ml RNase H, 50 U/ml E. Coli DNA ligase, 250 U/ml Ecoli DNA
polymerase and were incubated for 16 hr at 14 C˚.  Second strand reactions
cDNAs were extracted with 400 ul phenol (1:1) and centrifuged 5 min at 14,000
x g at 4 C˚.  Residual phenol was re-extracted with 200 ul TE (pH 7.6) and
centrifuged 5 min at 14,000 x g at 4 C˚ and both phenol and TE extractions were
pooled then extracted with 300 ul chloroform (1:1) and centrifuged 5 min at
14,000 x g at 4 C˚.  Extracted cDNAs were equally divided into two 1.5 ml
microfuge tubes both of which were precipitated 24 h at -80 C˚ in 2.5 M
ammonium acetate and 950ul 95% ethanol.  cDNAs were pelleted by
centrifugation for 30 min at 14,000 x g at 4 C˚, washed with 1 ml of 70% ethanol,
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centrifuged 5 min at 14,000 x g at 4 C˚, resuspended with 10 ul dH2O and stored
at -80 C˚.
5.18.1 cDNA enrichment and cloning
5.18.1.1 Adaptor ligation and polymerase chain reaction
To produce blunt ends (necessary for adaptor ligation), cDNAs were
digested with HaeIII (New England Biolabs).  Reactions were assembled with
the following components, 10 ul cDNA, 1.5 ul 10x HaeIII reaction buffer (50
mM Tris-HCl (pH 8.0), 10 mM MgCl2, 50 mM NaCl), 1U HaeIII, and were
incubated for 1 hr at 37 C˚.  Adaptors containing a restriction enzyme recognition
site for MluI (5’-A/CGCGT-3’),
5’--C T C T  T G C T T  A C G C G  T G G A C T A – 3’
                   3’—A C A C G A G A A C G A A  T G C G C A C C  T G A T--5’
were ligated to the blunt digested cDNAs.  Ligation reactions (total volume 20
ul) containing 10 ul digested cDNAs, 1 mM ATP, 2000 U/ml T4 DNA ligase
(Promega), 1 ug MluI adaptors were assembled and incubated 20 hr at 20 C˚.  The
ligation reactions were were transferred to 500 ul microfuge tubes and
polymerase chain reactions (PCR) were assembled (50 ul) with; 10 ul adaptor
ligated cDNA, 5 ul 10x Taq reaction buffer (500 mM KCl, 15 mM MgCl2, 100
mM Tris-HCl (pH 9.0)), 200 ng primer (5’CTCTTGCTTACGCGTGGACTA -
3’), 0.2 mM dNTPs (dATP, dCTP, dTTP, dGTP), and 2.5 U Taq DNA
polymerase (GibcoBRL).  Reactions were thermocycled in a MJ Research PTC-
150 Minicycler which was programmed as follows; pre-amplification
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denaturation, 5 min at 95 C˚, (1) 30 sec at 95 C˚, (2) 1 min at 60 C˚, (3) 3 min at
72 C˚, (4) cycle 24 times to step (1), (5) 10 min at 72 C˚, (6) hold at 14 C˚, (7) end
of protocol.  After thermocycling the reaction volumes were increased to 200 ul
with dH2O.  DNAs were recovered by extraction with 200 ul phenol (1:1) and
centrifugation for 5 min at 14,000 x g at 23 C˚.  The phenol phase was then re-
extracted with 100 ul TE (pH 7.5) and centrifuged for 5 min at 14,000 x g at
23 C˚.  The phenol/TE extracted DNA was next extracted with 300 ul chloroform
(1:1) followed by re-extraction of the chloroform with 100ul TE (pH 7.5) by
centrifugation for 5 min at 14,000 x g at 23 C˚.  Amplified cDNAs were
precipitated 20 hr at -80 C˚ with the addition of 100 mM NaCl and 1 ml 95%
ethanol.  Precipitates were centrifuged for 30 min at 14,000 x g at 4 C˚, ethanol
was aspirated and pellets were re-suspended in 20ul dH2O.
5.18.1.2 DEAE electroelution
DEAE electroelution was performed as described by Dretzen (Dretzen et
al., 1981) with modifications.  Amplified cDNAs were digested with MluI for 1
hr at 37 C˚.  Reactions were assembled with; 20ul PCR amplified cDNA, 2.4ul
10x MluI buffer (50 mM Tris-HCl (pH 8.0), 10 mM MgCl2, 50 mM NaCl), 1 U
MluI, and 0.6ul dH2O.  Digested fragments were mixed with non-denaturing
loading dye (50% (v/v) glycerol, 0.005% (w/v) bromophenol blue, and 0.005%
(w/v) xylene cyanol) and separated for 1 hr at 5v/cm on a Mini-Sub
electrophoresis system (BioRad) through 0.8% Agarose (BioRad)/ethidium
bromide (10 pg/ml) (Sigma) gels run in 1x TAE buffer  (0.04 M Tris-acetate,
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0.001 M EDTA).  DEAE membranes were cut into 1 cm2 squares, and were
prepared for electro-elution by soaking in 1x TAE 24 hr at 4 C˚.  Separation of
digested DNAs was monitored using a handheld longwave UV lamp.  DEAE
membranes were inserted into the gel at the 500 bp level (as judged by
comparison to co-electrophoresed l  HindIII digested marker) and the DNAs
were electrophoresed onto the membranes for 45 min at 5V/cm.  Membranes
containing bound DNAs were removed from agarose gels and placed in 15 ml
Falcon tubes containing 5ml NET (150 mM NaCl, 0.1 mM EDTA, 20 mM TRIS-
HCl (pH 7.5)) and washed overnight at 4 C˚ by repeated inversion.  DEAE
membranes were then transferred to 1.5 ml microfuge tubes (the NET was
discarded) containing 200 ul HSNET (1 M NaCl, 0.1 mM EDTA, 20 mM TRIS-
HCl (pH 7.5)) and were washed for 45 min by rotation at 65 C˚.  The initial 200
ul HSNET was removed and saved.  Membranes were washed a second time
with 100 ul HSNET by rotation for 10 min at 65 C˚ and the HSNET was pooled
with that from the first high salt wash 900 ul dH2O-saturated butanol was added
and DNAs were extracted by vortexing 30 sec.  The residual dH2O-saturated
butanol was extracted by the addition of 100 ul dH2O followed by vortexing for
30 sec, and both extractions were pooled then precipitated overnight at -20 C˚ by
the addition of 1 ml 95% ethanol.  DNAs were collected by centrifugation for 30
min at 14,000 x g at 4 C˚, ethanol was aspirated and the pellets were washed once
with 800 ul ice cold 70% ethanol and centrifuged for 5 min at 14,000 x g at 4 C˚,
and pellets were resuspended with 20 ul dH2O and stored at -80 C˚.
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5.18.1.3 Ligations
cDNAs containing MluI ends (an isoschizomer of BssHII) were ligated
into the BssHII site of modified Bluescript KS+vectors, multiple cloning site
shown below;
          5’-
GAATTCCTCGAGGCGCGCCTCGAGGGATCCTCTAGAGTCGACCTGCAGGCAAGCTT-
3’
 EcoRI      XhoI       BssHII     XhoI      BamHI       XbaI     SalI     PstI      SphI
HindIII
Ligation reactions were assembled with 2.5 ul DNA, 2 ul T4 DNA Ligase
buffer (100 mM TRIS-acetate, 100 mM magnesium acetate, 500 mM potassium
acetate) 1 ul pBluescript KS+ (25 ng/ul), 1 mM ATP, 2.5 U T4 DNA Ligase
(GibcoBRL), 5 U MluI, and were incubated overnight at 20 C˚.  Circularized
plasmids were precipitated for 30 min at -20 C˚ by the addition of 5 ul tRNA
(1ug/ul), 20 ul ammonium acetate (5M), 70 ul 95% ethanol, then centrifuged 20
min at 14,000 x g at 4 C˚.  Ethanol was discarded and the pellets were washed
with 100 ul ice cold 70% ethanol and centrifuged 2 min at 14,000 x g at 4 C˚.
Pellets were air dried for 30 min then resuspended in 5 ul dH2O.
5.19 Transformations
 DH5 a  cells were transformed with plasmid DNAs by the method
described by Sambrook (Sambrook, 1989).  Competent cells for transformations
were prepared by inoculating 10 ml culture tubes containing 5.0 ml of YT-media
(5 g yeast, 10 g Tryptone, 5 g NaCl, 250 ml dH2O) with DH5 a  cells and grown
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overnight at 37°C with shaking at 200 rpm.  100 ul aliquots of this cell
suspension were transferred to new culture tubes containing 5 ml of YT-media,
and grown for 6 hr at 37°C with shaking at 200 rpm.  Cells were pelleted by
centrifugation for 10 min at 4000 x g at 23 C˚, supernatants were discarded, and
2.5 ml of cold CaCl2 (50 mM) were added.  The cells were gently re-suspended,
incubated on ice for 1 hr then centrifuged for 10 min at 4000 x g at 23 C˚.
Supernatants were discarded and cell pellets were re-suspended in 500 ul of
CaCl2 (50 mM) and put on ice.  Transformation mixtures were assembled with 1
ul of plasmid DNA, 9 ul dH2O, 20 ul TCM buffer (10 mM Tris-HCl (pH 7.4), 10
mM CaCl2, 10 mM MgCl2) and 100 ul aliquots of the competent cell suspension
were added to the transformation mixtures and incubated on ice for 1 hr.
Transformation mixtures were heat shocked for 2 min at 42°C then allowed to
recover for 15 min at 23 C˚.  300 ul prewarmed (37 C˚)  YT-media was added, and
mixtures were incubated for 30 min at 37°C, then plated on S-Gal/ampicillin
plates (Sigma) and grown overnight at 37 C˚.
5.20 Screening of immunoprecipitated YY1-associated RNAs
5.20.1 Plasmid preparations
For preparation of plasmid DNAs for sequencing, culture tubes (10 ml,
Falcon) containing 5 ml of YT-Broth (5 g yeast, 10 g Tryptone, 5 g NaCl, 250 ml
dH2O)  and 375 ug ampicillin were innoculated with positive colonies from S-
Gal plates and grown overnight at 37 C˚ x 200 rpm.  Bacterial cells were collected
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by transferring media to 1.5 ml microfuge tubes which were centrifuged 20 sec at
14,000 x g at 23 C˚ and the media was discarded.  Plasmids were isolated by
alkaline lysis using Promega Wizard Miniprep Kits.  Plasmids positive for insert
were identified by PCR and restriction enzyme digestion using XhoI.
5.20.2 Polymerase chain reaction screening.
Polymerase chain reactions were assembled in 500 ul microfuge tubes
with the following components in a total reaction volume of 41 ul; 4.1 ul 10x Taq
reaction buffer (500 mM KCl, 15 mM MgCl2, 100 mM Tris-HCl (pH 9.0)), 0.75
ul M13 foreward/reverse primers (Invitrogen, Cat#18432-013, 100 ng/ul), 0.2
mM dNTPs (dATP, dCTP, dTTP, dGTP), 2.5 U Taq DNA polymerase
(GibcoBRL), 32.5 ul dH2O.  Reactions were thermocycled in a MJ Research
PTC-150 Minicycler which was programmed as follows; pre-amplification
denaturation, 2 min at 94 C˚, (1) 1min at 94 C˚, (2) 50 sec at 61 C˚, (3) 90 sec at
72 C˚, (4) cycle 29 times to step (1), (5) 5 min at 72 C˚.  Products were analyzed
on 1% Agarose (BioRad)/ Ethidium bromide (10pg/ml) gels run in 1x TAE
buffer  (0.04 M Tris-acetate, 0.001 M EDTA), and gel images were captured on
ScionImage (V1.1) software.
  Plasmids containing inserts were diluted to 100 ng/ul and sent for
sequencing from the M13 reverse primer at the DNA Sequencing
Laboratory/National Research Council (Saskatoon, Saskatchewan).  Sequence
data was converted into Microsoft Word™ documents and the 5’ and 3’
sequences were removed yielding the sequenced insert.  Insert sequences were
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copied into the Basic Local Alignment Search Tool (BLAST) (located at
http://www.ncbi.nlm.nih.gov/BLAST/) run by the National Centre for
Biotechnology Information (NCBI).  The BLAST was used to identify the insert
sequences by comparison to those existing in the NCBI database.  Virtual
digestions were carried out using software located at:
http://tools.neb.com/NEBcutter/index.php3.  Searches for open reading frames
(ORF) were conducted using software (open reading frame finder (ORF Finder))
located at the NCBI (http://www.ncbi.nlm.nih.gov/gorf/gorf.html) using
standard genetic code.
5.21 BLAST searches and parameters
Sequences were compared to both the nucleotide (nr) and expressed
sequence tag (EST) databases using the BLAST.  This allows comparison of
input nucleotide sequences against those in the database.  The parameters used
were as follows; Low complexity filter, Expect Value – 10, Word Size – 11. 
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6.0 Results
6.1  DNA gel mobility shift assay shows specific YY1 binding activity
Previously in our laboratory, a DNA binding activity was observed in
Xenopus embryos that was specific for the internal coding region activator a
element (CRAS a ) of replication-dependent histone genes, however the protein(s)
in these complexes were not identified (Ficzycz et al., 1997).  Subsequently, a
yeast one-hybrid screen of a HeLa cell cDNA library performed in the laboratory
of Myra Hurt established that the protein interacting with the histone regulatory
sequence in mammalian cells was the Yin Yang 1 (YY1) transcription factor
(Eliassen et al., 1998).
In our previous study, YY1 was referred to as p85 which was derived
from its approximate molecular mass as determined by ultraviolet cross-linking
(Ficzycz et al., 1997).  In order to confirm that the p85 binding activity was
indeed YY1, gel mobility shift assays were performed using the YY1 binding
element and specific YY1 polyclonal antibodies (sc-281, Santa Cruz
Biotechnology).  The YY1 antibodies used in this study are directed against the
mammalian form of YY1.  In order to ensure that the YY1 antibodies would
recognize the frog form of YY1, an amino acid sequence alignment was
performed by Santa Cruz Biotechnology (Santa Cruz, California) with the
peptides used to make the YY1 antibodies and homologus regions of the frog
protein.  This showed a 100% alignment between homologus regions of human
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Developmental profile of YY1 DNA binding activity.
A) Western blot of extracts prepared from stage VI oocytes that were microinjected with
mRNAs encoding Xenopus YY1.  Microinjection of mRNA is indicated at the top of the panel. B)
Gel mobility shift assay of rat liver nuclear (RLN), A6 and neurula stage embryo (St 13) extracts
using the YY1-binding element.  Antibodies (recognizing YY1, nucleolin or PCNA) were added to
binding reactions as indicated above the panel.  The positions of non-specific (NS) and specific
(YY1) bands are indicated at the left.  C) Gel mobility shift analysis showing relative YY1-DNA
binding activity in staged oocyte and embryonic lysates.  Developmental stages are indicated above
the panel.  The addition of competitor YY1 antibodies is indicated above the panel. D)  Gel mobility
shift analysis of AP-1 DNA binding activity during development.  The addition of unlabeled com-
petitor oligonucleotides (50-fold molar excess) is indicated below the panel.
Figure 2
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and frog YY1 (the alignment was performed by Santa Cruz Biotechnology; the
sequences of epitopes against which the antibody was made is proprietary).
Therefore it was expected that these antibodies would recognize the frog protein.
To provide further evidence that these antibodies recognize frog proteins, in vitro
synthesized YY1 mRNA encoding the frog protein were microinjected into stage
VI oocytes and incubated for 16 hr at 18 C˚ to allow for translation.  Analysis of
protein extracts by Western blotting indicated an increased detection of the YY1
signal (Figure 2A, lane 2) versus uninjected controls (Figure 2A, lane 1).
 To confirm the identity of the Xenopus factor, gel mobility shift assays
were performed using the CRASa  element which contains the known YY1
consensus sequence (5’-CATGGCG-3’ (Figure 2B) (Ficzycz et al., 1997).
Multiple complexes were detected after incubation of stage 13 embryonic
extracts with the YY1 binding element (Fig 2B, lane 5).  The addition of
polyclonal anti-YY1 (in vitro) antibodies to binding reactions disrupted the lower
complex indicating that it is the YY1-specific binding complex (Figure 2B, lane
6). Similar YY1 complexes and specific antibody disruptions were observed with
rat liver nuclear extracts (Fig 2B, lane 2) and crude whole cell extracts from the
A6 Xenopus kidney epithelial cell line (Fig 2B, lane 4).  The prominent slower
migrating complexes were not recognized by YY1 antibodies and are thought to
represent non-specific interactions that occur between the DNA probe and
nuclear factors present in Xenopus oocyte and embryo extracts (Ovsenek et al.,
1991).  The addition of polycloncal antibodies against PCNA or nucleolin did not
have any effect on the YY1 complex (Figure 2B, lanes 7 and 8).
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To examine YY1 DNA binding activity during development, crude whole
cell extracts were prepared from staged oocytes, eggs and embryos and subjected
to gel mobility shift assays using the YY1 binding element probe (Figure 2C).
The specific YY1 complex was detected in stage I and II oocytes (lane 1) as well
in embryos after the MBT (lanes 7-9) however no DNA binding activity was
seen in extracts taken between oocyte stage I/II and embryo stage 9 (lanes 2-6).
Addition of YY1 antibodies to binding reactions (lane 10) resulted in disruption
of the complex confirming the identity of YY1 complexes in these assays.
Controls were performed in order to test the possibility that the
fluctuations seen in the DNA binding of YY1 may be due to non-specific
biochemical properties of the extracts at different stages of development.  The
DNA-binding activity of the AP-1 transcription factor has been shown to be
stable through this period of development (Gordon et al., 1996).  Gel shifts using
the same extracts as in Figure 2C and the AP-1 consensus site probe
demonstrated that the DNA binding activity of AP-1 was stable throughout the
developmental stages analyzed (Figure 2D).  The addition of unlabeled AP-1
competitor oligonucleotides resulted in a complete competition of the binding
complex (lane 5) while the addition of YY1 competitor oligonucleotides (lane 6)
had no effect on AP-1 binding activity.
6.2  Northern blot analysis of YY1 mRNA expression during Xenopus
development
Northern blot analysis was performed to examine the pattern of YY1-
mRNA expression during early development.  Data shown in Figure 2C indicated
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Northern blot analysis of YY1 during Xenopus development.
Northern blot analysis of YY1 mRNA expression during oocyte and embryonic development.
Each lane contains 10ug total RNA isolated from developing oocytes (Roman numerals),
unfertilized eggs (E) and embryos (Arabic numerals, shown at top of panel).  Poly(A) and Poly(A)
RNA is shown at the top of the panel (lanes 11 and 12).  The positions of the RNA markers (Kb) are
shown at the left side of the panel.   The position of the YY1 mRNA is indicated on the right side of
the panel.
+ -
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that the DNA binding activity of YY1 was not constant throughout development,
thus YY1 mRNA levels were analyzed to determine whether these fluctuations
may be attributable to changes in the levels of YY1 mRNA expression during
development.  Total RNA was isolated from oocytes and embryos at various
stages of development, and electrophoresed through agarose/formaldehyde gels,
transferred to nylon membranes and probed with 32P-labeled YY1 cDNA probes.
A 4-kilobase mRNA transcript was detected (Figure 3).  Relatively constant
amounts of YY1 mRNA signal were detected in early and late stage oocytes
(lanes 1-4), unfertilized eggs (lane 5), in cleavage (lanes 6-8), and early neurula
stage embryos (lanes 9-10).  Due to the fact that zygotic transcription does not
commence until the MBT (Newport and Kirschner, 1982a) it appears that
transcription of the maternally encoded YY1 gene occurs very early during
oogenesis.  These blots also indicate that the maternal transcripts are relatively
stable throughout fertilization and early embryonic development.  The YY1
mRNA transcripts detected in Northern blots migrated just below the 28S
ribosomal RNA bands. To rule out the possibility of cross-hybridization to
ribosomal RNA, hybridization of the YY1 probe to Poly-(A)+ (lane 12) and Poly-
(A)- (lane 11) RNA isolated over oligo(dT) columns was analyzed.  The 4 Kb
YY1 mRNA signal was detected in Poly-(A)+ samples containing mRNA, but
not in the Poly-(A)-  sample containing ribosomal RNA.
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6.3 Western blot analysis of YY1 protein levels during development
Protein expression during development was characterized by Western
blot analysis.  Whole cell lysates were prepared from normally developing
oocytes and embryos.  Aliquots were separated on 10% polyacrylamide gels,
transferred to nylon membranes and probed with anti-YY1 antibodies.  A single
prominent 59 kDa protein was detected in unfertilized eggs and developing
embryos from cleavage through to neurula stages (Figure 4A).  The relatively
constant levels of YY1 protein are consistent with the constant levels of mRNA
detected on Northern blots (Figure 3).  The constant levels of YY1 observed
during early development by this assay provided evidence that the changes seen
in the DNA binding activity of YY1 (Figure 2C) are not due to fluctuations in the
absolute levels of maternally expressed YY1.
Protein levels of YY1 were also examined during oogenesis and through
oocyte maturation, fertilization and early embryogenesis (Figure 4B).  Similar
amounts of YY1 protein were observed in extracts from oocyte stages and
embryonic stages.  However, in stage I and II oocytes, the YY1 signal was
significantly smaller with an estimated molecular mass of 50 kDa (Figure 4B,
lane 1).  A more detailed analysis of of YY1 expression during oogenesis is
shown in Figure 4C.  This showed that YY1 is predominantly a 50 kDa protein in
stage I oocytes (lane 1) but by stage VI (lane 6) the majority of YY1 migrates as
a 59 kDa species.  The molecular mechanism resulting in the shift in mass is not
presently known.
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Western blot analysis of YY1 protein during development.
Each lane contains 10 ug oocyte/embryonic protein isolated from devlopmental stages as
indicated at the top of each panel.  In each blot, the samples were obtained from the same batch of
oocytes/embryos to reduce variability between different females.  A)  Western immunoblot of staged
extracts from eggs (E), and embryos at various stages of development.  B)  Western immunoblot
showing a comparison of YY1 expression in early and late oocytes and at stages of development
around fertilization.  C)  Western immunoblot showing comparison of YY1 expression during each
stages of oogenesis.  Positions of protein molecular weight markers are indicated at the left of the
panels.
Figure 4
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6.4  Phosphorylation state affects DNA binding activity of YY1
Next, the effects of phosphorylation on the DNA-binding activity and
relative molecular mass of YY1 were examined.  A correlation was observed
between appearance of the 50 kDa isoform of YY1 and a strong DNA binding
activity in early stage oocytes (Figure 2B).  As the oocyte matures, both of these
attributes change, that is the molecular mass increases to 59 kDa, concomitant
with the reduction of DNA binding activity.  Dephosphorylation by in vitro
phosphatase treatment of cleavage stage embryonic extracts was known to result
in recovery of DNA binding (Ficzycz et al., 1997).  In addition, Becker and
colleagues (Becker et al., 1994) identified 8 consensus phosphorylation sites
within human YY1 and showed that in Jurkat T-cell nuclear extracts,
phosphorylation was sufficient to cause an increase in the molecular mass
detectable by Western blotting.  Thus it was hypothesized that
hypophosphorylation of YY1 could contribute to both the high level of DNA
binding activity and appearance of the smaller 50 kDa isoform found in early
oocytes.  As oogenesis proceeds, an unidentified kinase might phosphorylate
YY1 resulting in both an increase in the molecular mass of YY1 and a loss of
DNA binding activity.  This hypothesis was tested by gel mobility shift assays
and Western blotting using stage VI oocytes.  Phosphatase treatment resulted in a
partial recovery of DNA binding activity (Figure 5A, lane 2).  This suggests that
YY1 binds DNA more efficiently in the dephosphorylated state and raised the
possibility that DNA binding activity of YY1 might be differentially regulated by
phosphorylation during development.  Also, it was possible that the increase in
the apparent molecular weight of YY1 during oocyte development might be
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Figure 5
Effect of phosphatase treatment on YY1 molecular mass and DNA binding affinity.
A) Stage VI oocyte extracts were treated with calf intestinal alkaline phosphatase prior to
binding reactions and were analyzed by gel mobility shift assays for DNA binding activity with the
YY1 probe.  B)  Western immunoblot of stage VI oocyte extracts (the same extracts that were
analyzed in Figure 5 A) treated with CIAP and analyzed for changes in the molecular mass of YY1.
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attributable to increased phosphorylation.  However, Western blots showed that
YY1 was detected at 59 kDa in both phosphatase-treated (Figure 5B, lane 2) and
untreated extracts (lane 3).  This indicates that the increase in the apparent
molecular weight of YY1 in stage VI oocytes is probably not attributable to
phosphorylation in vivo.
Additionally, these assays do not necessarily indicate that the
dephosphorylation event brought about by the addition of CIAP occurs directly
on the YY1 molecule.
6.5 Transcriptional activity of YY1
Given that relatively constant levels of YY1 with fluctuating DNA-
binding activity are present in oocytes and embryos, it was of interest to analyze
the transcriptional activity of this factor during development.  This was examined
using a series of reporter constructs containing the thymidine kinase (TK)
promoter linked to YY1 binding sites upstream of the Chloramphenicol Acetyl-
Transferase (CAT) gene.  Six reporter constructs were used in these experiments
(Figure 6A).  Control constructs contained only the CAT reporter with no
promoter elements (pCAT), or the thymidine kinase promoter located
immedately upstream of the CAT reporter (TK-CAT).  Previous experimental
data had shown that YY1 elements placed in front of the TK promoter were able
to activate CAT activity in mouse cells (Eliassen et al., 1998; Palla et al., 1989).
YY1-TKCAT contains 6 consecutive YY1 binding elements from the histone
CRAS (including flanking regions) of the mouse H3.2 gene (Eliasson et al.,
1998) in the forward orientation inserted upstream of the TK promoter.  YY1R-
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TKCAT contains the same YY1 binding elements in the reverse orientation
upstream of the TK promoter.  YY1M-TKCAT contains 6 repeats of a mutated
YY1 binding element (5’-tgagctatTGGTGCTttgcag-3’), and CRAS-TKCAT
contains a single YY1 binding site upstream of the TK promoter.
Batches of at least 100 embryos were injected at the 2 cell stage or 100
oocytes at stage VI were injected individually with 200 pg of each construct
DNA.  Embryos were allowed to develop at 18 C˚ to stage 10 (gastrula) and
oocytes were incubated for 18 hours at 18 C˚ to allow sufficient time for reporter
expression.  Extracts were prepared from oocytes and embryos and CAT activity
was analyzed by thin layer chromatography.  No
CAT activity was observed in either oocytes (Figure 6B, lane 1) or embryos
(Figure 6C, lane 1) that had been injected with constructs that did not contain a
promoter (pCAT).  Oocytes or embryos injected with the TK promoter upstream
of the CAT reporter showed a detectable level of reporter activity (Figure 6B,C,
lane 2).  Relative to this level of expression, none of the combinations of YY1
binding elements were able to stimulate or repress activity from the TK promoter
in oocytes or post-MBT embryos (Figure 6B,C, lanes 3-6).  Control experiments
using Chinese Hamster Ovary (CHO) cells (Figure 6D) demonstrated that YY1
binding elements situated upstream of the TK promoter are able to influence
CAT activity (Ficzycz et al., 2001) resulting in a 3-fold increase over basal
promoter activity indicating these constructs are responsive to YY1 binding
elements.  These data indicate that YY1 is transcriptionally inactive in oocytes
and post-MBT embryos.
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Figure 6
A)  Diagram of plasmid constructs containing the CAT gene driven by the TK promoter and
YY1 elements.  B)  Stage VI oocytes were microinjected with the indicated plasmids and incubated
for 8 hours at which time CAT assays were performed. (upper panel).  The experiment was repeated
at least 5 times with different batches of oocytes and representative data is shown.  C) Embryos
were microinjected after fertilization with the indicated plasmid constructs and then allowed to
develop to the gastrula stage at which point CAT assays were performed (upper panel).  The experi-
ment was repeated at least 5 times with different batches of embryos; representative CAT assays are
shown.  CAT activity is expressed as a perecentage of the highest relative activity (TK-CAT) which
was arbitrarily assigned a value of 100 (lower panel).  D) CAT assays of stable transfectant CHO
cells.  Constructs are indicated above the panel.  Activity is presented as percent acetylation.  The
experiment was performed with triplicate sets of plates.
Transcriptional activity of YY1 in oocytes and post-MBT embryos.
112
Figure 6
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In stage VI oocytes, the finding that YY1 was transcriptionally inactive
was not surprising given the absence of DNA binding activity during this period
of development (Figure 2C, lane 2) (Ficzycz et al., 1997).  In addition, these
findings are in agreement with the results of others showing that the YY1 binding
site from the L1 and L14 ribosomal protein genes did not affect transcription of
reporter constructs in oocytes (De Rinaldis, et al., 1998).  However it is
interesting that YY1 binding elements did not have any effect on transcription in
post-MBT embryos given that DNA binding activity at these stages of embryonic
development is restored to high levels (Figure 2C, lanes 7-9l) (Ficzycz et al.,
1997).  The lack of transcriptional activity of YY1-containing constructs seen in
this experiment is explained later in this thesis by exclusion of YY1 from the
nucleus during development.
6.6 Subcellular localization of YY1
A recent study of the developmental role of YY1 in mouse
embryos has revealed that it is localized to the cytoplasm of unfertilized mouse
oocytes and displays a mosaic pattern of sub-cellular localization in E3.5
blastocysts (Donohoe et al., 1999).  This was the first study to indicate that YY1
may not be exclusively localized to the nucleus, and the results in mouse
suggested that nucleocytoplasmic partitioning could play a role in YY1-
regulation in Xenopus embryos.
The subcellular distribution of YY1 in the cells of the developing frog
was next  analyzed.  Stage VI oocytes were manually dissected into nuclear and
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Figure  7
B  Western blot
Detection of YY1 in cytoplasmic fractions from oocytes and post-MBT embryos.
A) Western immunoblot analysis of YY1 in Stage VI oocytes.  Oocytes were manually dis-
sected into nuclear (N) and cytoplasmic (C) fractions, (W) indicates whole cell extracts.  Blots were
probed with anti-YY1 polyclonal (lanes 1-3) and Anti-PCNA (lanes 4-6) monoclonal antibodies
(indicated at the right of each panel).  B)  Western immunoblot analysis of YY1 in stage 13 embryos
that were fractionated into nuclear (N) and cytoplasmic (C) fractions, (W) indicates whole embry-
onic extract.  Blots were probed with anti-YY1 polyclonal (lanes 1-3) and anti-PCNA (lanes 4-6)
monoclonal antibodies .
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cytoplasmic fractions which were analyzed by Western blotting.  YY1 was
present in cytoplasmic (Figure 7A, left panel, lane 2), but not nuclear fractions
(Figure 7A, left panel, lane 3) indicating that YY1 is a cytoplasmic protein in
later stage oocytes.  Control blots were analyzed for the presence of proliferating
cell nuclear antigen (PCNA) which is an exclusively nuclear DNA binding
protein.  As seen in the right panel of Figure 7A, PCNA is detected only in the
nuclear fractions (lane 6) confirming that the enucleation procedure was carried
out with no cross contamination between nuclear and cytoplasmic fractions.
Biochemical fractionation into nuclear and cytoplasmic components was
employed to determine the subcellular localization of YY1 in embryos.  Western
blotting showed that YY1 was detected in cytoplasmic fractions (Figure 7B, left
panel, lane 2), but not in nuclear fractions (Figure 7B, left panel, lane 3) obtained
from neurula stage embryos (stage 13).  In control blots PCNA was detected only
in nuclear fractions (Figure 7B, left panel, lane 6) again indicating that the
fractionation was completed without contamination of nuclear or cytoplasmic
fractions.
An immunocytochemical study of the subcellular distrubution of YY1 in
Xenopus oocytes and embryos carried out by C. Eskiw in our laboratory showed
that YY1 is present exclusively in the cytoplasm from stage I oocytes through to
neurula stage embryos (Ficzycz et al., 2001).  When adult frog liver sections
were analyzed for YY1 by immunocytochemistry, it was found to be present in
the nuclei, however the precise time and location of YY1 translocation from
cytoplasm to nuclei during development has not been determined (Ficzycz et al.,
2001).  These data suggest that the cytoplasmic localization of YY1 in the
116
developing frog is likely to account for the complete absence of transcriptional
activity seen in Figure 6.
6.7 YY1 Contains a Known RNA-Binding Domain
Structural analysis of mammalian YY1 has shown that it contains four
C2H2 zinc finger domains that are essential for DNA binding activity (Galvin and
Shi, 1997, Thomas and Seto, 1999).  The presence of zinc fingers in YY1
provided an initial clue as to a potential function for this protein in the cytoplasm.
Certain RNA-binding proteins such as TFIIIA, which is known to bind 5S rRNA
(Brown et al., 1988), display some sequence similarity to zinc finger DNA-
binding transcription factors, particularly in the spacing of key cysteine and
histidine residues (Burd and Dreyfuss, 1994).  The amino acid sequence of
Xenopus YY1 was analyzed for similarity to established RNA binding motifs.
Figure 8 shows an amino acid alignment of Xenopus YY1 and TFIIIA between
residues 255 and 287. Located within the zinc fingers is a known RNA binding
motif, the Zinc Finger Knuckle.  No significant similarities were found between
YY1 and any other RNA binding motifs.
6.8 Endogenous YY1 interacts with maternal mRNAs.
The conserved spacing of key residues within the zinc finger knuckle
binding domain of YY1 suggested that it might bind RNA in the oocyte and
could therefore be a component of mRNP complexes.  To investigate this,
Xenopus oocyte lysates were analyzed for their capacity to be retained by oligo-
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Figure 8
Conservation of a zinc finger/knuckle RNA-binding domain in YY1
A partial amino acid alignment of Xenopus YY1 (PDB accession number JC2426) and
TFIIIA (PDB accession number TWXL3) are shown.  Key cysteine and histidine residues are
boxed.  Asterisks denote conserved residues.
        255 287
YY1             I  A C P H K G C T K M F R D  N S A M R K H L  H T H G P R V H V C A
                             *     *     *   *     *      *                                  *              *      *
TFIIIA        F V C E H A G C G K C  F A M K K S  L E R H  S V V H D P E K R K L K
           252                                     284
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(dT)-cellulose columns.  Previous studies have exploited the ability of native
mRNP particles containing maternal mRNA to bind selectively to oligo-(dT)
through the 3’-poly(A) tail (Marello et al., 1992, Matsumoto et al., 2000,
Cummings and Sommerville, 1988).  Stage VI oocyte lysates (treated with Rnase
inhibitors immediately after they are homogenized to protect endogenous RNAs
from degradation) were mixed with oligo-(dT)-cellulose beads, and following
extensive washing of the cellulose matrix, bound proteins were eluted in a buffer
containing 25% formamide by conventional gravity based chromatography.
Analysis of eluates on coomassie blue stained polyacrylamide gels indicated that
a small subset of total protein was retained on the oligo-(dT) matrix following
extensive washing (Figure 9A, compare lanes 2, 3 and 5).  The relative amount of
total protein retention is consistent with the results of others attempting to isolate
mRNPs from endogenous lysates by this method (Matsumoto et al., 2000).
Western blots of the same eluates showed that YY1 was present in the oligo-
(dT)-bound fractions (Figure 9B, top panel, lane 4).  Nucleolin, a known
component of mRNPs (Yurkova and Murray, 1997) was detected in bound
fractions by Western blotting indicating that mRNPs were successfully isolated
in this experiment (Figure 9B, centre panel lane 4).  When fractions were
assayed for PCNA, no protein was detected in the eluates, indicating that there
was very little or no non-specific retention of proteins on the oligo-(dT) columns
(Figure 9B, bottom panel, lane 4).
This experiment was also carried out on oligo-(dT) cellulose columns that
were run using a high pressure liquid chromatography (HPLC) control unit.  This
permitted the precise controlling of elution parameters and tracking of protein
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Endogenous YY1 interacts with maternal mRNA.
A)  Oocyte lysates were incubated with oligo(dT)-cellulose and following extensive washing
with binding buffer, bound proteins were eluted with 25% formamide.  Aliquots of the original
lysate, flow-though, wash and eluant were separated by10% SDS-PAGE, and proteins were de-
tected by coomassie blue staining.  B)  The same fractions were analyzed by Western
immunoblotting using antibodies against YY1, Nucleolin, and PCNA as indicated at the left of the
panel.  C)  Oocyte lysates were applied to to oligo(dT)-cellulose columns and proteins were eluted
with a gradient of increasing NaCl concentration.  Fractions (indicated at the bottom of the panel)
were analyzed by Western blotting for YY1.  Samples in the lower panel were from lysates that
were treated with RNase prior to loading onto the column.
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released from oligo-(dT).  Stage VI lysates were loaded onto columns at 4˚C and
the flow through was re-applied 3 times to ensure maximal RNA/mRNP binding.
Bound proteins were eluted from columns using a salt gradient (0.5M-2.0M).
YY1 was eluted from the columns at 600-750 mM NaCl (Figure 9C, top panel).
This reproduces the findings shown in Figure 9B, and supports the conclusion
that YY1 is retained on oligo-(dT) by virtue of its interaction with maternal
poly(A)+ mRNAs in the cytoplasm.  To eliminate the potential for non-specific
binding of YY1 to oligo-(dT), lysates were treated with RNase prior to
chromatography (these lysates were not supplemented with RNase inhibitors).
RNase treatment abolished the retention of YY1 on oligo-(dT) cellulose columns
(Figure 9C, bottom panel).  This demonstrated that the affinity of YY1 for oligo-
(dT) cellulose is dependent on intact RNAs in the cytoplasm and provided
compelling initial evidence that YY1 associates with maternal mRNA in the
cytoplasm and that it may be a component of mRNP complexes.
6.9 In vitro YY1 RNA-binding activity
In vitro RNA mobility shift assays were employed to test for the ability of
YY1 to bind directly to RNA.  A radiolabeled 393 nucleotide histone mRNA was
synthesized in vitro and used as a probe.  The rationale for using the histone
mRNA probe in this experiment was that it is a small message amenable to
mobility shift assays, and that it is an abundant message in the oocyte
(Woodland, 1980) providing a biologically relevant binding target.  In addition to
this, previous studies have used histone mRNA probes to demonstrate in vitro
binding activity of mRNPs (Matsumoto and Wolffe, 1998).  Stage VI oocyte
121
Figure 10
A  RNA Gel shift
B RNA Gel shift
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RNA gel mobility shift assay of endogenous YY1.
RNA mobility shift assays were performed using oocyte lysates and 32P-labeled H2A probes.
Increasing amounts of antibodies against YY1 (A) or PCNA (B) were added directly to the binding
reactions as indicated.  The positions of free mRNA, an unidentified complex, and the specific YY1-
mRNA complex are indicated at the right of the panels.
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lysates (supplemented with RNase inhibitors) were combined with radiolabeled
histone mRNA probes in vitro and the RNA binding reactions were incubated at
4 C˚ for 20 min then separated on 5% acrylamide/glycerol gels maintained at 4˚C
for the duration of electrophoresis.  Two distinct protein-mRNA complexes were
observed (Figure 10).  Antibody competition experiments using antibodies
against YY1 and PCNA added individually to RNA binding reactions were
performed in order to establish the specificity of these complexes.  The addition
of anti-YY1 antibodies to binding reactions resulted in a concentration-dependent
abolishion of the upper complex, indicating that this band is a specific YY1
containing complex (Figure 10A).  No effect was seen on the formation of the
upper or lower bands upon addition of anti-PCNA antibodies (Figure 10B).  This
suggests that abolishment of the upper complex produced by the addition of anti-
YY1 antibodies was the result of specific antibody recognition of YY1 in an
RNA-protein complex.  These data indicate that YY1 is able to associate with
RNA, however they do not identify whether YY1 binds directly to RNA or to
other proteins that may be present in the shifted complex.  As well, these data do
not distinguish whether YY1 binds RNAs with any sequence specificity.
Previous studies have shown that the major mRNP proteins in Xenopus (eg,
FRGY2) do not bind RNA with any degree of sequence specificity (Yurkova and
Murray, 1997), however this issue still remains to be addressed in the context of
YY1.
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6.10 Size exclusion chromatography of native mRNPs
The results presented in Figures 9 and 10 suggested that YY1 may be a
component of cytoplasmic mRNPs.  Previous studies have shown the molecular
mass of Xenopus oocyte mRNP complexes range from 350 kDa to 1000 kDa
(Yurkova and Murray, 1997; Matsumoto, 2000).  I next examined the molecular
mass of YY1-containing complexes.  Lysates were prepared from stage VI
oocytes, treated with RNase inhibitors to prevent the degradation of endogenous
RNAs and fractionated by size exclusion chromatography (SEC).  Two columns
were used for this analysis, one with a separation range of 10,000-300,000
daltons (Bio-Select 250, Bio-Rad) and one with a separation range of 10,000 –
1,100,000 daltons (Superdex 200 HR 10/30, Pharmacia).  Aliquots (200 ul) of the
oocyte lysates were applied to columns run in column buffer at 0.4ml/min and
eluted proteins were collected in 200 ul fractions which were precipitated in
acetone at -80 C˚.
Lysates were first applied to Bio-Select 250 columns (Figure 11),
fractions were separated by SDS-gel electrophoresis and the size distribution of
eluted proteins was analyzed by Western blotting.  All of the YY1 was detected
in the column flow-through void volume (greater than 300 kDa) (Figure 11,
upper panel).  The presence of YY1 in the void fractions suggested that in its
native state, YY1 exists in complexes that are larger than 300 kDa in the
cytoplasm.
To investigate whether the association of YY1 in large molecular mass
complexes occurred through interaction with mRNPs, endogenous RNAs were
degraded by in vitro RNase treatment (lysates used for these experiments were
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Figure 11 Western blot/SEC
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44158Void
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24 26
Presence of YY1 in high molecular mass complexes and the effect of RNase.
Size exclusion chromatography of native (upper panel) and RNase treated (lower panel) stage
VI oocyte lysates was performed.  The fractions (indicated below the panel) were analyzed for YY1
by Western immunoblotting.  The positions of molecular mass standards is indicated above the
panel.
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prepared without the addition of RNase inhibitors) prior to chromatography on
Bio-Select 250 columns.  Western blotting of separated proteins indicated that
YY1 was eluted in fractions close to its expected monomeric molecular mass (59
kDa) (Figure 11, lower panel).  Thus, in vitro degradation of RNAs appears to
destabilize the large molecular mass complexes permitting YY1 to separate in
fractions at or near its expected monomeric mass.   The integrity of large YY-
containing complexes was dependent on presence of intact maternal RNA
suggesting that YY1 associates with or is a component of mRNPs in the oocyte
cytoplasm.
6.11 Determination of the Mass of YY1-mRNP complexes
To accurately determine the molecular mass of YY1-associated mRNP
complexes, a different column was employed (Pharmacia SuperDex 200
HR10/30) which has a separation range of 10,000 – 1,100,000 daltons.  This
column was run with the same parameters and calibrated identically to the Bio-
Select column resulting in consistent data comparable between the columns (both
columns are packed with the same type of cellulose bead, differing only in pore
size).
YY1 was detected in fractions with an approximate molecular mass of
480 kDa by Western blotting (Figure 12, top panel).  Monomers were not
detected in untreated native lysates using either column (figures 11 and 12, top
panel) suggesting that the majority of endogenous YY1 is bound in large
molecular mass complexes.  FRGY2, the major mRNP component in Xenopus
oocytes (O’Connor et al., 1996, Tafuri and Wolffe, 1990, Deschamps et al.,
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Identification of 480 kDa YY1-mRNP complexes.
Size exclusion chromatography of oocyte lysates (top four panels) and liver cell lysates (bot-
tom panel) were analyzed for the presence of YY1 or FRGY2 (indicated on the right of the panel)
by western immunoblotting.  The positions of the molecular mass markers is indicated at the top of
the panels.  Oocyte lysates were treated with RNase or DNase prior to loading as indicated at the left
of the panel.
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1991, Deschamps et al., 1992, Murray et al., 1992) was isolated in a higher mass
range (around 500 kDa) in comparison to YY1 (Figure 11, indicated at right of
panel).  The elution profiles of YY1 and FRGY2 were partially overlapping, but
not identical.
To confirm that the 480 kDa YY1 containing complex is an mRNP,
lysates were treated with RNases prior to separation to degrade endogenous
RNAs (Figure 12, indicated on the left of panel).  SEC separation of these lysates
resulted in a redistribution of YY1 to fractions at approximately 59 kDa which is
close to its predicted molecular mass as a monomeric protein (Figure 12).  In
control experiments, aliquots of the same lysates were treated with DNase prior
to size exclusion chromatography.  No effect on the distribution of YY1 was
observed upon DNase treatment (Figure 12, indicated at left of panel).
Therefore, RNase-mediated destabilization of 480 kDa YY1 complexes was
likely a direct result of RNA degradation rather than an artifact of the
experimental protocol.  The finding that YY1 is isolated in high molecular mass,
RNase-sensitive complexes is consistent with the findings that YY1 was isolated
from Oligo(dT)-cellulose (Figure 9) and that it has mRNA binding activity in
vitro (Figure 10).  Thus, YY1 behaves biochemically like a bona-fide component
of mRNP complexes with potential RNA-binding activity.
Comparison of the relative size distribution of cytoplasmic and nuclear
YY1 was carried out using size exclusion chromatography. Concurrent studies in
our laboratory have established that YY1 is nuclear in adult liver cells (Ficzycz et
al., 2001), however the molecular mass of YY1 localized to the nucleus had not
been established.  Therefore, HepG2 cells (a liver cell line) were used as a source
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of nuclear YY1 from which it was possible to determine its molecular mass.
HepG2 lysates were passed over the SuperDex 200 HR10/30 (Pharmacia)
column which was run using identical parameters as in the experiments described
above.  YY1 eluted around its predicted molecular mass as a monomer, and no
high molecular mass complexes were detected (Figure 12, bottom panel).  This
suggested that when YY1 is localized to the nucleus, it is present as a monomer
and when present in the cytoplasm (Figure 12, top panel) it associates with or is a
component of large molecular mass complexes.  Previous data from our
laboratory has shown that YY1 is competent to bind DNA in rat liver nuclear
extracts (Ficzycz et al., 2001).  The findings that YY1 is monomeric and is
competent to bind DNA in HepG2 cells but is in large complexes and
incompetant for DNA-binding in stage VI oocytes suggests DNA-binding
activity is masked by its association with mRNPs in the cytoplasm.
6.12 Microinjected RNase destabilizes YY1-mRNPs
To analyze the association of YY1 with mRNPs in vivo, the effects of
maternal RNA degradation were tested by microinjection of RNase directly into
the cytoplasm of stage VI oocytes.  Similar techniques have been used previously
to examine the behaviour of the CBTF transcription factor in early Xenopus
embryos (Brzostowski et al., 2000).  Microinjection of RNase resulted in a
redistribution of YY1 from high to low molecular mass fractions after SEC on
SuperDex 200 HR10/30 columns (Figure 13A, indicated at right of panel)
confirming that association of YY1 in mRNP complexes is dependent on intact
maternal mRNA.
129
Figure 13
Microinjected RNase destabilizes YY-mRNPs and unmasks DNA binding, but does not pro-
mote nuclear translocation.
A)  Lysates from untreated oocytes (top panel) or oocytes microinjected with RNase and
incubated from several hours (bottom panel) were analyzed by SEC and Western immunoblotting
for YY1.  The positions of size standards are shown above, and fractions are indicated below.  B)
Oocytes were microinjected with RNase (indicated above the panel) prior to the preparation of cell
lysates, and gel mobility shift assays were performed on whole cell lysates (W), cytoplasmic frac-
tions (C) and nuclear fractions (N) using    P-labeled YY1 DNA probes.  The postions of nonspecific
(NS) and specific YY-DNA (YY1) complexes are indicated at the left of the panel.  C)  The same
samples were analyzed by Western immunoblotting using antibodies for YY1 (top panel) or PCNA
(bottom panel).
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YY1 is localized to the cytoplasm through early development (Figure 7A)
and displays high levels of DNA-binding activity in early stage oocytes (Figures
2C) (Ficzycz et al., 2001).  DNA-binding activity is masked through subsequent
oogenesis and reactivated at the midblastula stage after 12 hours of embryonic
development (Figure 2C).  Therefore it was possible that the DNA-binding
activity of YY1 may be blocked by virtue of direct mRNA-binding and/or
association with mRNPs.  Since RNA degradation releases YY1 monomers from
mRNP complexes (Figures 11, 12, 13A) it was possible that RNA degradation
may also unmask YY1 DNA-binding activity.  To test this, stage VI oocytes
were microinjected with RNase, incubated for 8 hours at 18 C˚ then manually
dissected into nuclear and cytoplasmic fractions which were then analyzed by gel
mobility shift assays using the ds-YY1 DNA probe.  The specific YY1-DNA
complex was not detected in untreated lysates (Figure 13B, lanes 1-3) consistent
with previous findings that its DNA-binding activity is masked in later oocyte
development (Ficzycz et al., 1997).  In contrast, high levels of the specific YY1-
DNA complex were detected in both whole cell lysates (Figure 13B, lane 4) and
cytoplasmic fractions (Figure 13B, lane 5) from RNase-injected oocytes, but not
in the nuclear fractions (Figure 13B, lane 6).  These data suggest that the DNA-
binding activity of cytoplasmic YY1 was unmasked upon release of YY1
monomers from mRNP complexes.
Recently it has been shown that a subunit of the CCAAT box
transcription factor, CBTF122 is tethered to the cytoplasm through its association
with mRNPs, displaying a novel mechanism by which the gene regulatory
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activity of a transcription factor may be regulated during development
(Brzostowski et al., 2000).  Since YY1 is excluded from the nucleus in oocytes
and during early embryonic development (Figures 7A,B) it was possible that
YY1 might be subject to a similar RNA-dependent cytoplasmic anchoring
mechanism.  To test this, maternal mRNAs were degraded in vivo by RNase
microinjection into the cytoplasm of oocytes.  It was hypothesized that this
would release YY1 monomers from 480 kDa mRNPs, unmask DNA-binding and
might also result in nuclear translocation.  Aliquots of the same extracts used for
SEC and gel mobility shift assays in Figure 13 (A,B) were analyzed by Western
blotting for subcellular redistribution of YY1.  YY1 was detected in the
cytoplasm but not in the nucleus in both uninjected controls (Figure 13C, left
panel, lanes 1-3) and in RNase-injected oocytes (Figure 13C, left panel, lanes 4-
6).  This suggests that cytoplasmic localization of YY1 is not solely dependent
on the stability of maternal RNA.  Further, it appears that interaction with
mRNPs is not sufficient to prevent nuclear translocation.  The control blots
showed complete nuclear localization of PCNA (Figure 13C, right panel)
confirming the viability of nuclear extracts as well as the efficiency of the
manual dissection used to obtain the subcellular fractions in this experiment.
Overall the results of the RNase microinjection experiments support the
conclusion that YY1 associates with mRNP complexes in vivo.  Destruction of
maternal RNAs results in release of YY1 monomers and unmasking of DNA-
binding activity, but does not promote nuclear translocation.
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6.13. Phosphatase sensitivity of YY1-mRNP complexes
Data presented in Figure 13 provided evidence that YY1 associates with
mRNPs which inhibits its ability to bind DNA.  It is unlikely that mass RNA
degradation is the mechanism which regulates the activity of YY1-mRNPs in the
cytoplasm in vivo.  However, phosphatase treatment of stage VI oocyte lysates is
known to upregulate the DNA binding activity of YY1 (Figure 5A) (Ficzycz et
al., 1997; Ficzycz, et al., 2001) and mRNPs are known to be regulated by
phosphorylation (Deschamps et al., 1997) therefore, it was possible that the
upregulation of YY1-DNA binding in response to phosphatase treatment seen in
Figure 4 was due to mobilization of YY1 from mRNPs brought about by
dephosphorylation.  To evaluate this possibility, it was necessary to establish
whether YY1-mRNPs are sensitive to phosphatase treatment.  Lysates were
prepared from stage VI oocytes and treated with RNase inhibitors (identically to
those used in experiments described in Figure 12).  For this experiment it was
essential to have the endogenous RNAs intact as this experiment was designed to
test whether YY1 could be liberated from intact endogenous RNAs by
dephosphorylation.  Lysates were then treated with Calf Intestinal Alkaline
Phosphatase (CIAP) and incubated at 4 C˚ for 45 minutes (using the same
conditions as those in Figure 5A to produce the increase in DNA binding
activity).  Phosphatase-treated lysates (200ul) were loaded onto the Superdex
200HR 10/30 column and the proteins were separated at 0.4 ml/minute.  Western
blots of fractionated untreated lysates indicated that YY1 was maintained in high
molecular mass complexes (Figure 14, top panel).  Analysis of phosphatase-
treated lysates indicated that YY1 eluted around its predicted molecular mass as
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YY1 containing mRNP complexes are sensitive to phosphatase.
Stage VI oocytes were treated with phosphatase in vitro (indicated at the left of the panel) then
separated by size exclusion chromatography.  YY1 was detected by Western immunoblot analysis.
Fraction numbers are shown at the bottom of the panel, molecular mass markers are shown at the top
of the panel.
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a monomer (Figure 14, bottom panel).  Thus, dephosphorylation appears to
release YY1 from high molecular mass mRNP complexes such that YY1 is
redistributed to its monomeric form.  It is hypothesized that release or
disassembly from mRNP complexes results in unmasking of DNA binding
activity.  The results of this experiment suggest phosphorylation as the
endogenous mechanism for the regulation of YY1 in mRNP complexes in
Xenopus oocytes.
6.14 YY1 is monomeric in stage I oocytes
Stage I oocytes display high levels of DNA binding activity which
decrease by stage III and remain low until after the MBT (Figure 2C) (Ficzycz et
al., 1997; Ficzycz, et al., 2001).  It is known that mRNPs assemble during early
stages of oogenesis (Davidson, 1986).  The high level of YY1-DNA binding
activity in stage I oocytes could therefore be attributable to the presence of
monomeric YY1 prior to association into mRNPs in the cytoplasm.  It was
therefore of interest to establish the molecular mass and hence, the possible
association of YY1 with mRNPs in stage I oocytes.  SEC of lysates prepared
from stage I oocytes (treated with RNase inhibitors) indicated that YY1 was
distributed into both high molecular mass complexes around 600-670 kDa
(Figure 15) as well as near its monomeric mass of approximately 50 kDa.  It is
possible that the two masses observed in this blot indicate the ongoing assembly
of YY1 into mRNPs.  The presence of monomeric YY1 in stage I oocyte extracts
is consistent with the observation of YY1 DNA binding activity in gel mobility
shift assays at this stage (Figure 2C).
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Fraction Numbers
YY1
Size distribution of YY1-complexes in stage I oocytes.
Stage I oocyte lysates were treated with RNase inhibitors and separated by size exclusion
chromatography.  YY1 was detected by Western immunoblot analysis.  Fraction numbers are shown
at the bottom of the panel, molecular mass markers are shown at the top of the panel.
Figure 15 Western blot/SEC
Stage I
5642 44 46 48 50 52 5432 34 36 38 4022 24 26 28 3012 14 16 18 206 8 10
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6.15 Dynamic association of YY1 with mRNP complexes through development
An analysis of the molecular mass distribution of YY1 in early embryos
was carried out to determine whether it remained associated with mRNP
complexes during this period of development.  Lysates from embryonic stages 4,
6, 8, and 15 were prepared (supplemented with RNase inhibitors) then loaded
onto the Superdex 200HR 10/30 column for SEC chromatography (Figure 16).
The mass of YY1-mRNPs in stage 4-8 embryos is approximately 480 kDa which
is consistent with the mass of these complexes in late stage oocytes.  However by
stage 15, the mass of the YY1-mRNP complexes shifted to a lower mass
centered around approximately 100 kDa.  Extracts were treated with RNase to
degrade endogenous RNAs prior to separation by SEC (shown at the bottom of
each panel).  YY1-mRNPs in pre-MBT stages were RNA dependent and behaved
similarly to complexes observed in stage VI oocytes.  YY1-mRNPs appear to
disassemble after the MBT suggesting that maternal RNAs may be released for
translation after the MBT.
6.16 Identification of RNAs associated with YY1-containing mRNPs
The evidence presented in this thesis demonstrates that YY1 is a
component of cytoplasmic mRNP complexes, a novel role for YY1.  I next set
out to determine the functional significance of this by identification of the RNA
species associated with YY1-mRNP complexes.  It was hypothesized that YY1-
mRNPs may associate with a subset of RNA(s) reflecting a specific biologic role
(ie, TFIIIA interacting with 5S rRNA) or that they may associate with a variety
of RNAs and play a general role in mRNA metabolism and storage (ie, FRGY2).
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Figure 16 Western blot/SEC
St 4
St 6
St 15
St 8
670 158 44 17
YY1 appears as a monomer after the MBT.
Analysis of embryonic lysates for the presence of YY1 by Western immunoblotting blotting
following size exclusion chromatography.  Developmental stages are indicated at the left of the
panel.  RNase treatment of lysates (in vitro) is indicated at the right of the panel.  The positions of
the molecular mass markers are indicated at the top of the panel.
RNase
-
+
-
+
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Previous studies indicated it is possible to immunoprecipitate cytoplasmic
mRNPs in order to identify their associated RNAs (Tenenbaum et al., 1999).
Aspects of this methodology were used for isolation of YY1-associated RNAs
from oocytes (A flow chart of the procedure is shown in appendix 1).
RNA associated with YY1 was immunoprecipitated using YY1
polyclonal antibodies that were bound to protein-A Sepharose beads.  Stage VI
oocyte lysates were initially analyzed by SEC and gel mobility shift assays to
ensure that high molecular mass YY1 containing complexes were not degraded
during lysate preparation (data not shown).  Lysates prepared from stage VI
oocytes supplemented with RNase inhibitors were mixed with YY1 antibody-
bound beads.  Following immunoprecipitation, proteins were degraded with
Proteinase K releasing the captured RNAs, which were then ethanol-precipitated
and used as templates for cDNA synthesis.
Precipitated RNAs were used as templates from which random primed
cDNAs were synthesized.  The result shown in Figure 9 suggests YY1 associates
with polyadenylated RNAs, so initial attempts used oligo-d(T) to prime cDNA
synthesis however this resulted in undetectable yields (data not shown).  The next
attempts involved the use of random primers which would also allow for cDNA
synthesis from non-polyadenylated messages that would have been missed if
only oligo-d(T) primers were used.  Control immunoprecipitations using protein-
A beads alone as well as PCNA antibodies bound to protein-A were also
performed however no detectable levels of cDNAs were synthesized.  Following
completion of synthesis reactions, cDNAs were digested with HaeIII, producing
a number of fragments with blunt ends.  This aspect of the procedure is an
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important consideration to the subsequent data because separate cDNA fragments
may have arisen from the same RNA template, but may have been generated by
digestion of the full length cDNA (see discussion).
Since the immunoprecipitation step isolates very small amounts of RNA,
it was necessary to amplify the cDNA population prior to cloning.  Following
blunt end digestions, adaptors were ligated onto the fragments in order to provide
primer annealing sites so that polymerase chain reactions could be employed to
amplify the cDNAs.  The use of random primers followed by HaeIII digestion
and adaptor ligation resulted in the synthesis of a population of cDNAs with
variable sizes that was detectable by ethidium-bromide staining after
electrophoresis of aliquots on agarose gels (Figure 17A).  The adaptors included
a restriction site for the enzyme MluI, which was essential in the subsequent
cloning stages of this procedure.  The digested linker-containing cDNAs were
PCR amplified then digested with MluI to produce sticky ends for ligations. The
cDNAs were isolated by DEAE electroelution, and ligated into the BssH I (an
isoschizomer of MluI) site of modified Bluescript plasmids.  DH5a  cells were
transformed with the vectors and colonies that contained inserts were identified
by colour selection.  Colonies that were positive for inserts (white) were picked
from plates, grown in liquid media and amplified plasmids were isolated using
Promega Wizard miniprep kits.
Two methods were used to verify that isolated plasmids contained insert
cDNAs.  Plasmids were digested with XhoI to release inserts, and inserts were
amplified by PCR from the M13 forward and reverse primer sites within the
vector.  The products of both PCRs and restriction digestions were analyzed by
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Figure 17
A   Agarose/ethidium bromide stained gel
B   Agarose/ethidium bromide stained gel
Enrichment PCR and representative screening gels.
A)  PCR products using specific foreward and reverse primers recognizing adaptor sequences
ligated to random prime synthesized cDNAs.  The cDNAs were synthesized from RNAs
immunoprecipitated using YY1 (lane 2) PCNA (lane 3) and the protein-A sepharose matrix (lane 4).
Size markers (l HindIII) are shown in lane 1 and are indicated at the left of the panel. B)  Repre-
sentative screening data.  Colonies that were positive by colourimetric screening (white) were proc-
essed and plasmids isolated then electrophoresed in 1% agarose/ethidium bromide gels (indicated at
the top of each panel).  Plasmids were digested with XhoI (indicated at the centre top of each panel)
and inserts were amplified by PCR (indicated at the top right of each panel).  Sets of 8 plasmid
preparations, restriction digests and PCRs were run on each gel.  Size markers (l HindIII) were
loaded at three intervals on the gels and are indicated at the left of the panel.
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ethidium bromide-stained  agarose gels and only plasmids that contained inserts
shown by both the PCRs and restriction digests were considered to be viable for
sequencing (representative data shown in Figure 17B).  Inserts in the PCR
amplified panels appear to be larger than in the restriction digested panels.  This
is because the sites for the M13 foreward and reverse primers flank the XhoI
digestion sites resulting in the generation of slightly larger fragments. These
plasmids were sent for DNA sequencing at the National Research Council-Plant
Biotechnology Centre (NRC/PBI), Saskatoon, Saskatchewan.  The clone
numbering system is based on the total number of colonies that were picked
(200).
106 plasmids were evaluated to be suitable for sequencing, 100 of which
were returned with high quality sequence data (based on chromatographic data
included with the sequence data).  All sequences are shown in Appendix 2.
Data obtained from the DNA Sequencing Laboratory were converted into
Microsoft Word documents and insert sequences were separated from 5’ and 3’
vector sequences.  The insert sequences were then used to search the non-
redundant (nr) and expressed sequence tag (EST) databases at the National
Center for Biotechnology Information (NCBI) for sequence alignments using the
Basic Local Alignment Search Tool (BLAST).
The criterion for considering a valid match was that alignment of the
YY1-precipitated cDNA clone with the sequence in the database have an E-value
of 1 x 10-5 or less.  The E-value is a statistical determinant that evaluates the
possibility that a particular aligned sequence could occur randomly within the
database.  The calculation of the E-value is based upon the length and complexity
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of the sequence that is being used for the search.  This does not eliminate short
sequences provided they are sufficiently complex.  A perfect alignment will
result in an E-value of 0.0.  The E-values are generated by the BLAST and are
not produced or altered independently of the database search tool.
The data obtained from this analysis are divided into four tables.  Table 3
summarizes the major categories of matches found by alignment using BLAST.
Table 4 shows sequences that produced positive matches between YY1-
precipitated cDNA clones and ribosomal RNAs while Table 5 contains
sequences that produced positive matches to known Xenopus protein coding
sequences.  Listed in Table 6 are the YY1-precipitated cDNA clones that were
found to match sequences in the NCBI (EST) database.
The remaining 71 YY1-precipitated cDNA clones that were sequenced
did not produce any significant alignments with sequences in either the nr or EST
databases.  However analysis of these cDNA for open reading frames (ORF)
indicated that 70 of 71 did contain ORFs suggesting that they represent
uncharacterized mRNAs in the oocyte.
Table 3. Results of Sequence Alignments to the NCBI Database.
Alignment of Clone Number of Clones in Alignment
               Xenopus Ribosomal RNA      18
Xenopus protein coding genes        3
Xenopus EST                8
No Matches                   71
                          
             Total Sequences Aligned                      100
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Since the cDNAs were developed using HaeIII to create blunt ends, multiple
predictable fragments belonging to the same cDNA are not unexpected.  Thus the
large number of sequences could have been generated by the HaeIII blunt-end
digestion in the procedure and does not necessarily reflect on the relative affinity
of YY1 for rRNA.
 Table 4. cDNAs aligned with Xenopus Ribosomal RNAs.
Sequence Alignment  E-Value (maximum)  Accession Number      Matching
Clones 
18s rRNA 3x10-15    XLRRN18S 044, 060,119
102, 146, 108
28s rRNA 3x10-10    XL28SR 051,063, 114,
153,059, 118,
126, 020, 068
104, 117, 161
Table 5. cDNAs aligned with known Xenopus protein-coding genes
Sequence Alignment   E-Value (Maximum) Accession Number      Matching
 Clone(s)
epithelial sodium channel, 0.0 XLU23535      121
(alpha subunit)
Prickle 4x10-37 AF387815      164
Sodium-phosphate co-transporter 1x10-23 L78836      039
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Table 6. cDNAs aligned with Xenopus Expressed Sequence Tags.
      Accession Number E-Value (Maximum)      Matching cDNAs      
BG233124 1x10-74 004
BJ075077 2x10-12 072, 115
BF845685 0.0 086
BJ041818 2x10-8 181
BG810899 5x10-46 143
BJ038912 2x10-85 030
BG234080  2x10-5 010
Figure 18 shows Northern blots and schematic representations of YY1-
precipitated cDNA clone alignments within selected frog sequences (Figure 18
A-E).  These schematics were generated by virtual digestions using HaeIII of the
indicated Xenopus sequences using software located at
(http://tools.neb.com/NEBcutter/index.php3).  Shown in Figures 18A and 18B
are the alignments of YY1-precipitated cDNA clones within both 18s and 28s
rRNAs.  A number of overlapping cDNAs were obtained that produced
alignments within 18 S rRNA (102, 146, 108) (Figure 18A) and 28s rRNA ((051,
059)(063, 114, 118)( 020, 104)) (Figure 18B).  This is due to either cDNA
synthesis from multiple rRNA templates or amplification of the templates via
PCR.  Northern blots of stage VI oocyte total RNA separated on 1%
agarose/formaldehyde gels, transferred to nitrocellulose membranes and probed
with with cDNA #108 (18S rRNA) and #051 (28S rRNA) are shown above each
schematic diagram.  These blots indicate hybridization to RNAs of the expected
size (1.8 and 4.0 Kb respectively) in total RNA.
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Of the 100 YY1-precipitated cDNA clones, 3 matched Xenopus protein
coding genes.  The proteins identified were; the alpha subunit of the epithelial
sodium channel, Prickle, and Xenopus sodium-phosphate co-transporter.
A single cDNA clone (164) was found to align with Prickle.  A schematic
alignment of cDNA 164 within Xenopus Prickle mRNA is shown in the lower
panel of Figure 18C.  A Northern blot is shown in the upper panel of the figure.
Total oocyte RNA was separated on 1% agarose/formaldehyde gels, transferred
to nitrocellulose membranes and probed with radiolabeled YY1-precipitated
cDNA clone 164.  A single prominent signal was detected at approximately 4.4
Kb which is consistent with the expected size of Prickle mRNA according to the
submission in the NCBI database (shown above each diagram, Accession
#AF387815).  This result confirms the efficiency of the YY1-IP protocol for
identification of YY1-associated mRNAs, since the sequences isolated are able to
hybridize with mRNA isolates from a stage VI oocyte.
The upper panel of Figure 18D is a Northern blot of total stage VI RNA
probed with radio labeled cDNA clone #121.  A prominent signal was detected
migrating at approximately 3 Kb, which is consistent with the predicted size of
the mRNA according to data submitted to the NCBI database.  Shown in the
lower panel is the schematic alignment between YY1-precipitated cDNA clone
#121 and the Xenopus Epithelial Sodium Channel.
The upper panel of Figure 18E is a Northern blot of total stage VI RNA
probed with radio-labeled cDNA clone #039.  A strong signal is detected at
approximately 4.5 Kb which is consistent with the size of the sodium phosphate
co-transporter mRNA according to data submitted to the NCBI database.  Shown
147
in the lower panel of Figure 18E is an alignment of clone 039 within a schematic
of the Xenopus sodium phosphate co-transporter (Accession #L78836).
Two clones of the 71 which did not align with sequences in the database
were chosen for Northern blots analysis to test for possible hybridization to
oocyte mRNA.
Shown in Figure 18 (F and G) are Northern blots of total oocyte RNA
separated on 1% agarose/formaldehyde gels, transferred to nitrocellulose
membranes and probed with radiolabeled YY1-precipitated clone 005 (Figure 18
F) and 060 (Figure 18 G).  These cDNAs did not align with sequences in the
NCBI database however they contain open reading frames and thus could code
for Xenopus proteins.
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Figure 18
Northern blot analysis of total oocyte lysates probed with select YY1-immunoprecipitated
probes.
Northern blot analysis confirming that YY1-precipitated cDNAs hybridize with RNAs in total
RNA (10ug) isolated from stage VI oocytes.  Probes used were (A) 060, aligned with 18S rRNA, (B)
051, aligns with 28S rRNA, (C) 164, aligns with Prickle (XPk), (D) 121, aligns with sodium epithe-
lial channel (ENaC) and (E) 039, aligns with sodium-phosphate co-transporter.  Blots shown in F
and G were probed with immunoprecipitated cDNAs that were not aligned with Xenopus sequences
in the NCBI database.  Size markers are shown at the left of each panel (in Kb).  Shown below each
of the panels (A-E) is a schematic diagram of alignments of immunoprecipitated cDNAs with each
of their RNAs as determined by the BLAST search.  Nucleotide numbers are shown at the top of
each schematic.  Vertical lines indicate locations of HaeIII digest sites as  found by virtual digestions
of each sequence (see Materials and Methods).  Boxed numbers indicate identities of cDNAs that
were found to align with the sequence.
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7.0 Discussion
The initial objective of the research presented in this thesis was to
examine the role of the YY1 transcription factor in the Xenopus model system.
Numerous studies  indicated its versatility in transcriptional activation and
repression in a variety of model systems and suggested a role in cell growth and
differentiation (Shi et al., 1997).  While this study began with the intent of
examining the transcriptional role of YY1, data obtained from initial experiments
resulted in a shift in the focus of the research.  The data presented here indicate a
novel role for YY1, as a component of mRNPs.
The first major finding is that, even though YY1 is abundantly expressed
throughout oogenesis and embryogenesis up to swimming larval stages, it does
not play a direct transcriptional role in early Xenopus development.  This finding
was somewhat surprising given the wealth of literature indicating the
transcriptional activity of YY1 in a variety of cell growth and differentiation
contexts.  YY1 mRNA and protein are present at relatively constant levels
throughout oocyte and embryo development through to neurula stages (Figures 3
and 4).  Analysis of cytoplasmic and nuclear subcellular fractions showed that
YY1 was present exclusively in the cytoplasm in both oocytes and embryos
(Figure 7).  These findings were confirmed in our laboratory by
immunocytochemical analyses of the subcellular distribution of YY1 through
development (Ficzycz et al., 2001).  Consistent with the cytoplasmic localization
of YY1, transcription assays showed YY1 has no stimulatory or repressive effect
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on basal transcription from the TK promoter in either oocytes or post-MBT
embryos (Figure 6).
I conducted several experiments in which YY1 was overexpressed in
embryos.  No overt morphological deformaties or defects were observed in the
developing embryos (data not shown).  Exogenous cytoplasmic YY1 may have
been incorporated into existing mRNPs or may have remained monomeric.  The
subcellular localization and incorporation into mRNPs was not monitored.
Remarkably, YY1 was never localized in nuclei throughout early
development.  However, analysis of adult frog liver sections by
immunocytochemistry indicated that YY1 is present in nuclei later in
development, but the time at which nuclear translocation occurs is not presently
known (Ficzycz et al., 2001).  This suggests that maternally expressed YY1 may
function in transcriptional regulation later in development, perhaps during
organogenesis.  It is not known when zygotically expressed YY1 appears in the
embryo or whether maternal and zygotic forms play similar or different roles.
The second major finding is that YY1 is a constituent of mRNP
complexes in the developing frog.  This is a novel and distinct activity that has
not been previously described for this protein.  A number of observations support
this finding.  YY1 has a conserved RNA-binding zinc finger/knuckle motif in the
DNA-binding domain (Figure 8).  YY1 in its native state in stage VI oocyte
lysates displays RNA-binding activity in RNA gel mobility shift assays (Figure
10), and specifically binds to oligo(dT)-cellulose (Figure 9) suggesting that it
associates with poly(A)+ mRNA in vivo.  Similar to other mRNP proteins, YY1
in stage VI oocytes is present in high molecular weight complexes of
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approximately 480 kDa (Figure 12).  The integrity of YY1 complexes is sensitive
to RNase treatment both in vitro and in vivo (Figures 11, 12, 13, 16).
Phosphatase-treatment of lysates resulted in release of YY1 monomers from high
mass complexes (Figure 14).  Thus the cytoplasmic location and its association
with mRNPs suggest that similar to FRGY2, YY1 functions in the storage and
translational control of maternal mRNA in the oocyte and developing embryo.
Amino acid sequence analysis of YY1 revealed that the spacing of key
histidine and cystine residues in the DNA binding domain of YY1 are conserved
with the zinc finger/knuckle RNA binding motif (Figure 8), suggesting that YY1
has the potential to bind RNAs in the cytoplasm.  RNA mobility shift
experiments using stage VI oocyte lysates demonstrated that YY1 binds
radiolabeled histone mRNA in vitro (Figure 10).  YY1 present in native oocyte
lysates was shown to be retained on oligo(dT)-cellulose columns suggesting it is
associated with poly(A)+ mRNAs in vivo (Figure 9).  Degradation of endogenous
RNA by RNase treatment of extracts in vitro prior to chromatography abolished
retention of YY1 by the oligo(dT) matrix (Figure 9) providing key evidence in
supporting of YY1 as an mRNP component.  Thus YY1 may directly contact
RNA through the zinc finger/knuckle however, the RNA binding assays and
oligo(dT) cellulose chromatography do not indicate whether YY1 present in
mRNP complexes makes direct contact with RNA, or associates with RNAs
indirectly through interactions with other proteins in mRNP complexes such as
FRGY2 and nucleolin.  Furthermore, these assays do not indicate whether YY1
or YY1 containing mRNPs recognize and bind select RNA sequences.
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The data shown in Figure 10 indicates that YY1 or YY1-mRNP
complexes associate with non-adenylated messages (non-adenylated probes were
used).  Thus the presence of YY1 in the column eluates of oligo(dT) is probably
through interaction of YY1 with internal sequences, 5’-cap or other proteins that
bind in these regions.
As shown in Figure 9B (lane 2), not all of the YY1 bound to the
oligo(dT) column.  There are two possibilities that may account for this
observation.  It may be that there are more YY1-mRNP complexes containing
poly(A)+ mRNA than the column has capacity to bind.  Secondly YY1-mRNP
immunoprecipitations indicate that YY1 complexes interact with 18S and 28S
rRNAs which would not be retained on the column thus accounting for the lower
YY1 signal in the eluant.  It is also possible that YY1-mRNPs interact with
poly(A)- RNAs.  This suggests that YY1-mRNPs are able to interact with
divergent RNAs in the cytoplasm.
The specific retention of YY1 on oligo(dT)-cellulose and its presence in
protein-mRNA complexes provided initial evidence that YY1 in its native state
in the oocyte cytoplasm associates with or is a component of mRNPs.  These
methods have been used by several laboratories to identify mRNP proteins such
xCIRP2 (Matsumoto et al., 2000), and FRGY2 (Matsumoto et al., 2000; Tafuri
and Wolffe, 1993).  Futher confirmation of this was obtained through SEC,
which showed that YY1 in native lysates is present in large complexes with a
molecular mass of approximately 480 kDa (Figure 12).  The presence of YY1 in
high molecular mass complexes was abolished by degradation of RNAs in stage
VI lysates resulting in the release of monomeric YY1 (Figure 11, 12, 13 and 16).
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SEC analysis of stage I lysates indicates that YY1 is present at two distinct
molecular masses (Figure 15).  In stage I oocytes, formation of mRNPs are at
their highest levels (Davidson, 1986), thus detection of YY1 both as monomers
and in complexes at this stage most likely reflects ongoing incorporation of YY1
into mRNPs.  The significance of the monomeric YY1 in these blots will be
discussed later.
Several similarities exist between YY1 and FRGY2 suggesting that their
biological roles in the developing frog may be similar.  Both FRGY2 and YY1
were originally identified as transcription factors recognizing similar consensus
ds-DNA binding elements (FRGY2; CTGATTGGCCAA (Wolffe et al., 1992)
and YY1; GGCCATTT (Hyde-DeRuyscher et al., 1995) and were later assigned
the role of mRNP proteins in the oocyte (Tafuri and Wolffe, 1992; Tafuri and
Wolffe, 1990; Richter, 1991; Galvin and Shi, 1997; Thomas and Seto, 1999;
Ficzycz and Ovsenek, 2002).  Although the amino acid sequences differ, both
proteins are highly expressed in the cytoplasm of oocytes.  Consensus RNA
binding domains (Wolffe et al., 1992, Figure 8 this thesis) have been identified in
both proteins; FRGY2 contains the RNP-1 domain, and YY1 contains the zinc
finger/knuckle.  FRGY2 and YY1 are able to associate with poly-A+ RNA, and
can shift the mobility of RNA in vitro (Matsumoto et al., 2000; Tafuri and
Wolffe, 1993).  Furthermore both of these proteins are assembled into high mass
mRNP complexes during early oogenesis in the oocyte (Darnborough, 1981;
Yurkova and Murray, 1997, Figure 15 this thesis).  Several groups have indicated
that phosphorylation increases the RNA binding affinity in vitro of FRGY2
(Dearsly et al., 1985; Kick et al., 1987; Braddock et al., 1994).
156
Dephosphorylation of stage VI oocyte lysates by phosphatase treatment in vitro
resulted in release of YY1 from mRNP complexes (Figure 14).  This does not
demonstrate that dephosphorylation of YY1 itself is responsible for the release of
monomers, however it does indicate that the affinity of YY1 for RNA or mRNPs
is negatively affected by dephosphorylation and thus its RNA affinity may be
regulated similarly to FRGY2.
The behaviour of FRGY2 and YY1 are not completely identical and it is
likely that FRGY2 and YY1 do not necessarily assemble together in the same
mRNPs, but rather that they are exclusive or only partially overlapping.  While
FRGY2 is observed to dissociate from mRNPs following fertilization (Tafuri and
Wolffe, 1992), YY1 is not released from mRNPs until after the MBT (Figure
16).  The molecular masses of the respective complexes as determined by SEC
differed slightly; YY1 complexes are approximately 480 kDa, while FRGY2
complexes are over 500 kDa.  The SEC elution profiles for both of these proteins
partially overlap (Figure 12), thus it is possible that certain subsets of mRNP
complexes might contain both YY1 and FRGY2.  The constituent proteins of
YY1-containing mRNPs have yet to be identified, and the possibility that YY1
may functionally associate with FRGY2 awaits further study.  Yurkova and
Murray (1997) reported that FRGY2 mRNPs had a mass of 320 kDa as
determined by SEC, which differs from the mass for FRGY2 (500 kDa)
presented in this thesis.  The reason for this is most likely due different
methodology used in their study.  Yurkova and Murray determined the mass of
FRGY2-RNP complexes without their associated RNAs.  They isolated the
FRGY2-mRNP first by sucrose gradients then digested the mRNP with
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micrococcal nuclease to degrade the RNAs.  They then followed this by ion
exchange chromatography and next analyzed mRNPs by SEC.  The data shown
in this thesis indicating that FRGY2 is present in complexes of approximately
500 kDa is a measurement of the mass of the complex including associated
RNAs.
7.1 Cytoplasmic retention of YY1
Given the large amount of literature indicating that the primary function
of YY1 is as a transcriptional regulator, the findings here that YY1 is exclusively
cytoplasmic in oocytes and through early embryonic development, (Figure 7) and
is a component of mRNPs (Figure 12) are somewhat surprising.  It is known that
the CBTF122 transcription factor is tethered to the cytoplasm through its
association with RNAs and migrates to the nucleus in response to RNA
degradation (Brzostowski et al., 2000).  This suggests RNA-association as a
novel mechanism to regulate transcriptional activity of CBTF122 during
development (Brzostowski et al., 2000).  Thus it is reasonable to speculate that
YY1 may be regulated by a similar mechanism.  However, unlike CBTF122, YY1
remains cytoplasmic in response to RNAse microinjection (Figure 13).  CBTF122
contains a bi-partite nuclear localization signal (NLS) (Robbins et al., 1991)
which was hypothesized to be masked through its interaction with RNAs in the
cytoplasm.  Since the addition of an extra NLS to CBTF122 did not promote
nuclear localization, retention in the cytoplasm was attributable to RNA
anchoring and not NLS masking (Brzostowski et al., 2000).  YY1 does not
appear to have a consensus NLS, however, portions of the second and third zinc
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fingers have been shown to be necessary for nuclear localization in RK13 cells
(Austen et al., 1997b).  A yeast two-hybrid screen showed that B23, which
contains an NLS and is involved in subcellular trafficking and ribosome
assembly, was able to bind YY1 the zinc fingers (Inouye and Seto, 1994; Yung et
al., 1985).  Thus is is possible that interaction between YY1 and B23 (or some
similarly functioning protein) is necessary for establishing subcellular
localization patterns in the oocyte.
Although there are differences in this aspect of the regulation of CBTF122
and YY1, the ability of transcription factors to bind RNA and associate with
mRNPs may be an important regulatory mechanism during development.
It may be that the primary biological function of cytoplasmic localization
of YY1 is to sequester it until its transcriptional activity is required at some point
later in development.  Immunocytochemical analysis of frog liver sections
revealed that YY1 is localized to the nuclei of this tissue (Ficzycz et al., 2001).
SEC of HepG2 lysates revealed that YY1 was present in these cells as a
monomer (Figure 12).  These data indicate that at some point during
development, monomeric YY1 relocates to the nucleus.  It is assumed that in the
nucleus, YY1 would be transcriptionally active (although this has yet to be
tested).
A precedent for cytoplasmic localization of YY1 has been established
during early mouse development in which YY1 is localized to the cytoplasm in
oocytes.  YY1 translocates to the nucleus by the two cell stage which is
coincident with the onset of zygotic transcription and displays a mosaic pattern
of sub-cellular distribution in E3.5 blastocysts (Donohoe et al., 1999).  This
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suggested that YY1 may function to regulate gene expression early in
mammalian embryonic development, however its transcriptional capability has
not been analyzed.  Donohoe and colleagues suggest it is possible that YY1 is
required for the development of more highly specialized cell types and
localization to the nucleus merely places YY1 in the correct environment to
become active when the appropriate developmental cues are received.  The
finding that YY1 homozygous knockout results in peri-implantation lethality
suggests that the YY1 plays an important function during early development.
It is interesting that the pattern of nuclear localization in Xenopus and
mouse embryos are somewhat different.  While in mouse embryos YY1 relocates
to the nucleus with the onset of zygotic transcription at the 2-cell stage, YY1
remains cytoplasmic in the frog well after the MBT (Figure 7).  It would appear
that YY1 plays a different role in the development of mouse and frog embryos.
7.2 Dynamic changes in the association of YY1 with mRNPs during
development
Taken together, the results of DNA-binding assays (Figures 2, 5, and 13)
and the profile of YY1 association with large mRNP complexes during
development (Figure 12) suggest that YY1 is available to bind to its cognate
dsDNA element only when it is released from, or not complexed with mRNPs.
DNA-binding activity (Figure 2) appeared only in stage I oocytes when assembly
of YY1-containing mRNPs is incomplete, and after the MBT when YY1-mRNPs
might disassemble (Figure 16).  Consistent with this, both RNase and
phosphatase treatment of native oocyte extracts releases YY1 monomers from
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complexes and results in the acquisition of DNA-binding (Figures 5 and 13).
Therefore, the working hypothesis is that association of YY1 with mRNPs masks
DNA-binding.  When YY1 is complexed with mRNPs the DNA binding
structures in the zinc finger domains are blocked or masked, and release of YY1
monomers from mRNPs exposes the DNA binding portions of the zinc fingers,
permitting association with ds-DNA.  It is important to note that from a
biological perspective, the ability of YY1 to bind DNA detected in oocyte and
embryonic extracts in this thesis is biologically irrelevant, since endogenous YY1
remains cytoplasmic (Figures 7 and 13) and has no gene regulatory activity
(Figure 6).  Interestingly, the RNA-mobility shift experiment (Figure 10),
suggests that YY1 in mRNP complexes are able to associate with exogenous
RNA, suggesting either that the zinc finger/knuckle domain remains exposed, or
other RNA-binding proteins in the YY1-mRNP complexes in the oocyte retain
additional RNA-binding capacity.
Dephosphorylation of stage VI oocyte lysates in vitro resulted in release
of YY1 monomers from high mass complexes as assessed by SEC (Figure 14).
This suggests as discussed above that the phosphatase-induced recovery of DNA
binding (Figure 5) is the result of liberation of YY1 monomers from YY1-
mRNPs.  However, phosphorylation sites on Xenopus YY1 have yet to be
identified, and release of monomeric YY1 from mRNPs following phosphatase-
treatment may not be due to dephosphorylation of YY1 itself.  It is possible that
other proteins in YY1-containing mRNP complexes are dephosphorylated
resulting in release of YY1.  The effect of changes in phosphorylation state on
mRNP-protein affinity for RNA and integrity of mRNP complexes have been
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well documented (Kick et al., 1987; Herbert and Hecht, 1999; Murray, 1991).
For example, FRGY2-mRNPs have been shown to be phosphorylated by an
mRNP associated kinase which increases its RNA binding affinity (Yurkova and
Murray, 1997; Kick et al., 1987; Dearsley et al., 1985; Cummings and
Sommerville, 1988; Marello et al., 1992; Murray, 1994; Murray, 1991).  These
findings suggest that phosphorylation plays a crucial role in regulating mRNPs
and raises the possibility that YY1 may be regulated in this manner.
7.3 Changes in molecular mass of YY1 during development
In stage I and II oocytes, the molecular mass of YY1 as indicated by SDS-
PAGE/Western analysis appeared to be significantly smaller (50 kDa)  than
observed in later stage oocytes and embryos (59 kDa) (Figure 4).  The underlying
molecular mechanism or the biological significance of this mass shift is not
currently understood.  Phosphatase-treatment of stage VI extracts had no effect
on the migration of YY1 on Western blots (Figure 5) and so it is unlikely that the
change in size during oocyte development is due to phosphorylation.  Another
post-translational modification that may account for the shift in molecular mass
of YY1 in oocytes is poly-ADP-ribosylation.  In HeLa cells, YY1 is subject to
poly-ADP-ribosylation in response to DNA damage which results in decreased
DNA-binding activity (Griesenbeck et al., 1999).  The effect of ADP-ribosylation
on YY1 in oocytes was not examined in this thesis.
Another possibility is that YY1 may be encoded on two genes expressed
differentially during development, one coding for the smaller 50 kDa isoform
expressed only in early oogenesis, reflecting a distinct developmental role.  By
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stage IV when the mass shift is observed to occur, the second gene coding for the
larger form of YY1 may be upregulated and then expressed through the
remainder of development while the 50 kDa form is degraded.  This hypothesis
has not been tested and a review of the literature has not indicated the presence of
two genes coding for YY1 in other organisms.  Additionally, when Xenopus YY1
was initially characterized, there was no evidence indicating that there were two
genes coding for YY1 (Pisaneschi, 1994).  It is possible that the 50 and 59 kDa
isoform are due to differential splicing of mRNAs.  The Northern blot shown in
Figure 3 indicate the presence of a second smaller RNA band at 3.8 Kb.  Thus it
is possible that the two splice variants exist in the developing however further
study will be required to resolve this issue.  What might be the functional
significance of the appearance of two isoforms at different points in
development?  It is possible that in stage I oocytes, the smaller form of YY1 is
produced very quickly and is immediately incorporated into mRNPs protecting
the large quantity of nascently synthesized RNA from degradation.
7.4 Identification of RNAs immunoprecipitated with YY1-mRNPs
A method based on immunoprecipitation was used to isolate and identify
the RNA species associated with YY1-mRNP complexes.  This is not a widely
used method but has proven successful in the isolation of mRNP bound RNAs
from mouse P19 embryonal carcinoma cells (Jain et al., 1997; Tenenbaum et al.,
2000).  Tenenbaum and co-workers (Tenenbaum et al., 2000) isolated mRNAs
bound to ELAV/Hu RNA binding proteins from P19 cells.  These proteins bind
to elements in the 3’-UTRs of proto-oncogene and cytokine mRNAs, increasing
163
expression of these transcripts.  Their study was designed to identify changes in
ELAV/Hu protein bound mRNA subsets in response to differentiation; HuB was
immunoprecipitated, and the associated mRNAs were used as templates for
synthesis of cDNAs used to probe microarrays.  They found that HuB, which
contains three RNA-recognition motifs (RRM), associated with specific
sequences in the 3’UTR of mRNAs that encoded cell-cycle regulators,
transcription factors, as well as other early response gene (ERG) products
(Tenenbaum et al., 2000).  To my knowledge, this method has not been used to
identify RNA species from Xenopus mRNP proteins.
Sequences of 100 YY1-precipitated cDNAs were used to search the
NCBI database for matches to known Xenopus laevis sequences.  Of these, 3
produced significant alignment with protein coding mRNAs, 18 with 18S, 28S
ribosomal RNAs, 8 with Xenopus ESTs, and the remaining 71 sequences did not
align significantly with Xenopus sequences in the database (Table 4).  The most
obvious conclusion that can be drawn from this data is that YY1-mRNP
complexes associate with both messenger and ribosomal RNAs.
Table 5 lists the three YY1-precipitated cDNAs that aligned with
Xenopus protein mRNAs.  These encode the alpha subunit of the sodium
epithelial channel (ENaC), prickle (XPk) and the sodium-phosphate co-
transporter.
The Xenopus epithelial sodium channel (accession #XLU23535) is a 632
amino acid protein that was first cloned by Puoti and colleauges (Puoti et al.,
1995).  These channels mediate sodium re-absorption by a sodium-selective
sensitive channel that is located in the apical membrane facing the external
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compartment of many tight epithelia (Garty, 1994; Garty and Benos, 1988).
These channels are responsible for the rate-limiting step in sodium reabsorption
and control of its activity is essential to the maintenance of the global sodium
balance and blood pressure.  Expression of this channel has been documented
late in frog development (stage 25), once the internal organs have formed (Puoti,
1995), however there is no evidence indicating earlier developmental expression.
Thus, the appearance of its mRNA in oocytes is a novel finding.
The Xenopus sodium phosphate (Na+/PO4
3-) co-transporter is a 674 amino
acid protein that was first cloned by Ishizuya-Oka et al., (1997).  It is expressed
in the differentiated intestinal epithelial cells at low levels in pre-metamorphic
frogs and at high levels in post-metaporphic frogs, and it functions to regulate co-
absorption of Na+ and PO4
3- in intestinal tissues (Ishizuya-Oka et al., 1997).
Again, there are no previous reports of this gene being expressed in oocytes.
Xenopus XPk is an 835 amino acid protein that was first cloned by
Wallingford and colleagues (Wallingford et al., 2002).  It is a member of a family
of proteins that are responsible for the planar polarity of the organism (Adler et
al., 2000; Gubb et al., 1999).  In vertebrates, planar polarity is essential for
proper development of skin, scales or feathers, and internal organs.  In
Drosophila for example, planar polarity is essential in the development of
proximal-distal orientation of wing cells as well as cells in the leg and leg
segments themselves (Adler, 1992; Gubb, 1993; Struhl et al., 1997).  Wallingford
and co-workers (Wallingford et al., 2002) have found XPk is expressed
maternally in Xenopus while zygotic expression was detected at the start of
gastrulation in the dorsal marginal zone and steadily increases until tadpole
165
stages.  They also found XPk expression later in development in the pronephric
duct, otic vesicle and the retina (Wallingford et al., 2002).
These proteins are of divergent function.  This indicates that YY1-
mRNPs are capable of associating with a variety of RNAs which perform diverse
functions within the developing frog at varying times during development.  The
presence of the sodium channel mRNA in stage VI oocytes (Figure 18 D, 2.7 Kb)
suggests that at least a portion is maternally formed and stored until the protein is
needed by the developing frog.  Data presented in this thesis indicating that YY1
is cytoplasmically localized in neurula stage embryos and complimentary data
from our laboratory indicating that it remains in this location into at least larval
stages, allow for the possibility that maternal mRNAs could be stored for this
length of time (Ficzycz et al., 2001).  However, data shown in Figure 16
indicating that YY1-mRNPs disassemble by neurula stage argues that maternal
mRNAs are released for potential translation soon after the MBT.  It is possible
that some YY1-mRNP complexes persist to store mRNAs until they are required
later in development.  It is also possible that the mRNAs coding for the sodium
epithelial channel are released from mRNPs during gastrulation for translation
into functional proteins or that YY1 monomers are released from mRNPs alone,
but the remainder of the mRNP proteins and possibly the associated mRNAs
remain complexed until needed later in development.  Still another possibility is
that mRNAs may be released concurrently with YY1 but are assembled into new
mRNPs that do not contain YY1 and are then stored until needed later in
development.
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Northern blots indicate the presence of Na+/PO4
3- co-transporter RNAs in
the oocyte at the expected size (4.6 Kb) (Figure 18 E).  This indicates that
Na+/PO4
3- co-transporter RNAs are expressed in the oocyte and associate with
YY1-mRNPs until they are required later in development.  Organogenesis
commences at approximately stage 20 once the neural tube closes and it is
possible that the Na+/PO4
3- cotransporter mRNA is translated once the gut begins
to form.  Given the data suggesting that YY1-mRNPs disassemble after the MBT
it is also possible that the cotransporter is released from YY1-mRNPs reflecting a
necessity for co-absorption of Na+ PO4
3- earlier in development.
The finding that Xenopus Prickle (XPk, 835 amino acids) mRNAs are
stored in mRNPs in the cytoplasm of oocytes is interesting.  Data shown in
Figure 18 C, demonstrate the presence of an RNA species in total Xenopus RNA
that is of the expected size (4.5 kb) for XPk.  The presence of Prickle mRNA in
YY1-mRNPs could reveal a mRNA-positioning mechanism associated with
pattern formation in early development.  However, immunocytochemical data
indicates that YY1 is uniformly distributed in the cytoplasm of oocytes and all
embryonic cells through to organogenesis (Ficzycz et al., 2001).  The association
with YY1 is probably not a mechanism to localize XPk mRNA to certain parts of
the developing embryo, as is the function of Staufen with respect to oskar and
bicoid localization.  Thus YY1-mRNPs serve to protect XPk mRNA from
degradation and regulate the timing of its translation during development.  It
would be interesting to assess the developmental consequences of disruption of
YY1-XPk interactions.  If the biological function of YY1 is similar to that of
FRGY2 in translational masking and protection of mRNAs from degradation, it
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is possible that premature release of XPk may perturb establishment of planar
polarity.
Of the 100 cDNAs isolated in the YY1 immunoprecipitations, 18
matched with 18S or 28S rRNAs.  What is the significance of YY1 in association
with rRNAs?  There are two hypothesis that account for this observation.  First, it
is possible that YY1 associates with rRNA and functions in the storage of
ribosomal RNA in the oocyte prior to assembly into ribosomes.  Second, it is
possible that YY1 associates with intact ribosomes in the oocyte and is able to
mediate translation.
It is possible that YY1 interacts with the ribosomal precursors as they
enter the cytoplasm for final assembly into functioning ribosomes.  Xenopus
contains approximately 400-600 copies (per haploid genome) of the ribosomal
gene that encodes the 40S precursor, which following processing results in the
18S, 5.8S and 28S ribosomal RNAs (Pardue, 1973).  Amplification of these
genes occurs at the pachytene stage in oocytes (although the process begins in
premeiotic oogonia) (Gall, 1968; Pardue and Gall, 1969; Van Gansen and
Schram, 1974; Kalt and Gall, 1974) resulting in approximately 2.5 x 106 genes
per oocyte.  Under optimal conditions (high levels of gonadotropic hormones),
the midvitellognic oocyte is able to synthesize 3 x 105 rRNA molecules (18S and
28S) per minute (Davidson, 1986; Keem et al., 1979; Wallace and Misulovin,
1978) which then exit to the cytoplasm for assembly into the 1 x 1012 ribosomes
that are necessary for the developing frog (Davidson, 1986).  It is possible that
YY1-mRNPs associate with rRNA precursors in order to regulate their
metabolism.  Such interactions may be similar to the regulation of 5S rRNA by
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TFIIIA.  However despite conservation of key residues in the zinc finger/knuckle
between TFIIIA and YY1, no evidence was found that would indicate YY1
associates with 5S rRNA.
Perhaps YY1-mRNPs are a structural component required for regulation
of the intact ribosome.  In this role, YY1-mRNPs associating with ribosomes
may function to unmask incoming mRNAs prior to translation.  However the
difficulty with this interpretation is that ribosomes have a molecular mass of
approximately 4.1 x 106 daltons (Spirin, 1969) in which case if YY1-mRNPs
were to have eluted with ribosomes, they would have appeared in much higher
molecular mass complexes.  This was not observed.
It is important to note the absence of 5S rRNA in the sequences isolated
from the YY1-mRNP immunoprecipitations.  Two possibilities might account for
the lack of 5S rRNA cDNAs.  The number of these transcripts expressed in
oocytes equals that of 18S and 28S rRNAs (Davidson, 1986) and their absence
implies that YY1-containing RNPs do not interact with 5S rRNAs, and thus most
likely not with ribosomes themselves.  Relative to the six 18S and twelve 28S
cDNAs, isolation at least some 5S cDNAs would have been expected if YY1-
mRNPs were indeed interacting with intact ribosomes.  Rather the lack of 5S
rRNA isolation supports the notion that YY1-mRNP complexes are involved in
storage of maternally derived 18S and 28S rRNA prior to their assembly into
functional ribosomes.  Second, it is possible that 5S rRNA were singly missed in
the screen.  5S rRNAs are small (120 bp) relative to 18S (1826 bp) and 28S
(4046 bp) and  may not have had been recognized by the random primers used to
generate the cDNAs (Miller and Brownlee, 1978).  It is possible that clones were
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not selected from plates at the initial screening and that 5S rRNAs may be
identified if more clones are sequenced.  It is also interesting and perhaps
significant to note that no tRNAs were not immunoprecipitated.
A number of cDNAs (8) were found to align with Xenopus ESTs in the
NCBI database (Table 6).  These sequences represent Xenopus mRNAs that have
yet to be identified and may code for novel frog proteins.  Anaylsis of ESTs that
were found to align with Xenopus immunoprecipitated cDNAs for sequence
matches amongst themselves using the BLAST did not reveal and sequence
homology indicating that they represent distinct RNAs in the oocyte.  In one case
(Table 5, accession #BG233124), a putative identification of the EST was
submitted by the author (Robert Strausberg, unpublished).  He suggests that a
portion of the EST is similar in sequence to that coding for the type B bovine
gustatory receptor (accession #P35350) which belongs to a superfamily of G-
protein coupled receptors (Matsuoka et al., 1993).  These receptors have been
implicated in signalling bitter and sweet taste stimuli (Striem et al., 1989; Hwang
et al., 1990).  It is possible that this EST represents either an amphibian homolog
of the gustatory receptor or a yet to be identified G-protein.  While the mouth and
oral plate of the frog begin to develop at stage 32, the possibility exists that
gustatory receptors are expressed earlier.  The isolation of clone BG233124
strengthens the conclusion that YY1 interacts with mRNAs encoding
functionally divergent proteins, and plays a general role in mRNA
storage/metabolism in the oocyte.
Analysis of ESTs that were found to align with Xenopus
immunoprecipitated cDNAs for sequence matches amongst themselves using the
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BLAST did not reveal any sequence homolgy indicating that they represent
distinct RNAs in the oocyte.
A total of 71 cDNAs that were synthesized from immunoprecipitated
YY1-associated RNAs and did not produce any significant alignments to
sequences in the NCBI database.  Analysis of the sequences indicated that 70 of
71 contained open reading frames.  This indicates that they may represent
unknown mRNAs in the oocyte.  Of the cDNAs isolated containing ORFs, only
3/74 matched to identified proteins coding sequences.  This is perhaps not
surprising given the how little of the frog genome that has been sequenced to
date.  Presently, approximately 254,000 Xenopus ESTs have been identified
however less than 2000 are full length or have been characterized (Klein et al.,
2002).  Analysis of these sequences indicated that 70 of 71 contained open
reading frames.  This indicates that they may represent unknown mRNAs in the
oocyte.
Two of the unidentified cDNAs were chosen at random and used as
probes for Northern blots to test for potential hybridization to oocyte mRNAs
and provide evidence of their validity.  The finding that both probes produced
discrete bands on the Northern blots (Figure 18F,G) provide compelling evidence
that some of the unidentified cDNAs correspond to protein coding messages in
the developing oocyte.
In addition to identification of YY1-bound RNAs the
immunoprecipitation method provided additional insights into whether YY1-
mRNP complexes associate with a single species of RNA or a variety of RNAs.
I conclude that YY1 plays a general role in the storage, metabolism or
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translational masking of maternal RNAs in the oocyte.  The original intent was
not to assess RNA binding sites for YY1-mRNPs on associated RNAs, and
conclusions in this regard are not made in this thesis.
It is essential to not make any attempt to draw statistical conclusions from
the distribution of sequences that were obtained (ie. 18 of 100 clones were
rRNAs therfore 18% of rRNAs are assocated with YY1-mRNPs).  The clones
were picked randomly and do not necessarily represent the actual mRNP
distribution within the cell.  In order to have ample amounts of cDNA for
efficient cloning, PCR was used to amplify the synthesized cDNAs.  The PCR
step will not representatively amplify all sequences that were
immunoprecipitated which ultimately skews the results.  Furthermore, the goal of
the study was to survey the types of RNAs that are present in YY1-mRNPs and
that no attempt was made to design the experiments such that conclusions as to
the abundance of a particular RNA sequence in the YY1-mRNPs could be drawn.
7.5 Biological function of YY1-mRNPs
 The reults presented in this thesis document the discovery of a novel role
for YY1, that of a component of mRNPs.  What is the major biological function
of YY1-mRNPs in the developing frog?
One hypothesis is that YY1 functions in the cytoplasm as an RNA
masking protein similar to FRGY2 (Bouvet and Wolffe, 1994; Deschamps et al.,
1991; Deschamps et al., 1992; Marello et al., 1992; Murray, 1994; Murray et al.,
1992; Ranjan et al., 1993; Tafuri and Wolffe, 1990; Tafuri and Wolffe, 1993;
Yurkova and Murray, 1997).  Given the divergent nature of RNAs found in
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association with YY1 in the oocyte (Table 3) it is likely that YY1-mRNPs
associate non-specifically with RNAs as a global repressor of translation.  YY1
may associate with ribosomes themselves as has been demonstrated for a number
of other mRNP proteins (eg, FRGY2, xCIRP2, FMRP).  In this role, the
association between YY1 and the ribosome may function to regulate the timing
and rate of translation of YY1-mRNP bound RNAs.
The presence of the zinc finger/knuckle binding domain in YY1 is similar
to that found in TFIIIA.  As such, it is possible that YY1 functions in the
metabolism of 18 and 28S rRNAs in a similar fashion to how TFIIIA regulates
5S rRNA.  Both mRNA and rRNAs were isolated in the YY1-mRNP
immunoprecipitation, suggesting that YY1 is not an exclusive regulator of rRNA
metabolism.  It is possible that YY1 may have several distinct biological roles.  It
may mask and protect maternal RNAs during development as well as regulate
their translation at the proper time by associating with ribosomes.  As the frog
matures, the role of YY1 may change to that of a transcription factor necessary
for regulating gene expression.  The possibility exists that YY1 may continue to
function as a mediator of RNA metabolism in adult tissues, although this remains
to be examined.
There are several issues that need to be addressed to unravel the
biological function of YY1.  Preliminary experiments involving overexpression
of YY1 in developing embryos by microinjection of YY1-vector DNA did not
result in overt morphological defects.  The tentative conclusion consistent with
the lack of transcriptional activity of YY1 in oocytes and embryos was that YY1
played no significant role in early development.  However given the subsequent
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findings that YY1 associates with mRNPs in the cytoplasm, it would be
interesting to repeat this experiment ensuring high exogenous expression levels
relative to endogenous protein, and monitor subcellular localization of exogenous
proteins and morphological effects.
The exact timing of disassembly of YY1-containing mRNP particles and
release of associated mRNAs and rRNAs have not been established. 
Analysis of SEC fractions from embryos at closer time intervals around
the MBT would indicate whether this landmark is significant in the regulation of
YY1-mRNPs.
The finding that YY1 associates with rRNAs in the cytoplasm was
interesting however the result of the immunoprecipitation-screen did not indicate
whether YY1 associates with the rRNAs or ribosomes themselves.  Sucrose and
nycodenz fractionation could be used to reveal whether YY1 is associated with
intact ribosomes in oocytes and embryos.  Co-immunoprecipitation of YY1 and
analysis of precipitates for ribsomal proteins by Westen blotting would indicate
whether YY1 associates with ribosomes.
The immunopreciptiation and identification of YY1-bound RNAs would
be better assessed using microarray technology.  At the time that YY1-mRNP
bound RNAs were identified for this thesis, Xenopus gene chips were not fully
available.  The use of microarrays would be much more efficient in assessing the
types of RNAs that associate with YY1-mRNPs potentially leading to a better
understanding of the biological role of YY1 during frog development.
The molecular mass of YY1-mRNPs is 480 kDa.  To better understand
the biological function of these complexes it will be necessary to identify all of
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the component proteins.  A number of similarities exist between YY1 and
FRGY2 however the presence of both of these proteins in the same complex has
yet to be demonstrated.  Co-immunoprecipitations followed by Western blotting
for YY1 and FRGY2 would indicate whether these proteins are part of the same
complex, and could be used to identify other proteins in YY1-associated mRNPs.
7.6 Summary
In summary, the work presented in this thesis reveals a novel role for
YY1 in the storage and metabolism of maternal RNA.  Thus YY1 can be
classified along with FRGY2 as a transcription factor with a dual role as an
mRNP constituent.  Future work should reveal the constituents of YY1-mRNPs
and uncover the recise role in RNA metabolism.
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Appendix 1.
Schematic diagram of the immunoprecipitation procedure employed to obtain YY1-mRNP associated
RNAs.
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Appendix 2.  Sequences obtained from the immunoprecipitation of YY1 containing
messenger ribonucleoprotein omplexes.
Sequences shown below were obtained from the immunoprecipitation of YY1
containing mRNP complexes.  The clone numbers are indicated above the sequence.
Clone numbers are assigned arbitrarily from the original plates they were picked
from.  Sequences are shown as single strands only in 5’-3’ as indicated in bold.
001:
5’GCAGCAATATCCAGACGAGGGATTAGAAGATCCTTGTGCATCACCGCCC
GAGCGACTTGGTAACGAGACCAGGTATCACGGGTTTCGGCATCATCAAAT
GCATTAAGCACTCGACGAAGTTCCAGTTCATCCGCTTCGTTATCCATCACT
GCGGACAGCGATTCCTGCAGGGCATCACGACTCATGGCGGTTCCTCTCTT
GGCTGTCGCCGCTGTCTCAGTTTTCCTGCAACAACGGCTGCAGGGCTTTAT
CGATGGCTTCCCGAGCCCGGAAGATCCGGGAGCGTACGGTACCCACCGG
ACATTGCATGACGCTCGCAATGTCTTCGTAACTCAGACCATCGAATTCAC
GTAAAGTTAACGCCGTACGCAAATCTTCTGGCAGTTGTTGAATAGTGCGA
TGGACGGTTCCTTCGATCTCGTCGCGCAGCAATGCACGCTCCGGCGACTC
GAGATCCTTGA3’
002:
5’CTTGGTGGCGCAATAGGCGATGTGCTGCCGGCTGCCCTTGCGCACCACG
TCATCGCTGATATGCACGATATCGGCAGGTGTCGAGCGTTGCAGCAAAGG
TGAACAATGCAGGTTGATCAGGTACGGCGCAAGCATGTGCACGCTGAACA
TGTCGATAAAGGCACGGCTTTCGTCGCCCGGGGTTTCGGCGACCCAGGCT
GAAGCGTTGTGGATGATTGCGCGCAGGCTTTGGGTATGGGTTTTGACTGC
GCCAATGAAAGCCGGCACGCCGGCTTCGCTGGAGAAGTCGGCAAACACG
CCGATGGCACCCCGTTCACGTAGCGCCTGCACGCCGGGGCGTTCGCTGCG
GTAGCTGAAAATCACGGCT3’
003:
5’AGGATCCCTCGAGGCGCGTAAGCAAGCAGCACATATTCAAACGAGAAC
TTTGAAGGTAGTCCACGCGTAAGCAAGAGCACATGCGGATATGTTCCAGC
CGCCGCGTATCCCCCACGTGCCCAAGGGGGATGTCACCCAGCCGCTGATT
GTCGCCGTGTTCGCGCATGGTCAAGGTGTCGGCGATCATCTGGGTCGGGT
GGAATTCAGCGGTGAGG3’
004:
5’GCAGGGAGGAAAATCTGTGCAAACTGTCGAACTCCCTTCTTCTCACAGA
GCTCTTCGTAATTACCATAGTCAAAGGTGGTGTCTCCATATTCATCATAGT
TTTCTGTTGTTGCTCTTATTGTGGTACTGATTTTTTCCTCCATGGTGGTTTC
TTTAATAAAGCAAAAATAATGTCATATTACATCATTGTAATTAACCAAGC
CATTAATCTGAAATATATTCATATACGTTTTGGTTAGTGAATTCACCAATT
GTGGGCTGGGTCTATTGATGCCATTGTGTCACTTTTGTTATTAAAACTTGT
ATAGCATTTCAAAAAAATGTACCTTCTCCTGTAAAAATATATATAATTCAT
TGTATCGTCAGAGTTCCATGACCTGAACAAAGCACTCAATCAACCTCATG
GAACTCCTCAGTGACCCATATTTTATATCTAACAATCAGGGTTCCAATATT
ATCAATATTTAGTTTTGACCACTAGCAAACATCTGGTACATGTAAAGCCA
AGAAAACCAATTTCTACAATAAAATGACTTACTTTACATACATACATACA
TAATGCCAGGGTGGTCTCTAGTTACACCAAAGATTGTTAAATAATGCTAC
AAGCCAACAGTTTATTAGTATTTGCAGGGGTGAT3’
005:
5’ATATGGGCACTAAGGGGTATAGGAAACATTTTCATTCTCTTCATAGTTG
GTATCTATACTGTTCGAATTACTATGTGTCTCATGTACAATTTAGAGGCTG
TGTCCATTTCGTGGACTATAACCCAGTGTCGCCCACACTGATTTTACAGTC
ACGATGTTGAGTGAAGGGGCACAGAGAGGCAGCATTGTCAGTCATTCGTG
TCGGTCTGTGGAACAATGACATTGAGCGGGATGGAAAAGGCTAATAGCAT
ATCCCCCTCATCAAGGCTCATGGGGGCACCTGTAACAGAACGAGGGGCTG
ATTCTCGACCCCTTGATTTTGGTTCCCAGATGAAATTTCAACATGGAAGGA
AAGTGCTGCTGTGGACACAGAGGTTGTCATTCATCTGGTTTCGGTTGCCAA
ATAGGGAGTATAAGAATTGGCGTTGATTAGAGACCCCTCCATCGAATATT
3’
007:
5’TCGAGGCGCGTAAGCAAGAGCACATATTCAAACGAGAACTTTGAAGGT
AGTCCACGCGTAAGCAAGAGCACATGCGGATATGTTCCAGCCGCCGCGTA
TCCCCCACGTGCCCAAGGGGGATGTCACCCAGCCGCTGATTGTCGCCGTG
TTCGCGCATGGTCAAGGTGTCGGCGATCATCTGGGTCGGGTGGAATTCAG
CGGTGA3’
010:
5’TAACTCGTGTAGAGCAATGCTTCCCCTAATTTTTCTATAAGCTTACACAA
ATATGGATTTTCATGCAGTGACTATACTTCTGCCTATTGTGTCATTCACTTT
GAGTATTTCTGGAAACTTTGAGAAGTAGTCCACACAAAGAAGGTATTCTG
ACCCATTAAAACAAAATGTCACTTCCTACCTTTCCCATGGTCGTCTTGGAA
GATGGTGAGGAATCAACGGTTCTTTTTGGTTGCTGTTCATATGATCATTGC
ATTTTGAACACCGAGAAACTGTTTTTTTTTTTATATCAGCCAACATACTGT
AGGATGTACATAGAGTATGTCTCAACTTCAAGCTCTTTGTTTGCATTTAAA
GTGAACCTGTCACCTACACATAAGAAGCTGTATAAAGAAAGTCTTTGCAA
ATTAAACATGGAACCTAATTTTTTTTTCATTAAAACATCCATTCCTGTTAT
AAAGGTTTTAAATATCTGAGCTATCAATCAATTATTACGTGCCCCACCTCT
ATGCTCAAGGCATAGACCTTCAATGACTTTCACTTTCCATTCAGCACTCCC
TAGATGTCACTAGGAATATACTACAGATATTGATGACATTTTTCACACCA
ATATATTATGTTAAGTAGTTATTTTTCATAT3’
017:
5’CAAGGTCAGAATTCCCGCCCAGGACTTTGACACGCCGGCGCAGAACCT
GGCGTGCGATAACCAGTCGTTCAACCCCTGGTTCGGTTTGGAGGCGCACC
GCCCCATCGGCGGCATCAATCGGCTGCGCAAAGCGGTGTACGAAGCCGTC
AGCGACTACCGCCACAGCCGCAACGCACCGTAAGGTGCGTTAAATTGCAG
GCGAAAAAAAACCCGCTCAATGAGCGGGTTTCTTGTGGCTACCTGGCGTT
CAGTGTTCCAGGTTACCGAATATGGCGCAGCGGACGGGACTCGAACCCGC
GACCCCCGGCGTGACA3’
018:
5’ACTACTATTGTCCTAGGAAGTCTATAGTCTACAGTTTGTATTCTCTATTC
GTTAGCAGCAAAAGCGCAGCAATTAGGTATATGTTAAATAAAAACATACT
GCAAATTAATCTTGCAAAACTGAAAAATGTTTTTATTGTTGGGAAATGGA
ATATGTTTGGAACTGATGAAGAGTCATGTCTTCTACAGGGAAGTGGGGCA
TTTAAACGAAAAAAGTCCATTCTTTGAACCACTGCTGCAATACTTTACACT
AATTACATTTAAAATGTTCTGCTGCTGTGCTGACCCTCTTATACTTTAACT
GCTTTGCATCACTCCCTTCTCACTTACTGTGACATCACTTGGGGGTTTGCT
ATCAGGAAAATGGTTTCATGTTGTGGATCTATTTGTGGGCAGGTTGTAAAT
ATCTATTGAGAATGGTGATCTTCTTTTTTTTATGCTTGCTCCTCTTCAGGTG
TGAGGACTGTAAGTTTTATTTTAACCTGACGT3’
020:
5’TTTAGCGCCGAGCTGATCGAAGCCTGCCGTTATCGCTTCGAATCTCCTTA
TGTCCATCTGAAGAAAACCTTCGTCGAGTTCTCAGAAAGCTGCTTCCCGC
CCGGCGAGCCTTTACTGCTGGGCACGCAGGCATTGATGGAGAAGATCTTC
AGCGAATTTACCTTCGATGCCGAAGCCACCCAGGTCGCCACACCGCTGGT
GGAAGTGCTGGAGCGCCGTCGCGGCGTGTGCCAGGACTTCGCTCACCTGA
TGCTTGCCTGCCTGCGTTCCCGTGGTAGTCCACGCGTAAGCAAGAGGACA
TTGATTTTCTTAATGCTTATTTTTCGTCACAGACACCAGAAACTGTTCCTCT
GAAGTATTACTAAGAAACATCCAAATTGAAGGTTGAGAGAAAACGAACT
CGAAGTTGCTCTTGCATTGCTTCTTAAAACCGTCCACTCAAATGGGTCTCT
AGAGTAAACTGCAACAAGATTCCAGAAAGGCTTGCATTAGTCCACGCGTA
AGCAAGAGCACACCGCCCCGCCGCCTAGCAGCTGACTTAGAACTGGTGCG
GACCAGGGGAATCCGACTGTTTAATTAAAACAAAGCATCGCGAA3’
022:
5’AGGGGGGGACAAATATGGGATACCTNTTCCACAAATGGATCTACGAAG
TTCTGAGNTACANGAAGACCATCNGTCTATACTAGNCCATGAANAATTAC
CTAGGCACATGTTTTTCNAAGGATTNCTTTTTCTCTGCAATANGAAAACNA
NACCTTGNACTTGATGGTANCTAAGCCGAAACCNTATTANCTAGCANAAC
AATTCTGTTGGGTNTATTTAANGTTNAAATGATTTTTAGAANAGATGGGC
GAAATGGCGAAAAATTTCCGAAACACATTGAAGTCAATGGGCGTCAAAA
TAATTTTGACACCTGACAATTTNATACGCGCAACTATTTTGTCCAAATCCA
TTAAATTCAATGGGTGTCTGAATAATTTTGACGCCCGACAATTTTATGCGT
GCGACTATTCTGACGCACAACATTTTTTTTAGTCACGCANGATTTTTTTGC
CAACAAATTTTTGGNGCAGTTTCATGAATTNATTCGCTGGCNG3’
023:
5’ACGCTATTCGATAACGACATTTTCTACAAACGATAATGGTCGTACTTTTA
GTTCTACAAACGGTGCATCTTATAGTTCAACTACTTGGTCGAATGATGATT
TCTTTAAAGCTTTAGAACGGCATATCAATTATTTCTTGTTCTATGCGAATC
GTCATGGTGGTCTTTAAACAACGACCGTTGTATAACAAGCCTCGCTGAAG
TGCGAGGCTTTATTTTATCCATACCGATGCTCGATTTCGATAACACCAACA
CATTCATCAAACCAGCAACAGTCAAATACTTTCATATATTCAGTCTAAACT
GTTGTAAAATTTATCAATAGTCTGACTTTGACAAATTCATTTAATCTAATT
CGTAATTTTACTTTTCAAATTAGGTTATGAATGCATCAAATCCAA3’
027:
5’CCCGTGGCTTCGCCGTCACCGGCGCTCAGGATCTGTGTGCTCTTGCTTAC
GCGTGGACTAACTAACGGGATCTGGAAGAAGTGACACTGATAGAGCAAG
AATTTGCCCTTGTTGTTTCCACTTAAACATGCTATCATTAGTAATGATATT
CCCAAACACATCTTGTGTTTCTTAGCGAGACTTTATGATACATGTTATTGT
GCATTGTAATACAATTTCTTTATATACTGCAACTAGATACACTGTTGGGTT
TTATAAGTAATTATATTAAATTATCTTGCTACATAGGTCATAGCTGTGAAT
AGACAAATAAAAAAATGCACCACAGTTTGCCATGGAAGAACGCTGAACG
CAATGAGGATATATGGGATGGACAAAATAATAGAAACACCACATGGAAA
ATGGCATTAAGTCTGAAAATTATCAGTATCTGTCGACTATAAATAGGGTTT
GACAATAAGCATGTTTATTTGCTGAATAAAAATATGTAGGTTTATTAAAG
ATATCATTTTCAATATGCCCCATGTTCTGCATAACCAAGAGCTTAATTGAC
AAGGAAA3’
028:
5’GAACTCTGCTGGATTTTTCGTTGCAGCCGTGCCCACTTTTGTAGAGGGCA
CCGAGATTGCTTTTCTTGAAGAACCGCCGAAGCCTGTAACGGGGCGGTAT
GTGGTCAGTATTAGTTCCGGGGTGACCGCATGAGGGTCGAGTTCTTTATA
GCCGATGATATTCAATCCCTGGAGGGAGGGAAAATCATGACGCTCGGACT
CTACCCGGACAGGGTCTTGCTAATATCGATCCCACCTGAAGCGCCGAAGG
ACACTCCATTGCTGCTTCCAAAGTTGTCAATATTAGCCTCCATTATTGACG
GCGCACCCGGCTCTTACGAAGTTACACCGGAACTTACTCCGCCCGCAGGA
GGGCTGTCTCCGACCAACGTGCCAACAAAAACTATTACTATCGAAACAGG
ACGGTCGATCAGCGCGATATTTAATTTTATG3’
029:
5’TCGCACCGAACGAATATCATCTCGCGGCAGAAACACAGCTCGGGAATC
CTCATAAGGACGGGGCAGGCGTCGGTGCAGGTAGGCAGCGCCATAAGCC
CGCATGGCATCGTGAAACGCCATGTAGCTCATCGGCTCGTCCCGTAGCGC
GAATATCTCAAAGTCACGCACCAGGGAACTGACAGAAGCGCTGTGCTCTT
GCTTACGCGTGGACTAACAAGACATTTCTGCCATATTACTAAACAGAAAA
TTGCAAAAAAAAACTAAAATAAACAATCCTACCTGAAAAAATGTTCCCTA
AAGATTTTGTTCAAAACCATAGTAGTACATTATGATTACAAGACGTTCATT
TTGTCACTGCTTCATTGTCTTAAATGTAATAGCTGAAAAACTAATCAGCAA
TAAACACTCCCTCCTTTAATGCCAGAAACAATAAGCATGTGA3’
030:
5’AATTTGAATCGTATAAATCAAAGCACATTCGATCTAATTCAAATCGAAG
TTTTTCCCAAAAAAAACTTTGATTTATCAAAGTCCACCAATTGACTCCAGA
TAGGTTCTAGGAGGTCCCCCATTGGCTAAAACAGCAATTTGGCAGGTTTT
AGATGGCGAATAGTCGAATTTTTAAAAAGATAAATTTCGATATTCAAATT
TTCGATTTTTTTTTTCAAATTCAAATCGAATTTGGACTATTCCCTAGTCGAA
GTACACAAAAAATAGCTCGAAATTCGAGTATTTTGAATTCGAAAATTCAC
TTCAAACTTTGATAAATCTGCCCCTAGTTGTCTCAACAAATGGAAATTGTC
TCTAGAACTACAATGTAGAAGGTCACCTTAATGCTAAAACCAAACACAAA
CAAAGACACAGTTTTAATAACTGATGCACACCCCATCTTTTTTGCTTCTCG
AGTAGTTGGTTTCAAACTTGAGTTGATAAGAATTATAGGGATTTTGTGGA
GAATAAAACGAACAACTATTTTTAAATACCGTATATACTCGAGTATAAGC
CGACCCGAGTATAAGCCGAGGTACCTAATTTTACCTACGAAAACTGGGAA
AACTTATTGACTCTAGTATAAGCCTAGACACAACTACAGCCCTGTCTCCC
AGCAGCGCACATTCTGCCAAAGCGACCCCCCCCAGCGATCAACCGGACTT
CTTTGCAAAGTTGGAT3’
032:
5’GGGACTGATGCGCAGGAATTTGCGGATCTGGGGTTCGTCATCAATGACA
AGAATCGTCGCGGTCTGGCTCATGGTGTCTCATCAAAACCCATTAAAAAA
TCACCCC3’
033:
5’TTCAGCCTNGCAGGTCGCACTCTAGCAGGGATCCCTCGAGGCGCGTAAG
CAAGAGACGCGGATCTCGTTGTACTGGCGGGCGGACATTTCAGTGCGTAG
CCGGGGTGTGCATTGGGCGAATGAGGTCTTCGATTGCCCGGCGATTTATG
CCTGTGGCAACCACGAGCATTACGGCGGAAACGTTGATCGGACGTT3’
035:
5’CACTCTTGGAAATTAAGGGTTGCGCTGATATCACTCAAACGGACATCAG
TGTCTTGAATGCTGCTGCAGAGGTTGCCCGTACATACGAGGCTACTTCTTA
CCAGGCAGGAATCAGCCTGGTAAAGCTGGTCGAGTTTTTGAACGAAAGTG
GGATCGTCCAGGCGCCGATTACTTGGAAGAACCCAATCAAGAAGCCCAA
AGAAATTAATCGCACTGACAGCGTAGGTAAGCAGAAGCGGGATGAAAAA
ATGCCGCCAGACTACCTGCTTGAGGCAATGGCTGAAATCTTCAATAATGA
TCTCTTGGGTGCAAGGGATCGATTTACCTCATCGATTTTCGCATTGTGTAT
GTGCGCGCCGTCGCGGATCACTGAGGTTCAGGATCTCCCAGTCAATTGCC
TTCACCGCGAAGTAGATAGTAAGGGTGTTGAGCGTACTGGGCTTAGGTT3’
037:
5’GAATATGACTCGGACCAAGGGCAAGGGCTGAATACCCACACCTACCAC
CCGCCACAAATCACTGTGGGAGCAGCTTGCCTGCGATAGCGGTGGCTCAG
TCAACAACGATGTTGAATGTGCCGCCCTCATCGCAGCATAGGTATCTTCA
CAACTTTGCGGGTTGCAACAGCAGACGGTAACCACGATGCGAAGCGAGC
CGCTCTTGATCTTGATCTGCTTTTGATCTTAGGCGCCCCGTTAAACCACGC
T3’
039:
5’TGCCACTAGCTCCGAGTGCCACCCCACCGGCAATTTACATTCTAGCCAG
CTGGAATTCAGTTCGAGGAGATTAGTTGCCTGAAGAAGAGGAGATTTGTC
GCCATGTGACTGAATCTCCACATGTGTCTCTGCCCTAACTGACTTCAGTCA
CTCTTTACTGCTGTACTGCAAGTTGGAGTGATATCACCCCCGCCCCCAACA
ACTCCCTAACACAAGATAACAGCTACCTGGTAGATCTAAGAACAGCACTC
AATAGTAAAATCCAGGTCCCATTGAGACACATTCAGTTACATCGAGTAGG
AGAAACAACAGCCTGCCAGAAAGCAGTTCCATCCTAAAGTGCTGGCTCTT
TCAGAAATCACATGACCAGGCAAAATGACCTGAGATGCACCTACTCACCA
ATATTATAAATAAATAAAATACACTTGCTGGTTCAGGAATGAAATTTTAT
ATTTTAGAGTGAATTATTTGCAGTGTAATTTAGAAATAAAAACTACATCCT
AAAAATCATGACACAATCCCTTTAATCTATGCGGTTGCTGTTAGAAGTTCT
ATATACAACTCTCTGGTCTTTGGTTCTGCTTTCGGAAACCAGGTGACTAAT
TGAAATGCCTT3’
041:
5’CTGNATCCGCTCAAAGACCTGCCGATCCCGCCGGACCTGCGCCGCGATT
CCTAGTGGGAGCGAGCTTGCTCGCGAAAAACTCACCGTCGCCGCGTTCAT
CCTGACTCCCCGCGTTATCTTTACCACCTTCGCGAGCAAGCTCGCTCCTAC
AACCTGTCAACTTTGACAGTANNCAATACNCCGCCTTCACTGTTTGATACA
GCGATGAGACGTGCAGCCCTGTACGANTCNGGAGGCGNTGGANGNATAG
NGTTACAGACATGNGATTTNATGC3’
042:
5’CGAGGGAGTTCTCAAAAATCTGGCGATTTCGTCGCGTGATGAGTTGCCA
GCGCGACGTCTCTCTTCAAAGCCCCAAAGTCATCGCTCAGTGACGAAGTC
CCAGCAAGTCGAATTCTGTTTCGCTGAATAAACGCTGTTCATCGCCACGTA
ATCAGGCGGCAGAAACGCCTGCGGTTGTGCCATACCGTTGGAAAGCCCAA
GAGGTCAAGTAATGCGTAATTTCGATCTTGACTTGAGTAGGGTTACCTAC
GAGCACTTCATCACCGGCAAGGCAGCCATAAACTTCCCGAGACCTCACGC
CATTTCGGGCGGATGGCACTTACCTAGCATATTGGAACAGCGAGGTCGGT
GAGGCGAAGGTGTCGCTTGCTGGTATCCATTACCCCGACACGAGATTTTG
CTTTGGTGACACGGGTATCTTGAACGCTACCGATGAGCTCGAACTGCGGG
GGTTGAAGATCGATCGCCAGATCTATATGGCTGACCACTTCCGCGCGACC
GGGGATATGGTTCTCAAATGGGTGTTCAGCAGTCAACAAGCTGGAAAGCG
TTCAAGATCATCGTCTCAGTCGATGGCTTGGTTCGCAG3’
043:
5’ACGTCATACACACCGACGATATCGGCGATAAACAAACCGTCGAACAGC
CCGCGCTCCAGGATTTGCGCCAGTTCAGTCCAGTATTCGAGGGTGTTGTA
GTGGGTGGACGTGTCCCGTGGGTGGGTCCACAAACCGTGGTTGATGTGCC
CGATGCAGTTCATGTTGAAGGCATTGAGCAGGATCTTTTTTTTGCTCATCA
GATGGTCCCCCGCAGCGGCGGGTTTTCATCGTTGAGGTAGTAGTTGCCGA
CCGCATGGTATTTCCAGCGGACCGGGTCGTGCAGGGTGTGCACCCGGGCG
TTGCGCCAGTGGCGGTCC3’
044:
5’GCTTTGGTGACTCTAGATAACCTCGGGCGCCACAGGAGACGATGTTTGT
TTAGGATTTTTCGGCACGATTAGGTGCTCCTGTATCTAGAAAAAATCGAGT
AGGCAGGAGCAACCCTTGAGCGGAAAGCCGACCTGAATGGTTGACATCC
AAAGTCGGTTTTTCTCTAATGCGCGTCCCACCAGTGTCCGCATTGGCTCAG
GGATTGGCGGGTATGTGTGCTCGGCGTCCAAACTTCGCACGCATACCCGC
TGTGTTCACTGAAACCTAAGCCTCTCGCCAAAAACACAACATGTAGTGCT
GTTGTAGAGATGACCTACAAGATAATGGGGTCAAAATGACATTGCAAGGT
AACAAGCCTGTGGATAACTTGTGCGCAAATCAGTGGTTGGATCCATTTCG
CCCCTGTATGTATGCCCAGCCCTTCTAAATCGCGGGATACGACGTTTCCTC
CTTGAAATATTTTGAAATACACTCCTTTCGCATGTCCTGTTCTCTATAGAA
CAGCCACCCTCAGCGTTTAAAAGTGACAATCCAGTGGCGTCATTTCTTCCT
TAGCTCTGGTTTGGTTTTATCCGTCAGCGGGGTATTGCGGGGCTATTTCCT
CTGACCTATCATCACGCCAGGCGGTGATGGTCGCCTGGCGCCTGTTTCGC
GAAGCAATAGCCCATCTGTGACACCCTTCAGTTTTACATCGGCATGTCCCC
TAACCAGACGCTGCC3’
045:
5’ACCTGTCTATCATCATTTCAAACACCAAATGTGTTGTGTAAACTCTAATA
GGTAGCCATTACCTGTACATAAAAATGCTTGCTACGGTGTGCCAGATTCA
CATATAGGGGCTGATTTATTATGCTGTGTAAAAAAACAGTGACAAAAATT
TGGCATAATTTTATAATGCGTTTTTTATTAGAGCAACTTCCACCAGAACTC
ACTTAAAAATGTCTGAAAATGTGTAAAACAATGGAATAAAATCTGGCATT
TGCACTGTGTAAAATAAAACACACGGTGATAAATTCGCCATTTATTTTAC
ACAGCGGTTTTTTTTTTTTCAGAAAATTTTACACAGCGTAATAAATAGGCG
TATATAGGGGTAATTTACTGAGACCCTGGACACAAGTGCAAGATCAGTTA
AGGACACAAATTTATCCCCTTGGCACTCATTTAATAAGCATATAAATATA
ACATATAAAAATTTACAAGGTTTANAGTGCAGAATCAGCCTCCCACATGG
GCAGAGGCTAAGCCTCCCCAAACCTCTCTGCTACATAAATAAAAATAAGA
AAAGAGGGGGGAAATGTGATGCCTTACTGAGTGGTGTCACTGACAGGTG
GTACAATTCCGTTTTGTAGTCAGCTCTTATTCAAGTGATTGTCTGATGTCT
ACCTGCCTAAGGGTCCTTANGCTTTGGGAGGGAGCCCTATATAGCTCCGG
TTA3’
048:
5’TGCGCGGCAAGGCTGCTGGCGGCGAGCGACAAGGCGAGACTCAGGCGG
GCTCCAAACACGGTAAAACCTCAATAAGGGCGGATACGGGTAGACCTTG
CGCCAGCCTTGCGGGTTCAGCATGGAAAAAACCGGAACACTGGAGTGCC
AGCATGCTCTATAACTGCATGACCTTCATCCTGCGCCCTTACGAGGTTTGC
CATGCCTGTTACCGTCAATACGCTCAACGCTGAAAACTTCCGTCACAGCG
TGAATATCAATAATCACGAGCTGTTTACCGACCTGCCCAAGAGCCTGGGC
GGTGACGATTC3’
049:
5’AGGCGCGTAAGCAAGAGCACAGCGATAGTCGCTGTGACCGGGCTCGAT
ACCCGCCTCGACACTGCGTCGCCAGGAATCCCAGATGACCTTGCGCACCC
CGTCCGGACGCACGACTTGATAGTCCACGCGTAAGCAAGAGCACATACAC
CAAATGTCTGAACCTGCGGTTCCTGCTCAGTACGAGAGGTAGTCCACGCG
TAAGCAAGGGCACAGGCGGTAAGCGGCATCCACGATCAGTGCCTGGCGC
TCGCGGGGCAGGGCTTTGAATGCAGGCTCCTGCAGTTGCTTTTGGTCATCG
CTGATTTTCAGCACCCACTGTTGCTCATCGCTATCGAGCGGCTTGGCGCGT
TCCAGCAGTTCACGTTCACGGGATGGGCGATAGTCGATCTTCTCCACCAG
CCCAGCGTCTTTTACCGCTTTGACCGTGTCGGTAGGGATCGCGGTGAGCG
GGAACTGTTCGGTCAGGCGCAGGTAGTCCACGCGTAAGCAAGAGCACAT
AGTCCACGCGTAAGCAAGAGCACATATTCAAACGAGAACTTTGAAGGTA
GTCCACGCGTAAG3’
051:
5’ACCGTCCTGCTGTCTATATCAACCAACACCTTTTCTGGGGTCTGATGAGC
GTCGGCATCCGCTAAGGAGTGTGCTCTTGCTTACGCGTGGACTAACAGTT
GCCTTGAAGGAAGGAGAAAAATACCGTGACTTTTTGCAAGAAAAAATCAT
TGCCTTGAATTTGCAAAAGCATGTGAAATTCGTAAACAAATATTTGCCTTT
GGACGAACTTTTAGAATACCTGCAAATGACGGATGTTTATTTGTTTACTTC
CAAAGATCCAAATCAAGCGGTTAGCGGAACTTTTGCTTACGCTTTAAGCT
GTGGATGTCCTGTGGTTTCCACCCCAATTCCTCATGCAAAAGAATTTTTGT
CGGGCGATACGGGTTTGCTTTCTGATTTTGGAAATTCGGCAGCATTAGCG
GAATGTGTAAACCGTTTATTATTTGATGTTGAATTGAAACAGAATATCATC
AATAATGGTTTACATAAAATTACCTGTACGGCTTGGGAAAACTCAGCTGT
AGCTCATGCCCAATTTTTACAAAAGGTTTCGGATAATCAAATTGAATTGC
ATTATAGAAATCCAGACATCAACTTAGATCACATCAAAAAAATGACAACT
GATTTTGGAATGTTGCAATTTTCAATTCTAAACCAG3’
053:
5’TCTCCAGTCCGATGAGTTGGTCTCCAAGAAGAAGAACAAGAAGCGCAA
GAACCGAAATTTGGGCAATGCTGACAATACAGCTTGTGCTCTTGCTTACG
CGTGGACTATGTGCTCTTGCTTACGCGTGGACTAACTGACAAATCCTGGGT
CTGTATCTCCCAAGCAGCGCTTAGATTAAATGCATCTCCAAAACCAATTTT
AGGGGAAAAATCTCCAGATTCACTAAAATCAGTGAGAAAAGCAAAACCT
GCTAGTCTGGGGGGGCATCACCCAACTTTCCCCTCTTTTTTTGCACTAAAA
TAAGGGTTATTTGCCAAAAAATCTCTCAGAGGGAATATACATTTAACACA
GTGCCAACCAACGGACAAAACCAACAGTCTAAACCCATGGGTTACAGTC
ACCTCTCTTACAGTATATGGGATCCTGCTATTTGTCCCCCAATCATTTGCT
ATCACCGCTTAACTGTCCCCATGGCACGTGCCTCTGCTGCCCTCCCCTAGT
TCCACACTTTGATAAAGCGAGCATGTATTTAGCTACAATGTTGGTAGATA
AGAGCAGGGCAGATACCCCAGGGCTGAGGGGCAAAACTCTAAGGAGCCT
GTTAATACTGGGAACAAAAATTAAGCACCTCATGGTGTAGTACAGGGGTC
CCCAAATGCTCCCTACAGTAGAAAATGTGTATATTTGCTGGCAGCCCTGC
ATAACATCCAAATCCTGGGT3’
054:
5’TGATTAAGAGGGACGGCCGGGGGCATTCGTATTGTGCTCTTGCTTACGC
GCCTCGAGGAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAA
CCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAG
CTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGC
GCAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATC
TGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTG
ATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCG
CCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGAC
CGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAAC
GCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTC
ATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGT
GCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTATCC
GCTCATGAGACAATAACCCTGATAAATGCTTCAATAATATTGAAAAAGGA
AGAGTATGAGTATTCAACATTTCCGTGTCGCCCTTATTCCTTTTTTGCGGC
ATTTTGCCTTCCTGGT3’
056:
5’AGCCTTGTCGTACCGCCGAGTACAACTGCATCTCGGCGCGCTGTTTAAA
GCCTCGATCAATCAGCGCCTGAGACAACCCGAAGGACGAGCCAGGGCTC
GGATAAAAAGCCCTACGTATATGCTTGCCGTATTCGCCCCCCACATTCAG
GGATGCGATCGTTTTGATCAGGTAGCTCACACTCAAGCGTTCTTTCCAGAC
GGGTTCCAGCCAGCGCGCCCGGTTCAAGCGCCAGCGGGTCCAGGGCGCTT
CAGGGTCGAGGTTGNGCAACGCCAATTGCAGCATGCTGAAGGTGGTACGT
TCCTTACTGACCACCGTTTTAATCTGACGATCACCCACCGCCCCCTGGCTC
GTCCAGCCCTCGTAGNGAGNGCTGACATCATCGGGCATGTCGAACAGGG
GGGTATCGATATCCAATTGCGGGTAGAAACCGTCCTCGGTCAATTTGGCA
ATCAGGGCTTTGCGAGCAAAGGGCTCCAAGTCAGGCAAGTCCTGCCAGA
GTTTGGTTTCCAGTGCAAAAAT3’
057:
5’TGGGGCAGCCGAGCCAATCATCGGTGTCCATGTCTACGTACATAACGCG
AACCTCAAATGCTGTATGTGCGTACAGTAATCGAGGTTTGGACGTGACGC
GATTTGAGCCGACGAGCTGTATGGGCTTGCGACTATTCCGACTCTATAAG
CACGGCGAGAGTCATTTTGATGAACTCTTCGTTGTGTCCGATTGTGAAGA
GGGCGCCTCGCACGTTGTCTGCCACCTCGGCGGAGCCACGTTGCTCAACC
CAATTTGACAGCTCCAGGATGGACGCCTCGAGTGCAAGTTGGTTTTCGTA
GAGTTTGAAAAGCAGGGAAGGGATTAGGTCTGAGTTCGGCATCGTTGTTC
CTCCGTGGAGCGAACAGCGTAGCAGGCAAATTATGGAGTTGGGAGATCGT
TCGGCAGGACGCCGGAGGAGGGGTAAATCATTTCCGCAACCCAATGCAC
GCCCCTTGATCCATGCGGGCTGTAGGCTGGCTAAAGCTCTAAGTTGCGGA
AAC3’
058:
5’GTATTCGGTGCATGTGGCAAATAAAGTTTGATTTGATTTATGTCTGTCTT
AGGTCAAATCAAATGTCATTTGTCGCATGCGCCGAATACAACAGGTATTA
GACCTTACAGTGGAATGCTTACGTACAAGTCTGTAACCAACAATGCAGTT
TTAAGAAAATACCCCCCAAAAAGTAAGAGACAAGAATAACAAAAAAATT
AAGAGCAACAGTAAAATAACAATAGCGAGACTATATACAGGGGGTACCG
GTACAGAGTCAATGTTCGGGGGCAGAGGTTAGTCGAGGTAATATGTACAT
GTAGGTAGAGGTACAGTAACTATGCATGGCTAATAAACAAGAGTAGCAG
AACCGTAAGGGGAGGTACAAAGTTAAAGGATTCTGACAGGTTAAGAAAC
TCCCCAGCTAGAACATCATGAATGAATGTTCTCCAAGAATAATAAGCCCT
AGTGGTTAGAGTGTAGAGGCGGCAGGGTAGCCTAGTGGTTAGAGCGTAG
AGGCGGCAGGGTAGCCTAGTGGTTAGAGCGTAGAGGAGGCAGGGTAGCC
TAGTGGTTAGAGCGTAGAGGCGG3’
059:
5’GTCCTGCTGTCTATATCAACCAACACCTTTTCTGGGGTCTGATGAGCGTC
GGCATCCGCTAAGGAGTGTGCTCTTGCTTACGCGTGGACTAACAGTTGCC
TTGAAGGAAGGAGAAAAATACCGTGACTTTTTGCAAGAAAAAATCATTGC
CTTGAATTTGCAAAAGCATGTGAAATTCGTAAACAAATATTTGCCTTTGG
ACGAACTTTTAGAATACCTGCAAATGACGGATGTTTATTTGTTTACTTCCA
AAGATCCAAATCAAGCGGTTAGCGGAACTTTTGCTTACGCTTTAAGCTGT
GGATGTCCTGTGGTTTCCACCCCAATTCCTCATGCAAAAGAATTTTTGTCG
GGCGATACGGGTTTGCTTTCTGATTTTGGAAATTCGGCAGCATTAGCGGA
ATGTGTAAACCGTTTATTATTTGATGTTGAATTGAAACAGAATATCATCAA
TAATGGTTTACATAAAATTACCTGTACGGCTTGGGAAAACTCAGCTGTAG
CTCATGCCCAATTTTTACAAAAGGTTTCGGATAATCAAATTGAATTGCATT
ATAGAAATCCAGACATCAACTTAGATCACATCAAAAAAATGACAACTGAT
TTTGGAATGTTGCAATTTTCAATTCTAAACCAGCCCGACATCAATTCAGGA
TATACTATTGATGACAATGCCAGAGCGATGATTGCCATGTGTCAG3’
060:
5’TAACACCGTCCGCGGGCTGTGCTCTTGCTTACGCGTGGACTACCAGGCG
GACGAATATGTTCGTGATAATCCGTGGACTGGTATCGGTATCGGCGCCGC
TGTCGGTGTGCTCTTGCTTACGCGTGGACTACCGCGTCGCCTGGATACTTC
AGCTANGAATAATGGAATANGACTCCNGNTCTATTTTGTTGGTTTTCGGA
ACT3’
061:
5’GCTTCATGCCTGTCGGTCGACTCTAGAGGATCCCTCGAGGCGCGTAAGC
AAGAGCACAAG
AGGTAGTCCACGCGTAAGCAAGAGAACAGACAAGTTCCATAGGTCCACT
ACTCTCCATTTTACCTAATGGGGTTAGTCCACGCGTAAGCAAGAGCACAC3
’
062:
5’GGGGGCATTCGTATTGTGCTCTTGCTTACGCGCCTCGAGGAATTCACTG
GCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACT
TAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAG
AGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAA
TGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTCACAC
CGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAG3
’
063:
5’GCTTCATGCCTGTCGGTCGACTCTAGAGGATCCCTCGAGGCGCGTAAGC
AAGAGCACAAGAGGTAGTCCACGCGTAAGCAAGAGAACAGACAAGTTCC
ATAGGTCCACTACTCTCCATTTTACCTAATGGGGTTAGTCCACGCGTAAGC
AAGAGCACACCCGACGCTCCAGCGCCATCCATTTTCAGGGCTAGTTGATT
CGGCAGGTGAGTTGTTACACACTCCTTAGCGGATTCCGACTTCCATGGTA
GTCCACGCGCC3’
064:
5’GACCATTTCCCGCGAACACCCCACAATACGTCCGATCTCCTGGCGCGTG
ACTTTGATCTGCATGCCGTCGGGATGGGTCATGGCATCGGGTTGCTTGCAT
AGCTCCAGCAGGCAGCGAGCGACGCGACCGGTGACATCGAAGAACGCCA
GGTCGCCGACTTTGCGCGTGGTGTCGCGCAGGCGCTGGGCGATCTGTCCG
CTCAGGGCATACAAGATATCCGGATCATGCT3’
065:
5’GATAGCCAGCTTCATGCCTGNAGGTCGACTCTAGAGGATCCCTCGAGGC
GCGTAAGCAAGAGAATCGTTAGCTAAATTAGTTTCGCCAATTTTATAAAG
AATAATTTCAAGTCTTTAGTCCACGCGTAAGCAAGAGCACACCTGGCGCC
CGGTGCCTCCCAAGACCGCCTGCGCTTTGTCACCACCATCGAAGACTGCG
TAAAAGACGCCGACTTCATCCAGGAAAGCGCCCCGGAACGCCTGGAACT
GAAGCTGCAATTGCACAGCCAGATCAGCGCCGC3’
067:
5’ACGCGTAAGCAAGAGCACACAGGAACGAGGGCAGGTCGCTGGTGCGTT
CGAAGATCACCAGGGTCGCCATCGGGACCACCATGGCGACCGCAAGGGT
GATCAGGAAGATGCCGATGATGAAACCGATGATACGCAGGGTCGGCAAC
GCCATGAAGTTCGCTCGGGTGATTGGGCTGAGGCGCCATTCTACCTGCGG
TGCAGGTCTTGTAAACCAAGGGCTGCGGTGGCTTGGTGTCTACACAACTT
CGCAGCGACGCTGAAGCTGTGGCGAGGGAGCTTGCTCCCGTGACGACCTA
CCCACTGGCGCCTATCTACCTGACACACCACGATCCAAATGTGGGAGCTG
GCTTGCTCGCG3’
068:
5’GCACAGAAGGGCAAAAGCTCGCTTGATCTTGATTTTCANCATGAATACA
GACCGNGAAAGC
GGGGTAGNCCACGCGCCTCGAGGAATTCACTGGNCGNCGTTTTACAACGG
CGNGACTGGGAAAACCCTGNCGTTACCCNACTTAATCGCCTTGCANC3’
069:
5’CAAGCGATGGATCAGCCGACCAACAATAGCGCTGCACCGGCAACCGGC
GAAATACCGTCTGGTCATCGCCAAACACCAGCAGATGATTCTCCGCGCTG
TGGCGAAAGTGGTAGTGAATACCTTCCTCTTCACACAGCCGCTGGATGAA
ATGCAGGTCGGACTCCCTGTACTGCACGCAAAATGTGTGCTCTTGCTTACG
C3’
071:
5’ATTTCTGACGGNTTTATCCGCGTGGGTGATGCTTGGCGTGCATGTCCTGC
AAACGTGCGCGTGCCACATGGGTGTAGATCTGGGTTGTGGATAAGTCGCT
GTGCCCAAGCAGCATTTGCACCACGCGCAAATCCGCACCGTGGTTGAGCA
AGTGGGTGGCGAACGCATGGCGCAGGGTGTGGGGTGACAGCGCCTTGCC
GATCC3’
072:
5’AAGTTCTGATAATACGCAAACTTACTCAACATATTGCAAAGCTGAAATC
TAAAAAGTTAGTTCATGCTTGTATATATCTGATACTAAAGAAAAAAAAGT
ACCAGGAATGCCCTGAATTGATAACATGTATCATGAGACCCAATATTACG
TTACAATTCTTCAAAACCAAAGCGATTGCTATTGACTATTACCCCTTGCAT
TTGTAGATTTCTTATAACATATACATTCCTAAACTGATCCTCTGTTCCTTTC
TCTATTTCTATTTGTTGCAACATATTTCTCATTTTCCTGTTCTGGATTATTC
ACACATAGCCGTATTTACTTTTACAGGTTTTGTTCATAGGACTCAATACAT
ATTATGTCAGTCTAGTATGCGTCATTCTTTCATTTAATTTTATCTGACAGTC
TATATTTAATCTCACTATTTTGACTGGATTCTAAACGTGTTTTATCTTTTTT
TAAGTAACTCTGTAGTCAGTTACTTGAGCTGAAACCGGATTATAAAATTC
ACAATGCAAATTCATGAAGAAGAAAAAAAAAAACACTGTTAGAGTGCTG
CTGAACCTCTGGGCTATAACAGTAAGTTAATTATATTAAAAACTGCATTTC
TAGCTATGTTCTGTTTTGNGTGTTTTAGTTCTCCCTAAACAATTCACAGATT
AAAATACGTAATATTTTTCAGGGTCTACCCCCCCCTTAG3’
075:
5’TGTTCAGCGGCTGGCAGGGCAAAAGCGCTGGAAGCCAGGACAGATAAC
AGAACGGTAGCGAGTAATTGGCGTTTCATGATGGTTGCTCCTTGGGAGGG
CGATAAAGTGGGTACAGGGCTAATGTTACCCTTGATAAGTCGATATAAAA
GTTCATAAACACAATGGTAATAATCAACAGAATTGATTGTTCTCGCCGGA
GGCTCTAGACCGAGCCTCTCAAGCCCGCGGCTTTGCACTGATGTGGGTAT
TTTCGACACGAACCTGGGTAACAATGGTGCGTCGTCGATGGGGAAAATGG
TCTGGTTGATCAGGAAAATCGCTTTTTTCGGCTAAATCCGCCGTTGCGTTA
AACCCCCAGGCACTTTGCCAGTCGTAGTCCTATAAGCTGTTTAAAAGGCT
GTTGCCCAGCCAGTCGTATTCAGGAGTCCTGTGCAATGACGCGCACTCGT
AAAATTGTCGCTTGGAGCTGCGCCAGCTTCGTTCTGTTGATTGCCATCGTG
GTACTGGTGTTGGTGTTCTTCGACTGGAACCGCATCAAGCCGCCCCTCAAT
GCCAAGGTCTCCGAAGAACTGCATCGTCCGTTCGCCATTAACGGCAACCT
CGCCGTGGTATGGCAGCGTGAGCCCGATGAAGCGGCTGGCGCGCCTGGGT
GCC3’
076:
5’AAGCGCCTGCTGTTGTTTACCGGCAGTTCGGCAAATGAAATCTGCTACC
AACTGGGGTTCAAGGACCCGGCGTATTTCAGCCGGTTTTTCTTGCGGTATG
CGCAGATGACGCCGGGGGAGTATCGGGTACGGCAGGCGGGGATGCGCTG
ATAAGGGATCGGACAAAAAATGCAACGTTGAGGAATTGGCTGATAGTGG
TCCGTTGAACGAGAAGGATGGTGTTACCTGTCGAGCCGGAACTTTTCTGA
CCGTC3’
079:
5’TACTGATTGCAGAACGGTGACCGTCCATCCGCAACCTTAATGTCTGGTC
GGTTTTCCCAACATATGAGAGTCCACAGGGGCATGTTATTAGGTATATCA
CATGAGTGGTTGTGCAGGTAATGTGATGTCTAATGGAGAATTTTTTACCCG
TTTGGGGATGATGAAATGATGTACCCGGTGTCATATACCTGCAAGATGTA
CAATTTGGACATTTGTGACACCCGGGTCTCCCTCCACTTAGCCATCCTTTC
TGGGTTTTGGAATAGCATTTAATTGGATCGCTTTTGACTAAAACGTCTCTC
AAATTGGTACCTCGTCTGTAGCACATCATAGGAGGTCCTTTCACAACTTTT
CCCAATGCAGTATCTATCTCTACGATCTTCCAAAGATCCCTGACCCCCTTA
TTAATGATCTTAGCACCAGTATTAAAGGTAGTGGTAAAGGTAAGTGCTTG
ATCTTTTTTCACTTGTATAGCCTTCTCACTCACCCTACACCTGGCAATCTCC
AAAGCATTTAATAGCACTGTGTCTGGGTATCCTCGCTTCTTAAAGCGAAA
C3’
084:
5’ACGAGTAGGTGTGCTCTTGCTTACGCGTGGACTACCAGTGTTTGACAAC
ACAAAGATGTGCTCTTGCTTACGCGTGGACTAAGGTTGTTTATCTTATGTT
TGCTTTTCAACTGCTAGGGAAGAGAAGACAATGCTTCTACTAATCCGACT
CAATCGCACAAGCACAAACATGACTTAAGTCACACTATCATGGTAACCTC
CTGCCCTTAAAGGAGCAGGTGAAAATGTTTGTCTCATCTGTGATATTTTGA
TAAATGTGATAAATTACTCATAAATTACTCATGTCATAAAAAATACATATT
ATTCAATATACCACATTAGTTTCTTCTTACTAGTAATACATGTATTGTTTTA
GAAACATAACAAAGCATGCTCATCTGTTTTTTTGTGTTTTGTTAGTATAAT
TTTCTCTGCATTTTTTTTTTTATCTACCTGCCAGTGACTGGTTGACCAAAAT
ATTAAATTTATTGCCATGTTCCTCACCTTGAAAGTTGCCTATGGGCAAGGA
GAAACTGAAATTCATGGCTTGATTTTATTTAAACAGCCATTGCAAACG3’
086:
5’CCCAGTTCCGAAAACCAACAAAATAGAACCGGAGTCCTATTCCATTATT
CCTAGCTGAAGTATCCAGGCGAAGCGTTTACTTTGAAAAAATTAGAGTGT
TCCAAGCAGGTGTGCTCTTGCTTACGCGTGGACTACCGTACTCCCCAGGC
GGTCAACTTAATGCGTTAGCTGCGCCACTAAAAGCTCAAGGCTTCCAACG
GCTAGTTGACATCGTTTACGGCGTGGACTACCAGGGTATCTAATCCTGTTT
GCTCCCCACGCTTTCGCACCTCAGTGTCAGTATTAGTCCAGGTGGTCGCCT
TCGCCACTGGTGTTCCTTCCTATATCTACGCATTTCACCGCTACACAGGAA
ATTCCACCACCCTCTACCATACTCTAGTCAGTCAGTTTTGAATGCAGTTCC
CAGGTTGAGCCCGGGGATTTCACATCCAACTTAACAAACCACCTACGCGC
GCTTTACGCCCAGTAATTCCGATTAACGCTTGCACCCTCTGTATTACCGCG
GCTGCTGGCACAGAGTTAGCCGGTGCTTATTCTGTCGGTAACGTCAAAAT
TGCAGAGTATTAATCTACAACCCTTCCTCCCAACTTAAAGTGCTTTACAAT
CCGAAGACCTTCTTCACACACGCGGCATGGCTGGATCAGGCTTTCGCCCA
TTGTCCAATATTCCCCACTGCTGCCTCCCGTAGGAGTCTGGACCG3’
087:
5’GTCTGGAAATATAGGGGCAAATCCAATAAACAATTGGAATTTACTTCCA
TTGATCTGTTTACTCAGTGGTTGTCACTTTTATCGAGAAAGGTTTGCAGAA
CGCGGGTTTTTTTATAAGGTTCCTGATGTACTAAGGGATTATTTATCAGCT
ATACCGCTGGAAATAAATGAAAAGGCACGATACAAACCCGGCATCGCTA
ACTATCACAATATCATCACATGTGGTTTTTCAACGTTGTTACCCTATATAA
GGCAACAACCATTGGCAATGCAGCAACGATTTAATTTATTATTTCCTGATT
TTGTTGACCACATACAATCGCCGTTACCACTTGCATCAACACTTTTAGAGA
GAATTACATTTTATGCGAAAAAAAATAGAGATGAGCTTGATGAAATCTCC
TGCAAATGGTGTTGTGATTAAAAGAAAAATTTCTGATGGATTGAAAGAAA
TAGTTTCTCTTAAAGAAAAAATCCTTCTTGAAACCACCGCAAAAATTCAG
AGTATTGAGGAAAAGAGAGAAGAAAAATTTATTCAAGGTTATTATGATGG
CTATACAAAAGGCATTATTGATGAGATGGATAATTTTATACCCTTGATAA
GCTTGCTATGCTCAGAACTTGAAAAAAAAGAATAAACATGATAAACCGAT
CTGAAGAGTATATTGTTAAAACCTTCAGAAAGAAGTTGATGTTTTTTTAGT
CCCCCGCGCCTCGANGGAATTCACCTGGNCGTCGTTTTACAACCGTCCGT
GGA3’
088:
5’TCTTTATGTCATAAATTTACTTTAGTTTTCCGGTCCATTCATCGGTCAGG
TTAACAGGTTATTATGTTGAGATACAATTAACATTAACTTAATGAGGAAG
CCTTTACTTTTGTGATAAAGTTATGGGTACTTCAGCGGATCAGTTATTATT
TCATGCCGTACAACAAAATGACCGCAGGGCATTTGACCGTCTCTATCTTAT
GTATTGGGAACAAATGTATATCAGGGCATGGAATCGTACGGGTGATGAGC
AAACGGCTCAGGATATTGTCCAGGAACTTTTCATTAATCTGTGGGAACGA
AGGGGAGAGATTCTGATTCAGACCAGTTTCCTGCAGTACTTATCAGGAGC
CTTAAAGTACAGACTGATCAATCATTTTCAATCCGAAAAAGTTAAGCGAA
GGGTATTAGAAAAAGTATTGCACAGAATGGCTGAACTTTCTGGTGGAATA
GATGATCTTGCAGATTATAAACATCTTGAACAAGCACTGGATGATGAATT
GGAGAAAATGCCGAAAAACATGAAAAACTCTTTGCTTCTTCGGCTTGATA
ATCTGTCTGTTAAAGATATTGCCCTCCGCCTGGACCTGGCAGAACAAACC
GTTTCCAATAACTTAAGTGCTGCCAGTAAACGCTTGCATAAGAATCTGGG
TTCTA3’
089:
5’AGTGCGGCAAATTCGAAATCGCTTAGCTTTTTCACAGGAATGACCTCGT
ATCTAGTTGTTTAACAAAGCTTTCGAGAGCGTCNGTCNGTCTTCGTCGATT
GCTTTCGCTATCCCTTCCATGCATCCCACGTACTCCTGCGCTTTTTGCNTGT
GTGGGGATCGCAATCTGGCTTGCGAGCAGATCAATGATCGAGCACACCTC
CCTGAACTGTGCTGCTATTTGTGCGTACCGTCGGGTTTTCAAGCTTCAGGA
CGCTAATAGAATAGTTTTTCGCTTGGTGCAGAACACGGTTTGCAGCATGT
AGCACATTATCGTACAGAATTGCAACCGTTTTTTGCTTCTGATTAAGCTCT
TCCTGAACCATTCCCGACGATCCTGATGTTTATAAAAGGTCGCGGGATTCT
ATAGCTATTGGTGAGACTGTCAACCTTCGCCAAAAGTCACAATCCAAATA
TGGGCTACCGTTAGTGGTCTCGTCAATACGATAAACCTAACAGTTTTATGA
AGCTTTTCTATGAAGAGAAATCGTAGCGAAACACCGATGAATCCTACGTT
ACGGCTGTTTCATTTCCTCTACAGCGTTAGTCAATTTGGGCGT3’
091:
5’GATGGTCANGGTGGCATGTGACTAACTGTCAGGATAATAGTGCAGGTGC
TACATGGAGAGTAACACTCAGGAGGGAGCAGTTCAGGGGCTGGATGAGT
CTCAGAAGACTTGGTGTGTGTACTCTTGCTTACGCGTGGACTACCTTGCTG
TCTAGTAGCTTCTTGTAGCTCAACGCACGTTCGAAGTCTCTTGCTTACGCC
GTGGACTACCAGCGTGGTTTGACNGGGGCGCTTAAGATCAAGATCAAAAG
CAGATCAAGAGCGACTCGTTCGATCGTGGTTACCGTCCGCTGCTACAGCC
CACTCAGTTGTGTAGATACCTATGCCGCTATGGGGCAA3’
092:
5’GGTCANGGTGGCATGTGACTAACTGTCAGGATAATAGTGCAGGTGCTAC
ATGGAGAGTAACACTCAGGAGGGAGCAGTTCAGGGGCTGGATGAGTCTC
AGAAGACTTGGTGTGTGTACTCTTGCTTACGCGGTGGACTACCTTGCTGTC
TAGTAGCTTCTTGTAGCTCAACGCACGTTCGAAGTCTCTTGCTTACGCCGT
GGACTACCAGCGTGGTTTGACGGGGCGCTTAAGATCAAGATCAAAAGCA
GATCAAGAGCGACTCGCTTCGATCGTGGTTACCGTCCGCTGCTACAGCCC
ACTCAGTTGTGTAGATACCTATNCCGCTATGGGGCAAGTTGTGGATATGC
TGACCGGCTCTCAAACAGTGATTGCCAAGGACGCCGACCATGACTGCCTT
GACCCTTGCTGCGGCNCAAACCGTTTCCATCCCGGGCGATGTCGCTGCCA
ATATCCAGCGGCACCTGGCGTTGATGTGTGCTCTTGCTTACGCGTGGACTA
CCCGCCCCATCGCCGTCCCCATGCCGTGACTGGAAAAT3’
093:
5’TGCTCTTGNTTACNCGCCTCGTAGGAATTCACTGGCCGNCGNTTTACAA
CGNCGCGACTGGGAAAANCCTGGCGTTACCCAACTTAATCGCCTTGCAGC
ACATCCCCCTTTCGCCAGCTGGCGTAATANCGAAGAGGCCCGCACCGATC
GCCCTTCCCAACAGNTGCGCAGCCTGAATGGCGAATGGCGCCTGATGCGG
NATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATGGTGCACT
CTCAGNACAATCTGCTCTGATGCCGCA3’
094:
5’CGCANCCACCTGACAGCATCATCCTGATGGATCGCTGGTACCCTTCTGA
TGCCGCGTTTCGTCGATTGATACCCTTTGCAGAGATTCTTGAGCTGAACAT
AGATCGACAGGTGCAAGTGCCGGATCTTCATGTGGGGGTTGTCACCGCGG
CGCAAATATCCTGGGCGCGGGCGGCAACACGACGGCGCGGGCTGAGCAG
TACGGTGATGTCTAAGCTGGAGGAGCAAGTTGTGTGTACCGAGGCGTTTG
AGCAAGCGGCTGTGGGGCAGGGGTGGGTGATGTGTCGCAATGAAGGGAC
GATTGAAGAGGCGATGAGGCGGGTGGTTTCGCAGATATATAAAGTCCTTT
GATCTAATTTGATCTGGACCAAGTGAGGTTCATCAATTTGAACTAATCACT
AAGCCTGCCCACCTAACGCTTTGCACGTTGCCTCAAGCCCAGGTTTTCCTG
GGCTACCCAATGACACACGAAGGTTTGGTTAATCATGAAGAGCGAAC3’
097:
5’TCATAGCTGGGCAACGGCGCATCCATCGGCAATTGCTGAAAAGCCAAC
AGCGCGTCGATGGCATCGGCAAATAATTGGTCGGCGTTTTCACCGTCAAT
CACGTCCAGATAGGTTTTTGTGCCCAGGTCATTGAGCAAAAGAAAGCCTC
GGGGCAAATCTTCTGCATAAATTTTTGGCACATTTATTCCCGATTTCGCGA
GCAAATGCGCGATATCGACGAAAGGTTTGCAGTTTTCCTGGGGGGGAGGC
GCGTCCATGACGACGAACGTATGGGCACCGCCCTCCCATCGGAAGTAACG
CCTGAAACTCGCGTCGCTG3’
101:
5’TGGATCGCTCCACCTGTGTAAATATCAAAACTCGCAATGTTGCTGAAAT
CATCGTTACCGGTAAAAAACATCAACCTGACACTTGCACCAACATACACA
TCGTCCATACGTATAACAATTTGATCCTGATCTGAATAAACCAGAAAAGT
TTCTAATTGGTTATTAAATGGCGCGGTGTACACGTTGTTTACGTTTGCACT
TCGGGCGATTCCTGGCGAAGTGATTATGTGTGCATTCTTAGCTAGCGTAA
AGTCATTGGCAGAGCTATAAATCGAGTCCCGGACCATGTGCCCCCATGCA
GCCAGCCCATATGGGTTCTTGTATGCATAGTCGGCGGGGAGCAGTGGCGT
GCTGCTTGGGAACTGAAAGGCGTTGAACGGCAGAGAGTCGCCAGTGATG
ACAACCTTGTAGCCCGAAGTGATCTTCGATGTTAGATCTTCCTTCTTTGTG
GCGCTTGGAACGTATGCCGAGAGGTTTTCACCGGCGCGAATCCAGGTGTT
TGCAGGCTCAGCTTCAAAGCTGCCTGTAATGGATTTCGGAAGAGTTGCAC
CGATGTATTTGTAAAGCGTTCCCCCGCTCAGCACCAGTTGGTCGTAAGTCG
TGATGCTGCCGGTACCCCAGGGCTTTGCAGCAGACGAGTATTCAAACCCA
ACAGGGAATGGGTCTGGATCGCGCTGTCCAGGCTGCCAAATACCGATTCC
ACCANGCTCGCCCCATCTGGCTNCGCAAGANCCGCACGCNAAGAAGCAT
CGCCGACAGCGGNGAGCTTTGGGCATNCGTANCCCATACTTCCGGNTACG
3’
102:
5’CTCGATCTCGTGTGGCTGAACGCCACTTGTCCCTCTAAGAAGTTGGACG
CCGACCGCCGGGGGTCGCGTAACTAGTTAGCATGGAGGAGTCTCGTTCGT
TATCGGAATTAACCAGACAAATCGCTCCACCAACTAAGAAC3’
104:
5’TTCGCGATGCTTTGTTTTAATTAAACAGTCGGATTCCCCTGGTCCGCACC
AGTTCTAAGTCAGCTGCTAGGCGCCGGGGCGGTGTGCTCTTGCTTACGCG
TGGACTACCTTTATGACCAACATCACTGTGCTCTTGCTTACGCGCCTCGAG
GAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCG
TTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTA
ATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTG
AATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGT
ATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCA
TAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACG
GGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCG
GGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGA
CGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGA3’
105:
5’GCTTTGAAAAACTCCTGTCTAGTCTTAAGTGTTCGGAAAGCTTCAGCCA
ATCCAAAGTCTGAACCTATTGCCTCCACCAAATCGTTACAAAGAGGTTCA
TAAGCTTCCGGCTCGGGTAAAGCAAGATTGATAATTTCATCTTTTTTGTTT
TTTAAATTGGTACAAGCTTTGTCGTAAGTTACTTTGCTCTCGTCTTGCATG
AATTGCCAGAAGCGCTCAAGACGATCTTTTGCATGGTCGTCAAGTGGTTG
CATACAAAGGACACACAACGCCTCTTCGCTAGTGTTCGGAAATTCGCTTT
CGGTGTAGGCATGAGAGGTGGAGAAATCTTTGGCTGCGGTGAAAAGAATT
TTCCAAGGGTCCGAGTGAACTCCCTCTAACGGGTCTGCTTTGTCAAAAGTT
GTGAGTGAAAAGTCGTAAGCTTTTTTTGCGGTGACTTCAGTAACCTGTAA
GTTATCAATTTCATCAGGTTTTGTTTCGTTTAATATTTTTGCGGCAGCAGCT
AGTTTTTGGACTGCTCGGGGAAGCCGCTCCGTCGAGATCTTTGTTAATTTC
GCAATGGTTTTTACTGTAGTGCCATTTTCGTAGTCGGCAACGGTGCCTGTT
AAGTTTGTTAGGTCGCTTGAATCTTGCTCACTCCAAGTGAGAGTGAGTTTC
ACATCGGCACTATTGGTTTTGTCCGACATACGATTTAACCAGG3’
107:
5’GCCCAATGCCCCAGTAACCGCCGGTGCTGTGCTCTTGCTTACGCGTGGA
CTACCCACGGATACTCTTTCACCATTTCACCCAGTACGCCCTGAATTTCAG
ACATATGCGCACCGAACATGGTTTCTGCCATCCATGCGATACCGTACACC
GCCACGATGGCGATCATACCGGAACGGAAGACTTCGTTTTTTGAGATAGA
CGCGGGATTGGTTTTGGTCAGGATAATAATCAGCGCCCCGGTCAGCAGCA
TAAACATCTGAATAACCAGTACCATCGACAGCGGTTTGCCGCCGAAGGAT
GGACGCAGGTCCGAATCAGCACCAAGAAGGGCGACTACAGCGATTGCCC
CGAGGAAAATCCACATTGCCAGCCAGTTGCTTTTCGGCAGTTTTTTATCCA
GCAGCGTCGCGGTATCACCGTAAACATACTCACGGTTTTCCGGTACGGAG
ATGAATTTCTGGAACTCTTCGTCTTTATCCAGATCTTTACCGCGGAACCAG
CTGAAGATACCGATCGCCAGGATACCGATTAACGTCGATGGAATGGTGAT
TGCCAGCAGATCGAGGAACTCAAGATGGCGACCATCAAAGGTGACATTA
CCCAGCATCGCAACCAGAGACACGACCGCAACCGACACCGGACTGGCGA
TAATCCCCACCTGTGCACCGATAGAACTTGCCGCCATCGGACGTTCCGGA
C3’
108:
5’GGGACTTAATCAACGCGAGCTTATGACCCGCACTTACTGGGAATTCCTC
GTTCATGGGAAATAATTGCAATCCCCGATCCCTATCACGAACGGGGTTCA
GCGGGTTACCCGCACCTGTCGGCGCAGGGTAGACACACGCTGATCCGTTC
AGTGTAGCGCGCGTGCAGCCCCGGACATCTAAGGGCATCACAGACCTGTT
ATTGCTCGAT3’
110:
5’GGGACTTAATCAACGCGAGCTTATGACCCGCACTTACTGGGAATTCCTC
GTTCATGGGAAATAATTGCAATCCCCGATCCCTATCACGAACGGGGTTCA
GCGGGTTACCCGCACCTGTCGGCGCAGGGTAGACACACGCTGATCCGTTC
AGTGTAGCGCGCGTGCAGCCCCGGACATCTAAGGGCATCACAGACCTGTT
ATTGCTCGAT3’
112:
5’AGCTGTACGGTAGTGACAATACCGGCGGCGATCAGCAGTAAATTCAGC
GACATCGGGTTTTGCCCCATATGGCTGGTTGAGCTGTCGGCAATAGCAAA
CAGGTAAATTGCCGCCACGGGCAGCAGCCACATGGTTTCGATTAACATGC
CGGTTTGCGCTTCAACGGCAATCTTCTTGCGTACCAGACCGTAGAAGGCA
AAACTAAATGCCAGTCCCAGCGCGATAATAGGTAGCGAACCAAAAGTCC
ACAGCTGGACTAACACGCCACATATCGCCAGAATCACCGCCAGCCATTGC
ATCCGGCGGAATCGCTCGCCGAGGAAAATCATCCCCAGCACAATGTTCAC
CAGCGGGTTAATAAAGTAACCAAGGCTCGCTTCCAGCATATGGTGATTGT
TCA3’
113:
5’TGATCGCCGACGGCACCATCTACGGCGGCATGCTGCCCAAGATCCGCTG
CGCGCTGGAAGCAGTGCAAGGCGGCGTCGGCAGCTCGCTGATCCTGGAC
GGTCGGGTACCGAATGCAATCCTGTTGGAAATCTTCACCGATACCGGTGT
GGGTACGTTGATCAGCAACCGCAAGCGTCCTTAATCGCTGCAAACAAAAA
AGCCCCGCTCAATTCAATTGAGCGGGGCTTTTTTGCATAGAGCGTGAGGA
CAATGGAGATCCCCTGTGGGAGCGGCCTTG3’
114:
5’ATGGAAGTCGGAATCCGCTAAGGAGTGTGTAACAACTCACCTGCCGAAT
CAACTAGCCCTGAAAATGGATGGCGCTGGAGCGTCGGGTGTGCTCTTGCT
TACGCGTGGACTAAGTTGCTGCGCCGCTTTGAGAAATCGACGAAGTCTTA
ATCAGTGTAATGTCGGATGCGTTTCGCTTATCTGACCTGGCATCGCGTGTC
CTCTTGCTTACGCGCCTCGAGGAATTCACTGGCCGTCGTTTTACAACGTCG
TGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATC
CCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCT
TCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTT
TCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAG
TACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCC3’
115:
5’AGCTCTGATAATACGCAAACTTACTCAACATATTGCAAAGCTGAAATCT
AAAAAGTTAGTTCATGCTTGTATATATCNGATACTAAAGAAAAAAAAGTA
CCAGGAATGCCCTGAATTGATAACATGTATCATGAGACCCAATATTACGT
TACAATTCTTCAAAACCAAAGCGATTGCTATTGACTATTACCCCTTGCATT
TGTAGATTTCTTATAACATATACATTCCTAAACTGATCCTCTGNTCCTTTCT
CTATTTCTATTTGTTGCAACATATTTCTCATTTTCCTGTTCTGGATTATTCA
CACATAGCCGTATTTACTTTTACAGGTTTTGTTCATAGGACTCAATACATA
TTATGTCAGTCTAGTATGCGTCATTCTTTCATTTAATTTTATCTGACAGNCT
ATATTTAATCTCACTATTTTGACTGGATTCTAAACGTGTTTTATCTTTTTTT
AAGTAACTCTGTAGTCAGTTACTTGAGCTGAAACCGGATTATAAAATTCA
CAATGCNAATTCATGAAGAAGAAAAAAAAAAACACTGTTAGAGTGCTGC
TGAACCTCTGGGCTATAACAGTAAGNTAATTATATTAAAAACTGCATTTCT
AGCTATGTTCTGTTTNGGGGGGTTNTAGTTCTCCCCTAAAACAATTCCACA
GGATTAAAAAATTACGTNAATAATTTTTCAGGGGTTCCTA3’
117:
5’GGAAACTCTGGTGGAGGTCCGTAGCGGTCCTGACGTGCAAATCGGTCGT
CCGACCTGGGTATAGGGGCGAAAGACTAATCGAACCATCTAGTAGCTGGT
TCCCTCCGAAGTTTCCCTCAGGATAGCTGGCGCTCGTCCGTCGCAGTTTTA
TCCGGTAAAGCGAATGATTAGAGGTCTTG3’
118:
5’GACGCTCCGGCGCCATCCATTTTCAGGGCTAGTTGATTCGGCAGGTGAG
TTGTTACACACTCCTTAGCGGATTCCGACTTCCATGGTAGTCCACGCGCCT
CGAGGAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCT
GGCGTTACCCAACTTAATCGCCTTGCAGCACAT3’
119:
5’GAATTCTGCTTCACAATGATAGGAAGAGCCGACATCGAAGGATCAAAA
AGCGACGTCGCCTTGGATGTGGTAGCCGTTTCTCAGGCTCCCTCTCCGGA
ATCGAACCCTGATTCCCCGTTACCCGTGGTCACCATGGTAGGCGCAGAAA
GTACCATCGAAAGTTGATAGGGCAGACATCCGAATGTATCGTCGCCGTCA
CGGGGACGTGCGATC3’
120:
5’CCAATCCTTCAAGCCTTGTCGTACCGCCGAGTACAACTGCATCTCGGCG
CGCTGTTTAAAGCCTCGATCAATCAGCGCCTGAGACAACCCGAAGGACGA
GCCAGGGCTCGGATAAAAAGCCCTACGTATATGCTTGCCGTATTCGCCCC
CCACATTCAGGGATGCGATCGTTTTGATCAGGTAGCTCACACTCAAGCGT
TCTTTCCAGACGGGTTCCAGCCAGCGCGCCCGGTTCAAGCGCCAGCGGGT
CCAGGGCGCTTCAGGGTCGAGGTTGTGCAACGCCAATTGCAGCATGCTGA
AGGTGGTACGTTCCTTACTGACCACCGTTTTAATCTGACGATCACCCACCG
CCCCCTGGCTCGTCCAGCCCTCGTAGTGAGTGCTGACATCATCGGGCATG
TCGAACAGGGGGGTATCGATATCCAATTGCGGGTAGAAACCGTCCTCGGT
CAATTTGGCAATCAGGGCTTTGCGAGCAAAGGGCTCCAAGTCAGGCAAGT
CCTGCCAGAGTTTGGTTTCCAGTGCAAAAATGCTGACCAGATAGCGGCGT
AACAAACGCTTATAGTGTTTGCGCTCAGCGGGCGATGCGATGCCGAGCCA
AGAAGGGAGTTTTT3’
121:
5’TGCTGTTCACATGGAACCCTTCTCCACTTCGGTAGTCCCGCGTAAGCAA
GAGCACAATTCCATATTTTACATAATGAATTTATTGCACCAGCCCAAATTT
TCAGCTTGTCAATAACAGCAACGATCCAAACTTGTCACAGGGGGTCACCA
TCTTGGAAAGTGTCTGTGACACTCACATGCTCAGTGGGCTCTGATTGGCTG
TTGAGAAGCTAAGCTTAGGGCTCGTCACTAATTATCCAGCAGAAAATGAG
CTTCCCTGGCTGTAATATAAGCTGATGCTACAGGTTTGCTGATTATTAAAT
TCTGATGCTAATTGCACTGGTTTCTGTGCTGCCATGTAGTAATTATCTGTA
TTAATTACTAATCAGTCTTATATTGTGACATTTCTATTC3’
122:
5’GACGAAAGCCTGCTGCTGGACGCCCTGACCCAACTGGTGGTCAAGCAC
GGCATCCTGCGGGTCAAGGGCTTCGCGGCGATCCCGAACAAGCCGATGCG
CCTGTGCTCTTGCTTACGCGCCTCGAGGAATTCACTGGCCGTCGTTTTACA
ACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAG
CACATCCCCCTTTCGCCAGCTGGCGTAATAGCGAAGAGGCCCGCACCGAT
CGCCCTTCCCAACAGTTGCGCAGCCTGAATGGCGAATGGCGCCTGATGCG
GTATTTTCTCCTTACGCATCTGTGCGGTATTTCACACCGCATATGGTGCAC
TCTCAGTACAATCTGCTCTGATGCCGCATAGTTAAGCCAGCCCCGACACC
CGCCAACACCCGCTGACGCGCCCTGACGGGCTTGTCTGCTCCCGGCATCC
GCTTACAGACAAGCTGTGACCGTCTCCGGGAGCTGCATGTGTCAGAGGTT
TTCACCGTCATCACCGAAACGCGCGAGACGAAAGGGCCTCGTGATACGCC
TATTTTTATAGGTTAATGTCATGATAATAATGGTTTCTTAGACGTCAGGT3’
123:
5’CNCGATNCGNGCCCAANCNCATGCNAAACTCGCTGTTGATCTTCNTCNC
GGNTGAAATGGNAATNNAATAATCTTCCATTACAAGATCNTAAGTCCCGN
CACCCCCTGGGCATTCCCTCTAGCAGGTCTTGCTTCACAACTTCGACAGCA
CCGGACAGTCCGGCTTCCTCAACACNCCTACGTGTGCTCTTGCTTACGCGC
C3’
124:
5’TACGTTCGTTAACTTTTCAGACGCGGGTCCAGCCATACCAACACAAGGG
TGGAGAGCGAACACATCAACAAAATGCCGACGAACCAAAGTAAATACCA
CATTGTTTCTGCTCCTTAGTACAACTCGTTTTCGTTACGGCGGAGAGTTTC
TGTTGTCATGCGCCCCCACATTTTGTAGTAGCTCCAGAGAGTGTAGAGCA
ACACAATGGGCAAAAATATCAGCACGATTACCAACATAATGCTCAGCGTC
AGCTGACTGGAAGTACTGTCCCACAACGTCAGGCTGGAGATCGGACTCAC
GCTTGACGGCATGACAAAGGGGAACAGCGTGATGCCTGCCGTGAAAATC
ACGCCAAATTGCACCAATGATGCCATCAAAAATCCCCAACCCGGGCGACC
ACGATAAATCGCCATCACCGTAAGCAATGGGCAGAAGAATCCCAGCAGC
GGGAAGATCCAC3’
126:
5’GCACGTTCGTGGGGAACCTGGTGCTAAATCATTCGTAGACGACCTGATT
CTGGGTCAGGGTTTCGTGCGTAGCAGAGCAGCTACCTCGCTGCGATCTAT
TGAAAGTCATTAGTCCACGC3’
128:
5’TCGGACCCACGCCTCGCGTTTTGAAAGCAACATGCTTGGTCTATTCTCGC
ATCGCAGATACGGCACCTGTATACGTCTATGTAGCCAATGACGGACCTAA
GCCTCATGTAATGTCACAAATCTCTTGCTCACCACCCAACACAGCCTACA
CCATTACGCCGAATCCAAACGCCCCCAAAAAGGGACAAATCATGGAACA
CAGAAGGAAGGACGTTGAACGCGGGGGTGTGTGTAGGAGCAGAGGTCAG
AAAGCAATGACACTGTGCTAGTGGCTTGTCAGCAGCCCAGGTCGTTTTTT
GGAGCCGATGGAATCCACCAGTCCG3’
130:
5’GCCGTGGACCGTGCCGTGCGCCGCAAGGAAGCCGTGGTGTTCTTTGGTT
GGGCGCCGCACCCGATGAACGTCAACGTCGAGATGACTTACCTCACCGGC
AGCGAAGACGCCCTGTTCTCTTGCTTACGCGTGGACTACCGACTGCACGC
GGGTGTTGAAGCTGATGTCACGGCTCAAGTCCAGCTTGCGGTCCACGAAG
TGGAAATATTCGCGCATCTGCCCCCAGTCGGGGAAGAGCTCTTTCCAGTT
GTACTCCTGCCACAGTTCGGGGATCGAGTACTGATAGATTTGGCAGTGCG
TATCCACCCGGGCGCCGGGATAGCAGTTCCAGTGCCAGATTCCGCCAACA
TCGCTACCGGCATCCAACAGATGCACTTTATAGCCGCGTTTGCGGAGGTG
ATAGAGTTGGTACAGACCTGAGAAGCCTGCGCCGATGAGCAGGACGTCG
AGCTTCTCGTTGACCGAGTTGTTCATGCCTTTGCTGTTCATGTCGCGTTTCC
CCTTGAGGGTTATAGTTGGAAGGGTAGCATTGTTTTCCGCCGTCTCGACGA
TGCGGACTCACTGTCGATGATCGCGTCTCGATAAGCCGCGTACGCTTAT3’
132:
5’GGGTCTGGGCATGCATTTGCTGCCAGCCACAAAAGCCATTCCTAAAGAG
ATGCTACCGATCGTCGACAAGCCGATGATTCAATACATCGTCGATGAGAT
TGTTGCTGCAGGTATCAAAGAAATCGTCCTGGTTACACATTCTTCCAAGA
ATGCAGTAGAGAACCACTTCGACACCTCTTATGAACTCGAAGCGTTGCTT
GAGCAGCGCGTAAAGCGTCAGCTGCTGGCGGAAGTTCAGTCTATCTGTCC
TCCTGGCGTGACCATCATGAACGTGCGTCAGGCGCAGCCGCTGGGTCTGG
GGCACTCCATTTTGTGCGCTCGCCCGATTGTCGGTGACAATCCGTTTATCG
TGGTACTGCCGGATATCATTATCGATAGTGCTTCTGCAGATCCGCTGCGT3’
136:
5’TGGTCTTCGGCGGAAGTGTTTTCGTGTTCGGTAGCCATTACATGTCCTCG
GCGCAGCAAACAATCATGAATTAGGGTTGAATCAGCGGCGGTTGATCGGC
TCAACCACTTGCAGCGCCAGGTTGCCCTTGTGGGAACCGAGCTTGACCTT
GAATGACGGCACGCCATTGGCGCGCATGATCAACTCTTCCGGCAAGTCGA
CGGGGATGATGTCCCCAGGCGCCATGTGCAAAATGTCCCGCAGGCGCAAC
TGGCGGCGGGTAGTCCACGCGTAAGCAAGAGAACATATTCAAACGAGAA
CTTTGAAGGTAGTCCACGCGTAAGCAAGAGCACACGCACCCGACTCTGCA
CGAGTCTGTGGTTAGTCCACGCGTAAGCAAGAGCACAGACAATGAATCAT
TGATATCGCGGTCTGGCGTAGTACCGCGTCAAGCTCGCTGCACAACACGA
CTGCACGTACCTTTGCGCTGTTGCTGGCATGACGCAGGAAAGCCAGCCCA
TCCATTCCTGACATTTTCAGATCGCAAAGAAGAATATCCACATGAGTGCT
GGCAGCCAGGATAGCCACGGCTTCGGCGCCATCCGCCGCTTGAAGAACCG
G3’
139:
5’TCATGTTACACAATACATGTATGTTTTGTTTGATAAAGTTCATATTTATC
CAAATATGAGTTTACATTGGCGCGTTACATTCACTAGTTCCAAAAACAAC
CCGTGATTTTGCATCGCCACATCATTCAACAGAAATACTCATCATAATTGT
AGATGATAATACAAGTTATACACATGGAATTATAGATATACCTCTCCTTA
ATGCAACCGCTGNGTCTGATTTCAAAAATACTTTACAGAATAAGCCAGCC
ATGCAATAATCTGAGACGGCGCTCAGAAATATTTGTCACNATAGCCGCCA
TCTTGACGTCAACATAAACAAGAAATGACATGATAAATATTCCCTTACCT
TTGATGATCTATATCAGAAAGCACTCCAGGAATCCCAGGTCCACAATACA
TGTTTGTTTTGTTCGATAATGTCCAAATACCTTATTTTGTTAGCGCGTTTGA
TATACATATCCAAACGCTCATTCTGGTCAGCGTTATATCCGACAAAAACG
TTAAAAAGTTATATTACAAGAAACATTTCNAACTAAGTACAGAATCAATC
ATTAGGATGTTTTTAACATATAGCTTCAATAAAGTTCCAACCCGAGTTCTC
CCTTCTTACCATGAAGAATAAGCATGGATCAAGAAAATGGCTGGACT3’
142:
5’GGGTGAAGAAGGGCGACAAGATTTTGGTCAAGTCCACCGGCAAGATCC
ACCTGGTGGACAGCGTCGGTGTATTCAACCCGAAACACACCGCCACCGTT
GACCTGAAAGCCGGTGAAGTAGGCTTCATCATCGCCGGTGTCAAGGACAT
CCATGGTGCGCCGGTCGGTGACACCCTGACCTTGAGCTCCACCCCTGACG
TCGATGTGCTGCCGGGTTTCAAGCGCATCCAGCCTCAGGTCTATGCCGGT
CTGTTCCCGGTCAGCTCCGATGACTTCGAAGATTTCCGCGAAGCCCTGCA
AAAACTGACCCTCAACGACTCGTCGTTGCAGTACACCCCGGAAAGCTCCG
ACGCCCTGGGCTTCGGCTTCCGCTGCGGGTTCCTGGGCATGCTGCACATG
GAAATCATCCAGGAGCGCCTTGAGCGCGAATACGACCTGGACCTGATCAC
CACTGCACCGACCGTTATTTTTGAGCTGGCGCTGAAAACCGGTGAAACGA
TTTACGTCGACAACCCGTCCAAGCTCCCAGACCTGTCTTCCATTGAAGAC
ATGCGCGAGCCCATCGTGCGCGCCAATATCCTTGTGCCGCAGGAACACCT
GG3’
143:
5’TATATTTTTAGAGAGACCTACTTGTTTGAGGGGTATAGTTTTCCTTTAAG
TCTACTAGAAAATCATGTAAACATTAAATAAACCCAATAGGCTGGTTTTG
CTTCCAATAAGGGTGAATTATAACTTAGTTTGGATCAAGTACAAGGTATT
GTTTCATTATAACAGAGAGAAAGGGAATTGTTTTTAAAAATGAGTCTATG
GGGAATATTTATCAAAGAGTGAAGTTAGAGATCACCACAG3’
144:
5’TCGATCAGAAGGACTTGTGCTCTTGCTTACGCGTGGACTAGTACTCAGT
ATTCGTGTCGTGTATAAACTTTAGTCTATGTATATTGCCTCGTAAACCAAG
AACCCAAGCCTACAAAAGTGAGTAGGGGTACTATCGTAAAGGATATATA
ATCCATTTATTTTTTAAAAACAACAGTCATTTTCGAGAAACATAAATGCGC
TTATAAATTGGAAAGACATAAAGAAAATAAAACAAAAATAAACATTTGTT
CTCTTCCACTGTCTTGTCTAATGTCTATAGAGTAAAGAGATAGAGACGAC
GTTGCAGTATCTCTCTCTCTCACACGATCAAGAAAACTCTCACGTTCACTG
GAGAAAACTATTATTCCGGTAAGATCTATTCAAATGGAGGATTCTAGAGC
TTTTCCTTTCGCCGGGAATCTAGACCCTCGAGCTCAAGCGTTCGTACCACT
AAACCCTATGTCTTCACGTTTTTACTTTCCGTACACTTCCCTGCCACCGCC
GCTTCTGCCACCTCCTCCGTCGGATCCAAGGATGTTCACGTTCTTTAATAT
CCCACCACATCCGATGAT3’
146:
5’AATAACAGGTCTGTGATGCCCTTAGATGTCCGGGGCTGCACGCGCGCTA
CACTGAACGGATTTNCGTGTGTCTACCCTGCNCCGACAGGTGCGGGTAAC
CCGCTGAACCCCGTTCGNGATAGGGATCGGGGATTGCAATTATTTCCCAT
GAA3’
148:
5’ACCTGCGTTCTCATCAGNACCTGGTGGCTTCGGTGTGGATGGGGCTGGG
TATCGCGTTNATGCACTACGTGGGCATGTCAGCCATGCGTTCCAGGTAGT
CCACGCGCCTCGAGGAATTCACTGGCCGTCGTTTTACAACGTCGTGACTG
GGAAAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACAT3’
153:
5’GGGGTTTTCTGAATGCTGCTGCGAAAGCCGACCATGCCGAAGCTGACGC
TGTCCAACTCGCCGCGCTCGGCAATGCGGGTTTGCAGCTCATGTGCTCTTG
CTTACGCGTGGACTAACTGAGCAGGATTACTATTGCGACAACACATCATC
AGTAGGGTAAAACTAACCTGTCTCACGACGAGAGGAACCGCAGGTTCAG
ACATTTGGTGTATGTGCTCTTGCTTACGCGCCTCGAGGAATTCACTGGCCG
TCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACCCAACTTAATC
GCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGT3’
161:
5’CGAGGCGCGTAAGCAAGAGCACATACACCAAATGTCTGAACCTGCGTA
GTCCACGCGAAGCAAGAGCACACCGCCACAAGCCAGTTATCCCTGTGGTA
ACTTTTCTGACACCTCCTGCTTAGTCCACGCGTAAGCAAGAGCACAGCAT
GGCGGTGCCGGGGGCGATGCCCACCAGCGCGGCGAACTCGTCCGAGGCA
TTGATCGCCTGGATGTGCTGCAAGGCGCGCACGATGGGCTTGCCGATGCT
TTCCAGGTATTCGTACAACGAATTGCCGATGGTAGTCCACGCGTAAGCAA
GAGCACATACACCAAATGTCTGAACCTGCGGTTCCTCTCGTAG3’
164:
5’AAATTTTTCAGACAAGCGGAAAAAAAAAGGATAAATAAATTTAAATCA
GCCCAATAGGAGCAGCGCAGCTCACATTGACTTCTAAAGGACCTCCATAA
CTTTTACTTGATAACATTTTGTATTAGAGGTTTTCATGGTTTTTGCACTTAG
GGGGTTATCTATTAAAGTCAGAATGCCAAAAACGTGAAAAATCTTAATTT
TACTATAAAATCTGAATTTTTAGTGGAAAAAAAAACCCTTGAATTTTTTTT
GATGATTTTGATTTATTATAACCTGAATCTGAAAAAAAAATCTCCAAGTG
GTCGGGGTCCTGTAGAAGTCAATGGCAAAGGTCCAATTTCAAATTTGACG
ATATCCTGGTCTGCGCAGAGTTTTGGACAAAAATTTCAAAAAAAAAAAAC
GGGGGTTTCGATCGATATCGCATTTGCAGGCATAAAACTCCAAAATTTGG
AAAAACGCTAATTTTTAGAGTTTTTTTCCAAACCGATTTTATCAAGTTTTTT
CAATCATAAATAAGGTCAA3’
168:
5’GCGCCTCGAGGAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGA
AAACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGC
CAGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGT
TGCGCAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGC
ATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCT
CTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGAC
GCGCCCTGACGGGCTTGTCTGCTCCCGGCATCCGCTTACAGACAAGCTGT
GACCGTCTCCGGGAGCTGCATGTGTCAGAGGTTTTCACCGTCATCACCGA
AACGCGCGAGACGAAAGGGCCTCGTGATACGCCTATTTTTATAGGTTAAT
GTCATGATAATAATGGTTTCTTAGACGTCAGGTGGCACTTTTCGGGGAAA
TGTGCGCGGAACCCCTATTTGTTTATTTTTCTAAATACATTCAAATATGTA3
’
170:
5’GGAGACTATAACTCAGGATTAATAGGTCATTTTAAACCTTTAAGTCACG
CAATGTTTTCGCAGCATGAGATGGTGGAGGAAATCGGTTCAATGTTCGAG
TTGGACCTGTGGGGGGGCAATTCCCTTGATGCGTCTCAATGGGAAGCCTA
CTGTAGGATTGTGCTGATGACGTACAAGGACAAGGTTAACAGCGACTTCT
GGGGTAGTTCAAGATCTCTTTGGCATGCCTTTGATAATATTGAGAGCATG
GTTAGCGACTTATATAGACTTAACGGAGTTGTCGATTATTCAATAAATGAT
GATTCAATAAAAAAATTGCGCGTTGCAGTGAGTTTTATACAGAGCATTAT
AGCCGCATTAGAAACTCTTGGTGTTCCTAAGCATTTGACACTTAAGAAAG
ACGGCGTAGTTGGAAATCACTACGATCAAATTGCAAATTTAATTTTTGAG
ATTATTCAAAGGGCTGCTGCAATCAAGGAGCCTTGGGCGCTGGCATGGTG
GATACACCACAACACATTATGGGGAGAAATATTCGGCGCATTTTCTTCTA
AAGGACCGGCGGCTAAGATTATTATGTTTAAGTTTAGACGCCTTGTCTATG
AAGAGTTCAAAAGAATGGAAGAATTTCCAAATTTCAAAGGAGCGAAATT
CGCAGGGT3’
171:
5’CNCTAGAGGATCCCTCGAGGCGCGTAAGCAAGAGCACATAGTCCACGC
GTAAGCAAGAGCACACTCCTTAGCGGATTCCGACTTCCATGGTAGTCCAC
GCGCCTCGAGGAATTCACTGGCCGTCGTTTTACAACGTCGTGACTGGGAA
AACCCTGGCGTTACCCAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCC
AGCTGGCGTAATAGCGAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTT
GCGCAGCCTGAATGGCGAATGGCGCCTGATGCGGTATTTTCTCCTTACGC
ATCTGTGCGGTATTTCACACCGCATATGGTGCACTCTCAGTACAATCTGCT
CTGATGCCGCATAGTTAAGCCAGCCCCGACACCCGCCAACACCCGCTGAC
3’
172:
5’TGCGTTTGGCAACCACCACTTCACCGTCACCCACTGAAAGCACTGGCGT
ACCCTGCGGCATGGCGAAATCAACACCTCTGTGTGGTGCAACGCGACCGG
TCACCGGATTAGTACGACGCGGGTTAAAATTAGACGAGATACGGAACTGT
TTCGCCGTCGGGAATCGCAAGAATCCTTTCGCCAGACCAGTACCGTTACG
ATCGTAGAATTTGCCATCTTCAGCGCGGATAGCGTAATAATCTTTACCTTC
TGAACGCAAACGTACGCCCAGCAGCTGGCTTTGCTCACGTTTACCATCAA
GCATTTCTCGAGACATTAACACCGCAAATTCATCGCCTTTTTTCAGTTTGC
GGAAATCCATTTGCCACTGCATGGCTTTAATCACTGCGCTCACTTCGGCGC
TGGTTAAACCGGCGTTTCTGGCGCTGGCAACAAAGCTTCCCCCGACGGTA
CCTTTCAGCAGATTGTTAACCCACTCTCCTTGCTGCATTTCGCTGGTCATTT
TAAAACCGTTAGCGGCAGTACGGTCATAGGTTCGGGTTTCACGACGAGAC
ACTTCCCAGGTGAGGCGCTGCAGTTCGCCGTCCGCGGTTAATGTCCAGGA
GAG3’
176:
5’TGCAAAGAGTGTACCACTGTAGCTAGATGCAGAAGCTGGAATAATGTTA
ACTGTACTAGCCACTTTACTATGATGTTTATTGGTTTTGTTAGTGCTTGGTT
CAAAGTTCCATAGGCTTTGAGTCATCTGCCCCCAAATCTGTTTTTTCCACA
AGCCCTGATATTTTTAGCATACAATTTTGTAGAACTATGGTTGTAGCTAGA
ACGCCTGTATTTTATTTTCACACAGCAGCCAAAGCACCTGTGTGACCCAG
AGAAGGGTAGTGTCCTGGAGAGGGGTCTTAGAAGGTTGTTAGAAGGAATT
GTAATTGGGTTTGCAGCGGCATCTAGAGGAAATGGCTCCTGATGTGATCT
GTTTCTTGGCATTAAAGGGTCTCTGGCTTGGAGAAAGGCAATGCATCAAG
CTATAGTAATTTAATGGGAAAGGAGAGAAAAAAAACAGTAAAGAATATT
TAGTTCCCTCATTTCTAATTATGTGTTCCTTCTGTAATCTTCTAATCCAGGG
TTGGTATATAGAATTCCTCTCAAATGCCAACTCCAATTGACTGGTGGTGGC
TGCCTGAGGCACGGAAGAGAGAAGGATGCTGAGACCCTGTTGGGCTTCCT
GGAAAGAATGCCACAATTGATTAGTGATGTCTGTCAGGAGTTGCTGCACC
TGTGTCACCCCCATAA3’
177:
5’CATGCGCTGAACATGTTTCCTCAAAAAGTGCTGCCGGATCATCTCCAGT
GATGGTGAACGCACTTTCATAAATCAAGATCGGCAGGAGAGGGTTATTCG
GCACCCAGTCATTTGATTTGAGCATCAATGTCTTCAGGTTACTTACCAACT
GGCGAGTATCTTTCATCTAAGCATCTCCCGCATGGGCAATCACATCGCTTG
AATGTAGGACGGATAGCAGGATCCCATATTCCTACATGGGGTTGAGCCAA
GGTGAACATTCATTCCCCACTCTAGAGCGGGTTAGGGTCGCCCCAGATAA
TTTAAACCTTCTGCATGAGCGCAGTGTCGATTGCTGAAGGCTCTGTGCCAG
GCTGAGGGAATGTCAATGATAGGGATCGTGATACCTGCCCATAACGAAGA
AAGGCTTATAGGCGATTGCCTGAACGCCGTGGTGATTGCCGCTGAGCATC
CTTCTCTTCAAGGGCAACCGGTCGAGATACTCGTCGTATTGGATCATTGCT
CCGACAACACGGGAGCAGTGGTAACAGCGAAGGGGATAACGTCGGTAGA
TGTCTGCTTTCGAAACGTGGGTAAGGCAAGANCCGTTGGGGCTGAGCAGT
TACTTAAAGCAGGTGCTCGGTGGCTCGCATTCACGGA3’
178:
5’GGCTTGCCCGCCGACCAGCGTGACGAGGTCATGAAACGCGGATCGCGG
CTGGATGAAAGCGCGCCGGGTTCGGGGCTGTTCTCTTGCTTACGGCGTGG
ACTATGTGCTCTTGCTTACGCGTGGACTACCGGATTCCACCAGGGGCGGG
CTGTCGAGGTCGACGCTCAAGCGCTCGGTGTGCTCTTGCTTACGCGCCTCG
A3’
181:
5’TTACACCAATAAAGATCTGGTTAAATACGTTGATATTGGTGCGACCTAC
TACTTCAACAAAAACATGTCCACCTATGTTGATTACAAAATCAACCTGCT
GGACAACGACGATGACTTCTACGAAGCAAACGGCATCGCTACCGATGAT
ATCGTTGCTGTGGGCTTAGTCTACCAGTTCTAATCAGTCAACTCGCTGCGG
CGTGTTACTGTAAAACTGAACACTAGCCTGAGTTCGTCCCTCATCGAACTC
AGGCTTTTTTATTGGCATCTCATCTCCATCTGCGGCACACGCAATTGCCGA
AGCATATCGATACAGCACCTTACCCTGCCCCTCCTGGCACAATAACATCA
ACCAGCTACTCTTCAAGCTAACACCCAAATGCATTTCTTTATGAATTAATC
CGTAACAAACACGCTTCCCATATAGAAATATTTGCAAAAATAGTGCATGA
AATAAGCTTTTTCTCTACCAATCCGGGATATAAATATTCATCAGCACC3’
183:
5’AGTTTGCCCATCGAATTTGCGCGAGTCGGTGATGGTGGAGAGCTCGCAA
CGGCAATCTGCGCGAATGCGCATCCATGCGCTGTTCTATGGGCAGTGTTG
AATGTAAAAAACCTGGAAGAGGCATGCGAGATAGTCCACGCGTAAGCAA
GAGCACAGTTTTGTCCGTCACGCCCCAGAACATCCGTGCAACGCTGCTGC
TGCGCCAGGAGATCGCGCTGCTCGACGTCAGGCACGAGGCGGAATTCGCC
ACC3’
184:
5’TCCCGAGCCATTGGCTGCCAGTCCAATACTGTTTAGAGGTATAAAGGTA
TTTTCTGTCAGGGCTGAAGTTTCCAGCGGAGTTACTGGTGCTGGTATGGGG
GACTGCAATGCTAGCAATGACTTCATCGCTATTTGTGTTAACCACCAAAA
GGCTGTCCTGCCCCGTTACGCATATTCTCTGTCCGTCTGGTGAGCACGTAA
TAGCGGTCTGTGCAACGCCAATGATTATTTCTTTCATGGCACCAGTGGTTA
AGTCAACTTTTACCAGTCGATTGATATTTGTCACGCAAACGTAGGCATAC
AATCCGTTCGGCGTGATAGCAATGCTGCCCGGACTCCCTCTGAAATTAAA
CACCGACCCCGCTGGTAACAACGACTTGACATTAACTTCGCTCCTGGCGG
AATAACCACCACTGTTTGCCCTCAACTCATAAGCCCCCACTTCCCCGGCGC
TGCGAATGCCCTCAACCGTCAACGCTCCATGCTCATCCGAAAGAAACGCC
TTGGTCCCGGTCGTCCCATCGTCAAAGGTAAAACC3’
185:
5’AGTCAGGAAGTGCGTGGGCGTCGCCAGAGCAGCAGAGAGCAGAAGGA
AGACGGAGGAGCTGGTAAGTTGCTTCTTTTTGCGATTTTAGGTCGATCCTG
CAACAATCCTGTGCTCTTGCTTACGCGCCT3’
186:
5’ACTGGCCGTCGTTTTACAACGTCGTGACTGGGAAAACCCTGGCGTTACC
CAACTTAATCGCCTTGCAGCACATCCCCCTTTCGCCAGCTGGCGTAATAGC
GAAGAGGCCCGCACCGATCGCCCTTCCCAACAGTTGCGCAGCCTGAATGG
CGAATGGCGCCTGATGCGGTATTTTCTCCTTACGCATCTGTGCGGTATTTC
ACACCGCATATGGTGCACTCTCAGTACAATCTGCTCTGATGCCGCATAGTT
AAGCCAGCCCCGACACCCGCCAACACCCGCTGACGCGCCCTGACGGGCTT
GTCTGCTCCCGGCATCCGCTTACAGACAAGCTGTGACCGTCTCCGGGAGC
TGCATGTGTCAGAGGTTTTCACCGTCATCACCGAAACGCGCGAGACGAAA
GGGCCTCGTGATACGCCTATTTTTATAGGTTAATGTCATGATAATAATGGT
TTCTTAGACGTCAGGTGGCACTTTTCGGGGAAATGTGCGCGGAACCCCTA
TTTGTTTATTTTTCTAAATACATTCAAATATGTATCCGCTCATGAGACAAT
AACCCTGATAAATGCTTCAATAATATTGAAAAAGGAAGAGTATGAGTATT
CAACATTTCCGTGTCGCCCTTATTCCCTTTTTTGCGGCATTTT3’
